


    
<!DOCTYPE html>
<html lang="en" class="no-js">
<head>

    
            
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />

    <!-- Meta Tags for Parse.ly -->
        
    
  
  
          
    
<meta name="parsely-title" content="Why Is Cancer Drug Revlimid So Expensive?" />
<meta name="parsely-link" content="https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma" />
<meta name="parsely-type" content="post" />
<meta name="parsely-image-url" content="https://img.assets-c3.propublica.org/images/articles/20250506-revlimid-lead-og.jpg?crop=focalpoint&amp;fit=crop&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=630&amp;imgixProfile=propublicaAssets&amp;q=90&amp;w=1200&amp;s=9e7f0c54edd2b9007de2f93dbfa9efd9" />

<meta name="parsely-pub-date" content="2025-05-08T05:00:00-04:00" />

<meta name="parsely-section" content="National" />
<meta name="parsely-author" content="David Armstrong" />
<meta name="parsely-tags" content="lang:en,storytype:enterprise,topic:Health Care" />
            <!-- Meta Tags for True Anthem -->
            <meta name="socialpost1" content="Cancer drug Revlimid is one of the bestselling pharmaceutical products of all time, with total sales of over $100 billion. It’s also extraordinarily expensive, costing nearly $1,000 for each pill, even though that pill costs just 25 cents to make." />
                    <meta name="socialpost2" content="Revlimid’s nearly $1,000/pill price tag has put the cancer drug’s lifesaving potential out of reach for some patients, who have been forced into debt or simply stopped taking it. The price also helps fuel Americans’ ballooning insurance premiums." />
                    <meta name="socialpost3" content="The price of cancer drug Revlimid has been hiked 26 times. Until now, no one has pieced together the full account of how regulators failed to rein in drugmaker Celgene and what Revlimid’s story reveals about unrestrained drug pricing in America." />
                    <meta name="socialpost4" content="“When I started taking the drug, I’d look at the smooth, cylindrical capsule in my hand and consider the fact I was about to swallow something that costs about the same as a new iPhone. A month’s supply ... is the same price as a new Nissan Versa.”" />
                    <meta name="socialpost5" content="Revlimid has its origin in a pill that cost patients $7.50 each. Decades later, the cancer drug costs more than $18,000 for a month’s supply — even though it still only costs about 25 cents to manufacture." />
            
    <!-- Critical JS -->
    <script>(function(H){H.className=H.className.replace(/\bno-js\b/,'enhanced')})(document.documentElement)</script>
    <script>(function(win,undefined){win.PP=win.PP||{};win.PP.utils=win.PP.utils||{};var PP=win.PP;// loadJS: load a JS file asynchronously. Included from https://github.com/filamentgroup/loadJS/
function loadJS(src,cb){"use strict";var ref=window.document.getElementsByTagName("script")[0];var script=window.document.createElement("script");script.src=src;script.async=true;ref.parentNode.insertBefore(script,ref);if(cb&&typeof cb==="function"){script.onload=cb}return script}PP.utils.loadJS=loadJS;// cookie function from https://github.com/filamentgroup/cookie/
function cookie(name,value,days){// if value is undefined, get the cookie value
if(value===undefined){var cookiestring="; "+window.document.cookie;var cookies=cookiestring.split("; "+name+"=");if(cookies.length===2){return cookies.pop().split(";").shift()}return null}else{var expires;var domain;// if value is a false boolean, we'll treat that as a delete
if(value===false){days=-1}if(days){var date=new Date;date.setTime(date.getTime()+days*24*60*60*1000);expires="; expires="+date.toGMTString()}else{expires=""}if(location.hostname.endsWith(".propublica.org")){// Cookie set on www.propublica.org can be read on
// projects.propublica.org (and vice versa)
domain="; domain=.propublica.org"}else{// Cookie limited to current hostname
domain=""}window.document.cookie=name+"="+value+expires+domain+"; path=/"}}// expose it
PP.utils.cookie=cookie;// basic logging function
function log(logLine){const logOn=new URLSearchParams(window.location.search).get("__pp-debug");if(logOn!==null){console.log(logLine)}}// expose it
PP.utils.log=log;// generic event throttler using requestAnimationFrame
function rafEvent(type,name,obj){obj=obj||win;var running=false;var func=function(){if(running){return}running=true;requestAnimationFrame(function(){obj.dispatchEvent(new CustomEvent(name));running=false})};obj.addEventListener(type,func)}PP.utils.rafEvent=rafEvent;PP.utils.rafEvent("resize","rafResize");PP.utils.rafEvent("scroll","rafScroll");// Create a series of breakpoints corresponding to the ones in css/config/_column-settings.scss
//
// Usage:
//
// 1. Check if breakpoint condition matches
//    if (PP.utils.aboveBreakpoint("lg").matches) { console.log("Is Desktop"); }
//    if (PP.utils.belowBreakpoint("lg").matches) { console.log("Is Mobile"); }
//
// 2. Listener that triggers when breakpoint condition changes
//    aboveBreakpoint("lg").addEventListener("change", function () { console.log("Mobile/Desktop breakpoint changed."); });
const breakpoints={xs:0,sm:36,md:48,lg:60,xl:78,xxl:88};PP.utils.breakpoints=breakpoints;function aboveBreakpoint(value){return window.matchMedia(`(min-width: ${PP.utils.breakpoints[value]}em)`)}function belowBreakpoint(value){return window.matchMedia(`(max-width: ${PP.utils.breakpoints[value]}em)`)}PP.utils.aboveBreakpoint=aboveBreakpoint;PP.utils.belowBreakpoint=belowBreakpoint})(this);;(function(){var undefined;var VERSION="4.17.5";var FUNC_ERROR_TEXT="Expected a function";var NAN=0/0;var nullTag="[object Null]",symbolTag="[object Symbol]",undefinedTag="[object Undefined]";var reTrim=/^\s+|\s+$/g;var reIsBadHex=/^[-+]0x[0-9a-f]+$/i;var reIsBinary=/^0b[01]+$/i;var reIsOctal=/^0o[0-7]+$/i;var freeParseInt=parseInt;var freeGlobal=typeof global=="object"&&global&&global.Object===Object&&global;var freeSelf=typeof self=="object"&&self&&self.Object===Object&&self;var root=freeGlobal||freeSelf||Function("return this")();var freeExports=typeof exports=="object"&&exports&&!exports.nodeType&&exports;var freeModule=freeExports&&typeof module=="object"&&module&&!module.nodeType&&module;var objectProto=Object.prototype;var hasOwnProperty=objectProto.hasOwnProperty;var nativeObjectToString=objectProto.toString;var Symbol=root.Symbol,symToStringTag=Symbol?Symbol.toStringTag:undefined;var nativeMax=Math.max,nativeMin=Math.min;var realNames={};function lodash(){}function baseGetTag(value){if(value==null){return value===undefined?undefinedTag:nullTag}return symToStringTag&&symToStringTag in Object(value)?getRawTag(value):objectToString(value)}function getRawTag(value){var isOwn=hasOwnProperty.call(value,symToStringTag),tag=value[symToStringTag];try{value[symToStringTag]=undefined;var unmasked=true}catch(e){}var result=nativeObjectToString.call(value);if(unmasked){if(isOwn){value[symToStringTag]=tag}else{delete value[symToStringTag]}}return result}function objectToString(value){return nativeObjectToString.call(value)}var now=function(){return root.Date.now()};function debounce(func,wait,options){var lastArgs,lastThis,maxWait,result,timerId,lastCallTime,lastInvokeTime=0,leading=false,maxing=false,trailing=true;if(typeof func!="function"){throw new TypeError(FUNC_ERROR_TEXT)}wait=toNumber(wait)||0;if(isObject(options)){leading=!!options.leading;maxing="maxWait"in options;maxWait=maxing?nativeMax(toNumber(options.maxWait)||0,wait):maxWait;trailing="trailing"in options?!!options.trailing:trailing}function invokeFunc(time){var args=lastArgs,thisArg=lastThis;lastArgs=lastThis=undefined;lastInvokeTime=time;result=func.apply(thisArg,args);return result}function leadingEdge(time){lastInvokeTime=time;timerId=setTimeout(timerExpired,wait);return leading?invokeFunc(time):result}function remainingWait(time){var timeSinceLastCall=time-lastCallTime,timeSinceLastInvoke=time-lastInvokeTime,timeWaiting=wait-timeSinceLastCall;return maxing?nativeMin(timeWaiting,maxWait-timeSinceLastInvoke):timeWaiting}function shouldInvoke(time){var timeSinceLastCall=time-lastCallTime,timeSinceLastInvoke=time-lastInvokeTime;return lastCallTime===undefined||timeSinceLastCall>=wait||timeSinceLastCall<0||maxing&&timeSinceLastInvoke>=maxWait}function timerExpired(){var time=now();if(shouldInvoke(time)){return trailingEdge(time)}timerId=setTimeout(timerExpired,remainingWait(time))}function trailingEdge(time){timerId=undefined;if(trailing&&lastArgs){return invokeFunc(time)}lastArgs=lastThis=undefined;return result}function cancel(){if(timerId!==undefined){clearTimeout(timerId)}lastInvokeTime=0;lastArgs=lastCallTime=lastThis=timerId=undefined}function flush(){return timerId===undefined?result:trailingEdge(now())}function debounced(){var time=now(),isInvoking=shouldInvoke(time);lastArgs=arguments;lastThis=this;lastCallTime=time;if(isInvoking){if(timerId===undefined){return leadingEdge(lastCallTime)}if(maxing){timerId=setTimeout(timerExpired,wait);return invokeFunc(lastCallTime)}}if(timerId===undefined){timerId=setTimeout(timerExpired,wait)}return result}debounced.cancel=cancel;debounced.flush=flush;return debounced}function throttle(func,wait,options){var leading=true,trailing=true;if(typeof func!="function"){throw new TypeError(FUNC_ERROR_TEXT)}if(isObject(options)){leading="leading"in options?!!options.leading:leading;trailing="trailing"in options?!!options.trailing:trailing}return debounce(func,wait,{leading:leading,maxWait:wait,trailing:trailing})}function isObject(value){var type=typeof value;return value!=null&&(type=="object"||type=="function")}function isObjectLike(value){return value!=null&&typeof value=="object"}function isSymbol(value){return typeof value=="symbol"||isObjectLike(value)&&baseGetTag(value)==symbolTag}function toNumber(value){if(typeof value=="number"){return value}if(isSymbol(value)){return NAN}if(isObject(value)){var other=typeof value.valueOf=="function"?value.valueOf():value;value=isObject(other)?other+"":other}if(typeof value!="string"){return value===0?value:+value}value=value.replace(reTrim,"");var isBinary=reIsBinary.test(value);return isBinary||reIsOctal.test(value)?freeParseInt(value.slice(2),isBinary?2:8):reIsBadHex.test(value)?NAN:+value}lodash.debounce=debounce;lodash.throttle=throttle;lodash.isObject=isObject;lodash.isObjectLike=isObjectLike;lodash.isSymbol=isSymbol;lodash.now=now;lodash.toNumber=toNumber;lodash.VERSION=VERSION;if(typeof define=="function"&&typeof define.amd=="object"&&define.amd){root._=lodash;define(function(){return lodash})}else if(freeModule){(freeModule.exports=lodash)._=lodash;freeExports._=lodash}else{root._=lodash}}).call(this);;/*! lazysizes - v5.3.2 */!function(e){var t=function(u,D,f){"use strict";var k,H;if(function(){var e;var t={lazyClass:"lazyload",loadedClass:"lazyloaded",loadingClass:"lazyloading",preloadClass:"lazypreload",errorClass:"lazyerror",autosizesClass:"lazyautosizes",fastLoadedClass:"ls-is-cached",iframeLoadMode:0,srcAttr:"data-src",srcsetAttr:"data-srcset",sizesAttr:"data-sizes",minSize:40,customMedia:{},init:true,expFactor:1.5,hFac:.8,loadMode:2,loadHidden:true,ricTimeout:0,throttleDelay:125};H=u.lazySizesConfig||u.lazysizesConfig||{};for(e in t){if(!(e in H)){H[e]=t[e]}}}(),!D||!D.getElementsByClassName){return{init:function(){},cfg:H,noSupport:true}}var O=D.documentElement,i=u.HTMLPictureElement,P="addEventListener",$="getAttribute",q=u[P].bind(u),I=u.setTimeout,U=u.requestAnimationFrame||I,o=u.requestIdleCallback,j=/^picture$/i,r=["load","error","lazyincluded","_lazyloaded"],a={},G=Array.prototype.forEach,J=function(e,t){if(!a[t]){a[t]=new RegExp("(\\s|^)"+t+"(\\s|$)")}return a[t].test(e[$]("class")||"")&&a[t]},K=function(e,t){if(!J(e,t)){e.setAttribute("class",(e[$]("class")||"").trim()+" "+t)}},Q=function(e,t){var a;if(a=J(e,t)){e.setAttribute("class",(e[$]("class")||"").replace(a," "))}},V=function(t,a,e){var i=e?P:"removeEventListener";if(e){V(t,a)}r.forEach(function(e){t[i](e,a)})},X=function(e,t,a,i,r){var n=D.createEvent("Event");if(!a){a={}}a.instance=k;n.initEvent(t,!i,!r);n.detail=a;e.dispatchEvent(n);return n},Y=function(e,t){var a;if(!i&&(a=u.picturefill||H.pf)){if(t&&t.src&&!e[$]("srcset")){e.setAttribute("srcset",t.src)}a({reevaluate:true,elements:[e]})}else if(t&&t.src){e.src=t.src}},Z=function(e,t){return(getComputedStyle(e,null)||{})[t]},s=function(e,t,a){a=a||e.offsetWidth;while(a<H.minSize&&t&&!e._lazysizesWidth){a=t.offsetWidth;t=t.parentNode}return a},ee=function(){var a,i;var t=[];var r=[];var n=t;var s=function(){var e=n;n=t.length?r:t;a=true;i=false;while(e.length){e.shift()()}a=false};var e=function(e,t){if(a&&!t){e.apply(this,arguments)}else{n.push(e);if(!i){i=true;(D.hidden?I:U)(s)}}};e._lsFlush=s;return e}(),te=function(a,e){return e?function(){ee(a)}:function(){var e=this;var t=arguments;ee(function(){a.apply(e,t)})}},ae=function(e){var a;var i=0;var r=H.throttleDelay;var n=H.ricTimeout;var t=function(){a=false;i=f.now();e()};var s=o&&n>49?function(){o(t,{timeout:n});if(n!==H.ricTimeout){n=H.ricTimeout}}:te(function(){I(t)},true);return function(e){var t;if(e=e===true){n=33}if(a){return}a=true;t=r-(f.now()-i);if(t<0){t=0}if(e||t<9){s()}else{I(s,t)}}},ie=function(e){var t,a;var i=99;var r=function(){t=null;e()};var n=function(){var e=f.now()-a;if(e<i){I(n,i-e)}else{(o||r)(r)}};return function(){a=f.now();if(!t){t=I(n,i)}}},e=function(){var v,m,c,h,e;var y,z,g,p,C,b,A;var n=/^img$/i;var d=/^iframe$/i;var E="onscroll"in u&&!/(gle|ing)bot/.test(navigator.userAgent);var _=0;var w=0;var M=0;var N=-1;var L=function(e){M--;if(!e||M<0||!e.target){M=0}};var x=function(e){if(A==null){A=Z(D.body,"visibility")=="hidden"}return A||!(Z(e.parentNode,"visibility")=="hidden"&&Z(e,"visibility")=="hidden")};var W=function(e,t){var a;var i=e;var r=x(e);g-=t;b+=t;p-=t;C+=t;while(r&&(i=i.offsetParent)&&i!=D.body&&i!=O){r=(Z(i,"opacity")||1)>0;if(r&&Z(i,"overflow")!="visible"){a=i.getBoundingClientRect();r=C>a.left&&p<a.right&&b>a.top-1&&g<a.bottom+1}}return r};var t=function(){var e,t,a,i,r,n,s,o,l,u,f,c;var d=k.elements;if((h=H.loadMode)&&M<8&&(e=d.length)){t=0;N++;for(;t<e;t++){if(!d[t]||d[t]._lazyRace){continue}if(!E||k.prematureUnveil&&k.prematureUnveil(d[t])){R(d[t]);continue}if(!(o=d[t][$]("data-expand"))||!(n=o*1)){n=w}if(!u){u=!H.expand||H.expand<1?O.clientHeight>500&&O.clientWidth>500?500:370:H.expand;k._defEx=u;f=u*H.expFactor;c=H.hFac;A=null;if(w<f&&M<1&&N>2&&h>2&&!D.hidden){w=f;N=0}else if(h>1&&N>1&&M<6){w=u}else{w=_}}if(l!==n){y=innerWidth+n*c;z=innerHeight+n;s=n*-1;l=n}a=d[t].getBoundingClientRect();if((b=a.bottom)>=s&&(g=a.top)<=z&&(C=a.right)>=s*c&&(p=a.left)<=y&&(b||C||p||g)&&(H.loadHidden||x(d[t]))&&(m&&M<3&&!o&&(h<3||N<4)||W(d[t],n))){R(d[t]);r=true;if(M>9){break}}else if(!r&&m&&!i&&M<4&&N<4&&h>2&&(v[0]||H.preloadAfterLoad)&&(v[0]||!o&&(b||C||p||g||d[t][$](H.sizesAttr)!="auto"))){i=v[0]||d[t]}}if(i&&!r){R(i)}}};var a=ae(t);var S=function(e){var t=e.target;if(t._lazyCache){delete t._lazyCache;return}L(e);K(t,H.loadedClass);Q(t,H.loadingClass);V(t,B);X(t,"lazyloaded")};var i=te(S);var B=function(e){i({target:e.target})};var T=function(e,t){var a=e.getAttribute("data-load-mode")||H.iframeLoadMode;if(a==0){e.contentWindow.location.replace(t)}else if(a==1){e.src=t}};var F=function(e){var t;var a=e[$](H.srcsetAttr);if(t=H.customMedia[e[$]("data-media")||e[$]("media")]){e.setAttribute("media",t)}if(a){e.setAttribute("srcset",a)}};var s=te(function(t,e,a,i,r){var n,s,o,l,u,f;if(!(u=X(t,"lazybeforeunveil",e)).defaultPrevented){if(i){if(a){K(t,H.autosizesClass)}else{t.setAttribute("sizes",i)}}s=t[$](H.srcsetAttr);n=t[$](H.srcAttr);if(r){o=t.parentNode;l=o&&j.test(o.nodeName||"")}f=e.firesLoad||"src"in t&&(s||n||l);u={target:t};K(t,H.loadingClass);if(f){clearTimeout(c);c=I(L,2500);V(t,B,true)}if(l){G.call(o.getElementsByTagName("source"),F)}if(s){t.setAttribute("srcset",s)}else if(n&&!l){if(d.test(t.nodeName)){T(t,n)}else{t.src=n}}if(r&&(s||l)){Y(t,{src:n})}}if(t._lazyRace){delete t._lazyRace}Q(t,H.lazyClass);ee(function(){var e=t.complete&&t.naturalWidth>1;if(!f||e){if(e){K(t,H.fastLoadedClass)}S(u);t._lazyCache=true;I(function(){if("_lazyCache"in t){delete t._lazyCache}},9)}if(t.loading=="lazy"){M--}},true)});var R=function(e){if(e._lazyRace){return}var t;var a=n.test(e.nodeName);var i=a&&(e[$](H.sizesAttr)||e[$]("sizes"));var r=i=="auto";if((r||!m)&&a&&(e[$]("src")||e.srcset)&&!e.complete&&!J(e,H.errorClass)&&J(e,H.lazyClass)){return}t=X(e,"lazyunveilread").detail;if(r){re.updateElem(e,true,e.offsetWidth)}e._lazyRace=true;M++;s(e,t,r,i,a)};var r=ie(function(){H.loadMode=3;a()});var o=function(){if(H.loadMode==3){H.loadMode=2}r()};var l=function(){if(m){return}if(f.now()-e<999){I(l,999);return}m=true;H.loadMode=3;a();q("scroll",o,true)};return{_:function(){e=f.now();k.elements=D.getElementsByClassName(H.lazyClass);v=D.getElementsByClassName(H.lazyClass+" "+H.preloadClass);q("scroll",a,true);q("resize",a,true);q("pageshow",function(e){if(e.persisted){var t=D.querySelectorAll("."+H.loadingClass);if(t.length&&t.forEach){U(function(){t.forEach(function(e){if(e.complete){R(e)}})})}}});if(u.MutationObserver){new MutationObserver(a).observe(O,{childList:true,subtree:true,attributes:true})}else{O[P]("DOMNodeInserted",a,true);O[P]("DOMAttrModified",a,true);setInterval(a,999)}q("hashchange",a,true);["focus","mouseover","click","load","transitionend","animationend"].forEach(function(e){D[P](e,a,true)});if(/d$|^c/.test(D.readyState)){l()}else{q("load",l);D[P]("DOMContentLoaded",a);I(l,2e4)}if(k.elements.length){t();ee._lsFlush()}else{a()}},checkElems:a,unveil:R,_aLSL:o}}(),re=function(){var a;var n=te(function(e,t,a,i){var r,n,s;e._lazysizesWidth=i;i+="px";e.setAttribute("sizes",i);if(j.test(t.nodeName||"")){r=t.getElementsByTagName("source");for(n=0,s=r.length;n<s;n++){r[n].setAttribute("sizes",i)}}if(!a.detail.dataAttr){Y(e,a.detail)}});var i=function(e,t,a){var i;var r=e.parentNode;if(r){a=s(e,r,a);i=X(e,"lazybeforesizes",{width:a,dataAttr:!!t});if(!i.defaultPrevented){a=i.detail.width;if(a&&a!==e._lazysizesWidth){n(e,r,i,a)}}}};var e=function(){var e;var t=a.length;if(t){e=0;for(;e<t;e++){i(a[e])}}};var t=ie(e);return{_:function(){a=D.getElementsByClassName(H.autosizesClass);q("resize",t)},checkElems:t,updateElem:i}}(),t=function(){if(!t.i&&D.getElementsByClassName){t.i=true;re._();e._()}};return I(function(){H.init&&t()}),k={cfg:H,autoSizer:re,loader:e,init:t,uP:Y,aC:K,rC:Q,hC:J,fire:X,gW:s,rAF:ee}}(e,e.document,Date);e.lazySizes=t,"object"==typeof module&&module.exports&&(module.exports=t)}("undefined"!=typeof window?window:{});;/*! lazysizes - v5.3.2 */!function(e,t){var a=function(){t(e.lazySizes),e.removeEventListener("lazyunveilread",a,!0)};t=t.bind(null,e,e.document),"object"==typeof module&&module.exports?t(require("lazysizes")):"function"==typeof define&&define.amd?define(["lazysizes"],t):e.lazySizes?a():e.addEventListener("lazyunveilread",a,!0)}(window,function(e,i,o){"use strict";var l,d,u={};function s(e,t,a){var n,r;u[e]||(n=i.createElement(t?"link":"script"),r=i.getElementsByTagName("script")[0],t?(n.rel="stylesheet",n.href=e):(n.onload=function(){n.onerror=null,n.onload=null,a()},n.onerror=n.onload,n.src=e),u[e]=!0,u[n.src||n.href]=!0,r.parentNode.insertBefore(n,r))}i.addEventListener&&(l=function(e,t){var a=i.createElement("img");a.onload=function(){a.onload=null,a.onerror=null,a=null,t()},a.onerror=a.onload,a.src=e,a&&a.complete&&a.onload&&a.onload()},addEventListener("lazybeforeunveil",function(e){var t,a,n;if(e.detail.instance==o&&!e.defaultPrevented){var r=e.target;if("none"==r.preload&&(r.preload=r.getAttribute("data-preload")||"auto"),null!=r.getAttribute("data-autoplay"))if(r.getAttribute("data-expand")&&!r.autoplay)try{r.play()}catch(e){}else requestAnimationFrame(function(){r.setAttribute("data-expand","-10"),o.aC(r,o.cfg.lazyClass)});(t=r.getAttribute("data-link"))&&s(t,!0),(t=r.getAttribute("data-script"))&&(e.detail.firesLoad=!0,s(t,null,function(){e.detail.firesLoad=!1,o.fire(r,"_lazyloaded",{},!0,!0)})),(t=r.getAttribute("data-require"))&&(o.cfg.requireJs?o.cfg.requireJs([t]):s(t)),(a=r.getAttribute("data-bg"))&&(e.detail.firesLoad=!0,l(a,function(){r.style.backgroundImage="url("+(d.test(a)?JSON.stringify(a):a)+")",e.detail.firesLoad=!1,o.fire(r,"_lazyloaded",{},!0,!0)})),(n=r.getAttribute("data-poster"))&&(e.detail.firesLoad=!0,l(n,function(){r.poster=n,e.detail.firesLoad=!1,o.fire(r,"_lazyloaded",{},!0,!0)}))}},!(d=/\(|\)|\s|'/)))});
//# sourceMappingURL=initial.js.map
</script>

        <script>
    window.dataLayer = window.dataLayer || [];
    window.dataLayer.push({
        'contentType': 'Item', // updated taxonomy TK
        'publicationDate': 'May 08, 2025 05:00:00',
        'articleTopic': 'Health Care',
        'articleTitle': 'The Price of Remission',
        'authorName': 'David Armstrong',
        'seriesName': '',
        'contentRegion': 'National',
        'contentLanguage': 'en',
        'craftId' : '2784844',
        'articleVersion' : 'V5',
        'contentLocation' : '',
        'storyType': 'enterprise',
        'impact': "false"
    });
</script>

    <!-- PRECONNECT -->
        <link href="https://assets.propublica.org" rel="preconnect">
    <link href="https://assets.propublica.org" rel="dns-prefetch">
        <link href="https://img.assets-c3.propublica.org" rel="dns-prefetch">
    <link href="https://img.assets-d.propublica.org" rel="dns-prefetch">

    <!-- STYLES -->
    <link rel="stylesheet" href="https://assets.propublica.org/static/prod/v5/css/main.78aa2f01.css">

    <!-- OTHER -->
            
        <link rel="icon" href="https://assets.propublica.org/static/prod/v5/images/favicon.ico">
    <link rel="icon" href="https://assets.propublica.org/static/prod/v5/images/icon.min.svg" type="image/svg+xml">
    <link rel="apple-touch-icon" href="https://assets.propublica.org/static/prod/v5/images/apple-touch-icon-180x180.png">
    
    <style>

.opener--grid .opener__topic-title-dek-wrapper--valign-center, .opener--split .opener__topic-title-dek-wrapper--valign-center {
  align-self: start !important
}

.opener--grid .opener__topic-title-dek-wrapper, .opener--split .opener__topic-title-dek-wrapper {
margin-top:5rem;
}
.opener__topics--vertical-rule::after, .opener__hed--vertical-rule::after {
  height: 0px !important;
}

.article-meta-1 .article-meta-1__byline {
margin-top:0px;
}
 
  html.force-light-mode body.neutral-cool {
    --color-accent-10: var(--warm-10);
    --color-accent-20: var(--warm-20);
    --color-accent-30: var(--warm-30);
    --color-accent-40: var(--warm-40);
    --color-accent-50: var(--warm-50);
    --color-accent-60: var(--warm-60);
    --color-accent-70: var(--warm-70);
    --color-accent-80: var(--warm-80);
    --color-accent-90: var(--warm-90);
  }

  @media (prefers-color-scheme: light) {
    html:not(.force-dark-mode) body.neutral-cool {
      --color-accent-10: var(--warm-10);
      --color-accent-20: var(--warm-20);
      --color-accent-30: var(--warm-30);
      --color-accent-40: var(--warm-40);
      --color-accent-50: var(--warm-50);
      --color-accent-60: var(--warm-60);
      --color-accent-70: var(--warm-70);
      --color-accent-80: var(--warm-80);
      --color-accent-90: var(--warm-90);
    }
  }

  /* Styling aimed at dark mode */

  html.force-dark-mode body.neutral-cool {
    --color-accent-10: var(--warm-80);
    --color-accent-20: var(--warm-70);
    --color-accent-30: var(--warm-60);
    --color-accent-40: var(--warm-50);
    --color-accent-50: var(--warm-50);
    --color-accent-60: var(--warm-40);
    --color-accent-70: var(--warm-30);
    --color-accent-80: var(--warm-20);
    --color-accent-90: var(--warm-10);
  }
  @media (prefers-color-scheme: dark) {
    html:not(.force-light-mode) body.neutral-cool {
      --color-accent-10: var(--warm-90);
      --color-accent-20: var(--warm-80);
      --color-accent-30: var(--warm-70);
      --color-accent-40: var(--warm-60);
      --color-accent-50: var(--warm-50);
      --color-accent-60: var(--warm-40);
      --color-accent-70: var(--warm-30);
      --color-accent-80: var(--warm-20);
      --color-accent-90: var(--warm-10);
    }
  }
  .first-line {
    font-family: var(--fonts-sans);
    font-weight: 700;
    text-transform: uppercase;
    color: var(--color-accent-70);
    letter-spacing: 1px;
  }

  .bb-heading__kicker {
    color: var(--color-accent-70);
    font-weight: 500;
    font-size: var(--scale-1);
  }
</style>

    <!--mastodon-->
    <link rel="me" href="https://newsie.social/@ProPublica" />
    <meta name="fediverse:creator" content="@propublica@newsie.social" />

<title>Why Is Cancer Drug Revlimid So Expensive? — ProPublica</title><meta name="description" content="When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.">
<meta name="referrer" content="no-referrer-when-downgrade">
<meta name="robots" content="all">
<meta content="David Armstrong" property="author">
<meta content="Why Is Cancer Drug Revlimid So Expensive?" property="headline">
<meta content="13320939444" property="fb:profile_id">
<meta content="229862657130557" property="fb:app_id">
<meta content="en_US" property="og:locale">
<meta content="ProPublica" property="og:site_name">
<meta content="article" property="og:type">
<meta content="https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma" property="og:url">
<meta content="The Price of Remission" property="og:title">
<meta content="When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me." property="og:description">
<meta content="https://img.assets-c3.propublica.org/images/articles/20250506-revlimid-lead-og.jpg?crop=focalpoint&amp;fit=crop&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=630&amp;imgixProfile=propublicaAssets&amp;q=90&amp;w=1200&amp;s=9e7f0c54edd2b9007de2f93dbfa9efd9" property="og:image">
<meta content="https://vimeo.com/propublica" property="og:see_also">
<meta content="https://www.pinterest.com/propublica" property="og:see_also">
<meta content="https://www.instagram.com/propublica" property="og:see_also">
<meta content="https://www.linkedin.com/company/propublica/" property="og:see_also">
<meta content="https://github.com/propublica" property="og:see_also">
<meta content="https://www.youtube.com/user/propublica" property="og:see_also">
<meta content="https://en.wikipedia.org/wiki/ProPublica" property="og:see_also">
<meta content="https://www.facebook.com/propublica/" property="og:see_also">
<meta content="https://twitter.com/propublica" property="og:see_also">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@propublica">
<meta name="twitter:creator" content="@propublica">
<meta name="twitter:title" content="The Price of Remission">
<meta name="twitter:description" content="When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.">
<meta name="twitter:image" content="https://img.assets-c3.propublica.org/images/articles/20250506-revlimid-lead-og.jpg?crop=focalpoint&amp;fit=crop&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=630&amp;imgixProfile=propublicaAssets&amp;q=90&amp;w=1200&amp;s=9e7f0c54edd2b9007de2f93dbfa9efd9">
<link href="https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma" rel="canonical">
<link href="https://www.propublica.org" rel="home">
<link type="text/plain" href="https://www.propublica.org/humans.txt" rel="author"></head>

<body id="www-propublica-org" class="entry-type-article bg-white text-dark neutral-cool user-level--0 accent-blue" data-pp-location="v5 body">
    
            
    
<style>
    .site-header__banner {
        font-family: Graphik, sans-serif;
        font-size: 13px;
        line-height: 1.2;
        position: relative;
        z-index: 100;
    }
    @media screen and (min-width: 40em) {
        .site-header__banner {
            font-size: 15px;
        }
    }
    a.site-header__banner-link {
        align-items: center;
        background: linear-gradient(
            to right,
            #e98406,
            #cf176d,
            #2074df
        );
        color: white;
        display: flex;
        justify-content: center;
        overflow: hidden;
        padding: 0.5em 1em;
        text-decoration: none;
        transition: unset;
    }
    .site-header__banner-link > * + * {
        margin-left: 8px;
    }
    .site-header__banner-cta {
        background: #da352b;
        border-radius: 0.2em;
        color: white;
        display: inline;
        font-size: 0.85em;
        font-weight: 700;
        padding: 0.5em 1em;
        text-transform: uppercase;
        text-align: center;
        /* see here for smooth box-shadow calculation: https://shadows.brumm.af */
        /*
        box-shadow:
            0 1.3px 1.3px rgba(0, 0, 0, 0.07),
            0 4.5px 4.5px rgba(0, 0, 0, 0.042),
            0 20px 20px rgba(0, 0, 0, 0.028)
        ;
        */
    }
    /*
    .site-header__banner-copy {
        display: none;
    }
    @media screen and (min-width: 50em) {
        .site-header__banner-copy {
            display: block;
        }
    }
    */
    /*
    .site-header__banner-link:focus .site-header__banner-cta,
    .site-header__banner-link:hover .site-header__banner-cta {
        background: #9b0000;
        color: white;
    }
    */

    .site-header__banner-title {
        padding-right: 0.25em;
    }

    @media screen and (min-width: 60em) {
        .opener--grid {
            /* Tweak full height to account for promo bar height */
            grid-template-rows: minmax(calc(100vh - 2.25rem), auto) auto auto;
        }
    }
    @media screen and (min-width: 60em) {
        .opener--grid .opener__art.opener__art--inset,
        .opener--grid .opener__art.opener__art--inset > img,
        .opener--grid .opener__art.opener__art--inset > video {
            /* Tweak full height to account for promo bar height */
            max-height: calc( 100vh - 2.25rem - 2 * var(--opener-page-margins));
        }
    }
</style>


    <!-- Load SiteHeader variant based on variable -->

<script type="application/json" class="svelte-config">
                            {"componentName":"SiteHeader","props":{"type":"minimal","fixedNavScrollStart":".opener, .opener-event, .custom-opener"},"contextArray":[]}
                        </script>
                        <a class="site-header-skip-link a11y a11y-focusable--absolute svelte-5qrmpy" href="#main" data-svelte-h="svelte-19fmzuu">Skip to content</a>   <div class="site-header--minimal hide-print svelte-5qrmpy" data-pp-location="svelte-siteheader"><div class="variant-minimal__inner-wrap svelte-5qrmpy"><div class="variant-minimal__section-menu svelte-5qrmpy"> <button class="button shape--round-rect  button-is-icon-only  svelte-1r0prvj" data-link="Menu" data-pp-skip="false" data-testid="minimal-menu-button" style="--button-bg-color: transparent; --button-border: none; --button-color: var(--site-header-color-button-text, var(--color-neutral-80)); --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg role="img" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><title>Menu</title><path fill-rule="evenodd" clip-rule="evenodd" d="M2 12C2 11.4477 2.44772 11 3 11H21C21.5523 11 22 11.4477 22 12C22 12.5523 21.5523 13 21 13H3C2.44772 13 2 12.5523 2 12Z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M2 6C2 5.44772 2.44772 5 3 5H21C21.5523 5 22 5.44772 22 6C22 6.55228 21.5523 7 21 7H3C2.44772 7 2 6.55228 2 6Z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M2 18C2 17.4477 2.44772 17 3 17H21C21.5523 17 22 17.4477 22 18C22 18.5523 21.5523 19 21 19H3C2.44772 19 2 18.5523 2 18Z" fill="currentColor"></path></svg></span> <span class="text font--sans svelte-1r0prvj a11y">Menu</span>  </button></div> <a class="variant-minimal__wordmark svelte-5qrmpy" href="https://www.propublica.org"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 574.24 75" fill="currentColor"><title>ProPublica</title><path d="M66.4,13.48,66,14.91l6.23,11.45,1.15.47L75,26.29V75H50.95A41.2,41.2,0,0,0,62.13,46.88a40.61,40.61,0,0,0-3.39-16.26,45.17,45.17,0,0,1,7.79-4.95l1.69-.2.14-.41L65,18.83H64.5l-.88,1.29c-2.91,1.9-4.67,2.3-8.54,3.79A41.35,41.35,0,0,0,20.46,5.42,39.87,39.87,0,0,0,0,10.91V0H75V8.81ZM57.32,47A37.54,37.54,0,0,1,44.65,75H0V16A37,37,0,0,1,57.32,47ZM43.7,37.06c0-8.13-6-12-17.75-12H7.18v3.66l4.2.95V62.2l-4.2.95v3.73H27.85V63.14l-7.18-.95V50.14h5.15C37.26,50.14,43.7,45.53,43.7,37.06Zm-9.76.27c0,5.15-2.78,8.33-7.25,8.33h-6V29.47H27C31.37,29.47,33.94,32.32,33.94,37.33Z"></path><path d="M116.53,60.07l9.15,1.08v4.2H99.39v-4.2l5.28-1.36v-44l-5.28-1.36V10.41H123c15.31,0,22.9,5.28,22.9,16.13,0,11.18-8.33,17.41-23.1,17.41h-6.3Zm0-21.14h6.84c6.44,0,10.5-4.61,10.5-12.06,0-7.18-3.73-11.45-10.09-11.45h-7.25Z"></path><path d="M200.74,61.15v4.2H185.9l-16-20.6h-2.51v15l5.28,1.36v4.2H150.27v-4.2l5.28-1.36V23.35l-5-1.36V17.93H175.2c10.5,0,17.55,5.08,17.55,12.67,0,8.4-5.76,12.2-11,13.55l13.48,15.79ZM167.41,39.74h4.47c5.76,0,8.81-3.18,8.81-8.88,0-5.35-2.85-7.93-8.81-7.93h-4.47Z"></path><path d="M199.59,41.64c0-14.77,9.82-24.73,25.68-24.73s25.68,10,25.68,24.73-9.82,24.73-25.68,24.73S199.59,56.48,199.59,41.64Zm38.89,0c0-9.69-3.25-19.17-13.21-19.17S212.05,32,212.05,41.64s3.25,19.17,13.21,19.17S238.48,51.33,238.48,41.64Z"></path><path d="M270.79,60.07l9.15,1.08v4.2H253.31v-4.2l5.62-1.36v-44l-5.62-1.36V10.41h24c15.31,0,22.9,5.28,22.9,16.13,0,11.18-8.33,17.41-23.1,17.41h-6.3Zm0-21.14h6.84c6.44,0,10.5-4.61,10.5-12.06,0-7.18-3.73-11.45-10.1-11.45h-7.25Z"></path><path d="M354.26,22l-4.95,1.36V47c0,12.87-7.79,19.38-20.05,19.38-13.62,0-20.73-7.86-20.73-20v-23L303.58,22V17.93h22V22l-5.08,1.36V47.74c0,7.25,4.34,12.06,11.45,12.06,6.84,0,11.25-4.47,11.25-11.31V23.35L338.14,22V17.93h16.12Z"></path><path d="M403.85,52.21c0,8.88-7.11,13.14-22,13.14H357.58v-4.2l5.56-1.36V23.35L358.26,22V17.93h23.92c12.6,0,19.51,3.79,19.51,11.72,0,6.17-4.06,9.08-10.91,9.89v.27C399.31,40.76,403.85,45.1,403.85,52.21ZM375,38.32h5.76c6.1,0,9-2.78,9-7.79,0-5.22-3.12-7.59-9-7.59H375Zm16.8,13.41c0-5.62-3.79-8.67-11.25-8.67H375V60.34h6.64C388.07,60.34,391.79,57.29,391.79,51.74Z"></path><path d="M451.07,48.62l-4.4,16.73H408v-4.2l5.28-1.36V23.35L407.65,22V17.93h22.76V22l-5.28,1.36v37l14.16-.81L447,47.26Z"></path><path d="M475.4,61.15v4.2H453v-4.2l5.28-1.36V23.35L453,22V17.93H475.4V22l-5.28,1.36V59.8Z"></path><path d="M478,41.78c0-15.85,12.13-24.86,27-24.86a35.6,35.6,0,0,1,18.29,5.15l-2,13.21h-4.2l-1.69-9.08a13.23,13.23,0,0,0-10.09-4.13c-9.15,0-14.7,6.57-14.7,18.22,0,13.21,6.84,19.31,15.24,19.31,6.17,0,10.23-3.39,13.41-9.55l4.27,2c-4.27,10-11.65,14.36-21.07,14.36C488.4,66.37,478,56.48,478,41.78Z"></path><path d="M574.24,61.15v4.2H551.48v-4.2L557,60l-2.85-8.13h-16.6l-3.12,8.2,5.42,1.15-.07,4.2-16.53-.07v-4.2l4.27-1.08,14.9-37.33-4-1.29V17.93h13.69L569.3,60Zm-27.57-31-.47-1.56-.47,1.56-6.23,16.73h12.94Z"></path></svg></a>  <a data-pp-view="" href="https://give.propublica.org/give/346423/#!/donation/checkout?c_src=UpRed" class="button shape--round-rect    svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--red-50); --button-border: none; --button-color: var(--white); --button-font-size: var(--scale-2); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale2); --icon-size: 1em;"> <span class="text font--serif svelte-1r0prvj">Donate</span>  </a></div></div>  <div class="site-header--fixed svelte-5qrmpy" aria-hidden="true" data-pp-location="svelte-siteheader"><div class="variant-fixed__inner-wrap svelte-5qrmpy"><div class="variant-fixed__section-menu svelte-5qrmpy"> <button class="button shape--round-rect  button-is-icon-only  svelte-1r0prvj" data-link="Menu" data-pp-skip="false" data-testid="minimal-or-full-menu-button-in-fixed-nav" style="--button-bg-color: transparent; --button-border: none; --button-color: var(--site-header-fixed-color-button-text, var(--color-neutral-80)); --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg role="img" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><title>Menu</title><path fill-rule="evenodd" clip-rule="evenodd" d="M2 12C2 11.4477 2.44772 11 3 11H21C21.5523 11 22 11.4477 22 12C22 12.5523 21.5523 13 21 13H3C2.44772 13 2 12.5523 2 12Z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M2 6C2 5.44772 2.44772 5 3 5H21C21.5523 5 22 5.44772 22 6C22 6.55228 21.5523 7 21 7H3C2.44772 7 2 6.55228 2 6Z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M2 18C2 17.4477 2.44772 17 3 17H21C21.5523 17 22 17.4477 22 18C22 18.5523 21.5523 19 21 19H3C2.44772 19 2 18.5523 2 18Z" fill="currentColor"></path></svg></span> <span class="text font--sans svelte-1r0prvj a11y">Menu</span>  </button></div> <a class="variant-fixed__wordmark svelte-5qrmpy" href="https://www.propublica.org"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 574.24 75" fill="currentColor"><title>ProPublica</title><path d="M66.4,13.48,66,14.91l6.23,11.45,1.15.47L75,26.29V75H50.95A41.2,41.2,0,0,0,62.13,46.88a40.61,40.61,0,0,0-3.39-16.26,45.17,45.17,0,0,1,7.79-4.95l1.69-.2.14-.41L65,18.83H64.5l-.88,1.29c-2.91,1.9-4.67,2.3-8.54,3.79A41.35,41.35,0,0,0,20.46,5.42,39.87,39.87,0,0,0,0,10.91V0H75V8.81ZM57.32,47A37.54,37.54,0,0,1,44.65,75H0V16A37,37,0,0,1,57.32,47ZM43.7,37.06c0-8.13-6-12-17.75-12H7.18v3.66l4.2.95V62.2l-4.2.95v3.73H27.85V63.14l-7.18-.95V50.14h5.15C37.26,50.14,43.7,45.53,43.7,37.06Zm-9.76.27c0,5.15-2.78,8.33-7.25,8.33h-6V29.47H27C31.37,29.47,33.94,32.32,33.94,37.33Z"></path><path d="M116.53,60.07l9.15,1.08v4.2H99.39v-4.2l5.28-1.36v-44l-5.28-1.36V10.41H123c15.31,0,22.9,5.28,22.9,16.13,0,11.18-8.33,17.41-23.1,17.41h-6.3Zm0-21.14h6.84c6.44,0,10.5-4.61,10.5-12.06,0-7.18-3.73-11.45-10.09-11.45h-7.25Z"></path><path d="M200.74,61.15v4.2H185.9l-16-20.6h-2.51v15l5.28,1.36v4.2H150.27v-4.2l5.28-1.36V23.35l-5-1.36V17.93H175.2c10.5,0,17.55,5.08,17.55,12.67,0,8.4-5.76,12.2-11,13.55l13.48,15.79ZM167.41,39.74h4.47c5.76,0,8.81-3.18,8.81-8.88,0-5.35-2.85-7.93-8.81-7.93h-4.47Z"></path><path d="M199.59,41.64c0-14.77,9.82-24.73,25.68-24.73s25.68,10,25.68,24.73-9.82,24.73-25.68,24.73S199.59,56.48,199.59,41.64Zm38.89,0c0-9.69-3.25-19.17-13.21-19.17S212.05,32,212.05,41.64s3.25,19.17,13.21,19.17S238.48,51.33,238.48,41.64Z"></path><path d="M270.79,60.07l9.15,1.08v4.2H253.31v-4.2l5.62-1.36v-44l-5.62-1.36V10.41h24c15.31,0,22.9,5.28,22.9,16.13,0,11.18-8.33,17.41-23.1,17.41h-6.3Zm0-21.14h6.84c6.44,0,10.5-4.61,10.5-12.06,0-7.18-3.73-11.45-10.1-11.45h-7.25Z"></path><path d="M354.26,22l-4.95,1.36V47c0,12.87-7.79,19.38-20.05,19.38-13.62,0-20.73-7.86-20.73-20v-23L303.58,22V17.93h22V22l-5.08,1.36V47.74c0,7.25,4.34,12.06,11.45,12.06,6.84,0,11.25-4.47,11.25-11.31V23.35L338.14,22V17.93h16.12Z"></path><path d="M403.85,52.21c0,8.88-7.11,13.14-22,13.14H357.58v-4.2l5.56-1.36V23.35L358.26,22V17.93h23.92c12.6,0,19.51,3.79,19.51,11.72,0,6.17-4.06,9.08-10.91,9.89v.27C399.31,40.76,403.85,45.1,403.85,52.21ZM375,38.32h5.76c6.1,0,9-2.78,9-7.79,0-5.22-3.12-7.59-9-7.59H375Zm16.8,13.41c0-5.62-3.79-8.67-11.25-8.67H375V60.34h6.64C388.07,60.34,391.79,57.29,391.79,51.74Z"></path><path d="M451.07,48.62l-4.4,16.73H408v-4.2l5.28-1.36V23.35L407.65,22V17.93h22.76V22l-5.28,1.36v37l14.16-.81L447,47.26Z"></path><path d="M475.4,61.15v4.2H453v-4.2l5.28-1.36V23.35L453,22V17.93H475.4V22l-5.28,1.36V59.8Z"></path><path d="M478,41.78c0-15.85,12.13-24.86,27-24.86a35.6,35.6,0,0,1,18.29,5.15l-2,13.21h-4.2l-1.69-9.08a13.23,13.23,0,0,0-10.09-4.13c-9.15,0-14.7,6.57-14.7,18.22,0,13.21,6.84,19.31,15.24,19.31,6.17,0,10.23-3.39,13.41-9.55l4.27,2c-4.27,10-11.65,14.36-21.07,14.36C488.4,66.37,478,56.48,478,41.78Z"></path><path d="M574.24,61.15v4.2H551.48v-4.2L557,60l-2.85-8.13h-16.6l-3.12,8.2,5.42,1.15-.07,4.2-16.53-.07v-4.2l4.27-1.08,14.9-37.33-4-1.29V17.93h13.69L569.3,60Zm-27.57-31-.47-1.56-.47,1.56-6.23,16.73h12.94Z"></path></svg></a>   <a href="https://give.propublica.org/give/346423/#!/donation/checkout?c_src=UpRed" class="button shape--round-rect    svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--red-50); --button-border: none; --button-color: var(--white); --button-font-size: var(--scale-2); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale2); --icon-size: 1em;"> <span class="text font--serif svelte-1r0prvj">Donate</span>  </a></div></div> <div class="site-header-overlay svelte-5qrmpy" data-testid="overlay" data-pp-location="svelte-siteheader-overlay" style="opacity: 0; pointer-events: none;"><div class="variant-overlay__top-inner-wrap svelte-5qrmpy"><div class="variant-overlay__section-menu svelte-5qrmpy"> <button class="button shape--round-rect  button-is-icon-only  svelte-1r0prvj" data-link="Menu" data-pp-skip="false" data-testid="close-overlay-button" style="--button-bg-color: transparent; --button-border: none; --button-color: white; --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: var(--scale0);"><span class="icon-before svelte-1r0prvj"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><title>Close</title><line x1="18" y1="6" x2="6" y2="18"></line><line x1="6" y1="6" x2="18" y2="18"></line></svg></span> <span class="text font--sans svelte-1r0prvj a11y">Close</span>  </button></div> <a class="variant-overlay__wordmark svelte-5qrmpy" href="https://www.propublica.org"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 574.24 75" fill="currentColor"><title>ProPublica</title><path d="M66.4,13.48,66,14.91l6.23,11.45,1.15.47L75,26.29V75H50.95A41.2,41.2,0,0,0,62.13,46.88a40.61,40.61,0,0,0-3.39-16.26,45.17,45.17,0,0,1,7.79-4.95l1.69-.2.14-.41L65,18.83H64.5l-.88,1.29c-2.91,1.9-4.67,2.3-8.54,3.79A41.35,41.35,0,0,0,20.46,5.42,39.87,39.87,0,0,0,0,10.91V0H75V8.81ZM57.32,47A37.54,37.54,0,0,1,44.65,75H0V16A37,37,0,0,1,57.32,47ZM43.7,37.06c0-8.13-6-12-17.75-12H7.18v3.66l4.2.95V62.2l-4.2.95v3.73H27.85V63.14l-7.18-.95V50.14h5.15C37.26,50.14,43.7,45.53,43.7,37.06Zm-9.76.27c0,5.15-2.78,8.33-7.25,8.33h-6V29.47H27C31.37,29.47,33.94,32.32,33.94,37.33Z"></path><path d="M116.53,60.07l9.15,1.08v4.2H99.39v-4.2l5.28-1.36v-44l-5.28-1.36V10.41H123c15.31,0,22.9,5.28,22.9,16.13,0,11.18-8.33,17.41-23.1,17.41h-6.3Zm0-21.14h6.84c6.44,0,10.5-4.61,10.5-12.06,0-7.18-3.73-11.45-10.09-11.45h-7.25Z"></path><path d="M200.74,61.15v4.2H185.9l-16-20.6h-2.51v15l5.28,1.36v4.2H150.27v-4.2l5.28-1.36V23.35l-5-1.36V17.93H175.2c10.5,0,17.55,5.08,17.55,12.67,0,8.4-5.76,12.2-11,13.55l13.48,15.79ZM167.41,39.74h4.47c5.76,0,8.81-3.18,8.81-8.88,0-5.35-2.85-7.93-8.81-7.93h-4.47Z"></path><path d="M199.59,41.64c0-14.77,9.82-24.73,25.68-24.73s25.68,10,25.68,24.73-9.82,24.73-25.68,24.73S199.59,56.48,199.59,41.64Zm38.89,0c0-9.69-3.25-19.17-13.21-19.17S212.05,32,212.05,41.64s3.25,19.17,13.21,19.17S238.48,51.33,238.48,41.64Z"></path><path d="M270.79,60.07l9.15,1.08v4.2H253.31v-4.2l5.62-1.36v-44l-5.62-1.36V10.41h24c15.31,0,22.9,5.28,22.9,16.13,0,11.18-8.33,17.41-23.1,17.41h-6.3Zm0-21.14h6.84c6.44,0,10.5-4.61,10.5-12.06,0-7.18-3.73-11.45-10.1-11.45h-7.25Z"></path><path d="M354.26,22l-4.95,1.36V47c0,12.87-7.79,19.38-20.05,19.38-13.62,0-20.73-7.86-20.73-20v-23L303.58,22V17.93h22V22l-5.08,1.36V47.74c0,7.25,4.34,12.06,11.45,12.06,6.84,0,11.25-4.47,11.25-11.31V23.35L338.14,22V17.93h16.12Z"></path><path d="M403.85,52.21c0,8.88-7.11,13.14-22,13.14H357.58v-4.2l5.56-1.36V23.35L358.26,22V17.93h23.92c12.6,0,19.51,3.79,19.51,11.72,0,6.17-4.06,9.08-10.91,9.89v.27C399.31,40.76,403.85,45.1,403.85,52.21ZM375,38.32h5.76c6.1,0,9-2.78,9-7.79,0-5.22-3.12-7.59-9-7.59H375Zm16.8,13.41c0-5.62-3.79-8.67-11.25-8.67H375V60.34h6.64C388.07,60.34,391.79,57.29,391.79,51.74Z"></path><path d="M451.07,48.62l-4.4,16.73H408v-4.2l5.28-1.36V23.35L407.65,22V17.93h22.76V22l-5.28,1.36v37l14.16-.81L447,47.26Z"></path><path d="M475.4,61.15v4.2H453v-4.2l5.28-1.36V23.35L453,22V17.93H475.4V22l-5.28,1.36V59.8Z"></path><path d="M478,41.78c0-15.85,12.13-24.86,27-24.86a35.6,35.6,0,0,1,18.29,5.15l-2,13.21h-4.2l-1.69-9.08a13.23,13.23,0,0,0-10.09-4.13c-9.15,0-14.7,6.57-14.7,18.22,0,13.21,6.84,19.31,15.24,19.31,6.17,0,10.23-3.39,13.41-9.55l4.27,2c-4.27,10-11.65,14.36-21.07,14.36C488.4,66.37,478,56.48,478,41.78Z"></path><path d="M574.24,61.15v4.2H551.48v-4.2L557,60l-2.85-8.13h-16.6l-3.12,8.2,5.42,1.15-.07,4.2-16.53-.07v-4.2l4.27-1.08,14.9-37.33-4-1.29V17.93h13.69L569.3,60Zm-27.57-31-.47-1.56-.47,1.56-6.23,16.73h12.94Z"></path></svg></a>  <a data-pp-view="" href="https://give.propublica.org/give/346423/#!/donation/checkout?c_src=UpRed" class="button shape--round-rect    svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--red-50); --button-border: none; --button-color: var(--white); --button-font-size: var(--scale-2); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale2); --icon-size: 1em;"> <span class="text font--serif svelte-1r0prvj">Donate</span>  </a></div> <div class="site-header-overlay__wrap-expanded svelte-5qrmpy" data-pp-location="masthead wrap-expanded"> <div class="site-header__section-search svelte-5qrmpy"><form class="search-form svelte-5qrmpy" role="search" action="https://propublica.org/search" method="get"><label class="a11y hed-form hed-site-search" for="search-form__input-text" data-svelte-h="svelte-zdbb25">Search ProPublica:</label> <div class="search-form__input-wrap svelte-5qrmpy"><input placeholder="Search" id="search-form__input-text" class="search-form__input-text svelte-5qrmpy" type="search" value="" name="qss">  <button class="button shape--circle  button-is-icon-only  svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--cool-70); --button-border: none; --button-color: white; --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale4); --icon-size: var(--scale0);"><span class="icon-before svelte-1r0prvj"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><title>Search</title><circle cx="11" cy="11" r="8"></circle><line x1="21" y1="21" x2="16.65" y2="16.65"></line></svg></span> <span class="text font--sans svelte-1r0prvj a11y">Search</span>  </button></div></form></div>   <nav class="site-header__section-links-expanded svelte-5qrmpy" aria-label="Expanded Links" hidden><div class="site-header__links site-header__links-topics svelte-5qrmpy"><strong class="site-header__links-heading svelte-5qrmpy">Topics </strong> <ul class="site-header__links-list svelte-5qrmpy"><li class="svelte-5qrmpy"><span class="icon svelte-5qrmpy"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 15 15" fill="currentColor"><title>Racial Justice</title><path d="M15,12.23v0L14,4.55l.24.06.11,0a.38.38,0,0,0,.36-.27.38.38,0,0,0-.25-.47c-.19-.06-.39-.1-.59-.15a.38.38,0,0,0-.29-.26.37.37,0,0,0-.28.11c-.6-.15-1.21-.28-1.82-.39V1.29A1.29,1.29,0,0,0,10.17,0,1.32,1.32,0,0,0,9.11.57a1.37,1.37,0,0,0-2,.26A1.3,1.3,0,0,0,6.23.51a1.32,1.32,0,0,0-1.12.66A1.13,1.13,0,0,0,4.46,1,1.19,1.19,0,0,0,3.27,2.14V3.25c-.53.1-1,.21-1.57.34a.37.37,0,0,0-.28-.11.38.38,0,0,0-.29.26c-.19,0-.39.09-.58.15a.38.38,0,0,0-.25.47.38.38,0,0,0,.36.27l.11,0L1,4.55,0,12.21v0A2.67,2.67,0,0,0,2.6,15a2.67,2.67,0,0,0,2.57-2.73h0a.19.19,0,0,0,0-.07.13.13,0,0,0,0-.06h0L2,4.27c.41-.1.82-.18,1.24-.25v.37a4,4,0,0,0-.12,1A3.93,3.93,0,0,0,5.21,8.81v1.77a.38.38,0,1,0,.75,0v-2a.39.39,0,0,0-.21-.34A3.19,3.19,0,0,1,3.9,5.39a1.18,1.18,0,0,0,.56.16,1.2,1.2,0,0,0,.8-.32,1.35,1.35,0,0,0,1,.43,1.29,1.29,0,0,0,1-.44,1.29,1.29,0,0,0,.6.32,3.58,3.58,0,0,0-.89.85.37.37,0,0,0,.3.59.39.39,0,0,0,.31-.15A2.81,2.81,0,0,1,9.76,5.61a.38.38,0,0,0,0-.75H8.14a.59.59,0,0,1-.58-.59v-.5h2.82a.73.73,0,0,1,.75.71v.89A3.19,3.19,0,0,1,9.28,8.24a.39.39,0,0,0-.21.34v2a.38.38,0,1,0,.75,0V8.81a3.93,3.93,0,0,0,2.06-3.44V4.48A1.33,1.33,0,0,0,11.8,4c.4.07.79.15,1.18.24L9.87,12.11h0a.13.13,0,0,0,0,.06.25.25,0,0,0,0,.07h0A2.67,2.67,0,0,0,12.41,15,2.67,2.67,0,0,0,15,12.25ZM1.65,5.35l2.59,6.53H.83Zm1,8.9A1.88,1.88,0,0,1,.81,12.63H4.39A1.88,1.88,0,0,1,2.6,14.25ZM4.9,4.36a.44.44,0,0,1-.44.44A.44.44,0,0,1,4,4.36V2.14a.44.44,0,0,1,.44-.44.44.44,0,0,1,.44.44Zm1.91,0a.58.58,0,1,1-1.16,0V2.14a.7.7,0,0,0,0-.14.4.4,0,0,0,0-.15.58.58,0,1,1,1.16,0Zm.73-2.58a.43.43,0,0,0,0-.11.65.65,0,1,1,1.29,0V3H7.56V1.85S7.54,1.78,7.54,1.74ZM9.6,3V1.63s0,0,0-.06,0,0,0,0V1.29a.57.57,0,0,1,1.14,0V3.07a1.49,1.49,0,0,0-.36,0Zm4.58,8.86H10.77l2.59-6.53Zm-1.77,2.37a1.89,1.89,0,0,1-1.79-1.62H14.2A1.88,1.88,0,0,1,12.41,14.25Z"></path></svg> </span> <a class="site-header__link svelte-5qrmpy" data-link="Racial Justice" href="https://www.propublica.org/topics/racial-justice">Racial Justice</a> </li><li class="svelte-5qrmpy"><span class="icon svelte-5qrmpy"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 15 15" fill="currentColor"><title>Healthcare</title><path d="M6.77,4.81H6.28a10,10,0,0,1-4.19-.92L.44,3a.67.67,0,0,1-.36-.67.7.7,0,0,1,.49-.6L4.38.65a1.14,1.14,0,0,1,1,.19,1.08,1.08,0,0,1,.42.86.56.56,0,0,0,.54.56h.48a.37.37,0,0,1,.37.37A.38.38,0,0,1,6.77,3H6.29A1.3,1.3,0,0,1,5,1.7a.31.31,0,0,0-.13-.26.31.31,0,0,0-.29-.06L.92,2.43l1.5.79a9.35,9.35,0,0,0,3.86.84h.49a.38.38,0,0,1,0,.75Z"></path><path d="M8.76,4.81H8.29a.38.38,0,1,1,0-.75h.47a9.24,9.24,0,0,0,3.87-.85l1.5-.78L10.45,1.38a.3.3,0,0,0-.27.05.35.35,0,0,0-.13.27A1.3,1.3,0,0,1,8.77,3H8.29a.38.38,0,0,1-.38-.38.37.37,0,0,1,.38-.37h.47A.56.56,0,0,0,9.3,1.7,1.1,1.1,0,0,1,9.72.84a1.08,1.08,0,0,1,.93-.19l3.82,1.1A.7.7,0,0,1,14.61,3L13,3.88A9.92,9.92,0,0,1,8.76,4.81Z"></path><path d="M7.52,13.82a.34.34,0,0,1-.23-.08L6,12.76a1.72,1.72,0,0,1-.61-1.52,1.63,1.63,0,0,1,.77-1.33L9.61,8A.88.88,0,0,0,10,7.33a1.11,1.11,0,0,0-.28-.91l-.33-.29a.38.38,0,1,1,.51-.55l.32.29a1.8,1.8,0,0,1,.52,1.55A1.59,1.59,0,0,1,10,8.65L6.56,10.56a.89.89,0,0,0-.39.74,1,1,0,0,0,.32.87l1.26,1a.39.39,0,0,1,.07.53A.41.41,0,0,1,7.52,13.82Z"></path><path d="M7.53,13.82a.41.41,0,0,1-.3-.14.39.39,0,0,1,.07-.53l1.26-1a1,1,0,0,0,.32-.87.89.89,0,0,0-.39-.74L5.07,8.65a1.62,1.62,0,0,1-.76-1.24,1.82,1.82,0,0,1,.51-1.54l.32-.29a.38.38,0,0,1,.51.55l-.33.3a1.08,1.08,0,0,0-.27.89A.92.92,0,0,0,5.44,8L8.86,9.91a1.63,1.63,0,0,1,.77,1.33A1.72,1.72,0,0,1,9,12.76l-1.26,1A.34.34,0,0,1,7.53,13.82Z"></path><path d="M7.52,15a.37.37,0,0,1-.37-.38V.44A.37.37,0,0,1,7.52.06.38.38,0,0,1,7.9.44V14.57A.38.38,0,0,1,7.52,15Z"></path></svg> </span> <a class="site-header__link svelte-5qrmpy" data-link="Health Care" href="https://www.propublica.org/topics/health-care">Health Care</a> </li><li class="svelte-5qrmpy"><span class="icon svelte-5qrmpy"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 15 15" fill="currentColor"><title>Politics</title><path d="M12.54,14.89h-10a.38.38,0,0,1-.38-.37V11a.38.38,0,0,1,.38-.38h10a.38.38,0,0,1,.38.38v3.55A.38.38,0,0,1,12.54,14.89Zm-9.66-.75h9.29v-2.8H2.88Z"></path><path d="M14.52,14.89H.53a.38.38,0,0,1,0-.75h14a.38.38,0,0,1,0,.75Z"></path><path d="M11.71,11.35H3.34A.37.37,0,0,1,3,11V8.7a.38.38,0,0,1,.37-.38h8.37a.37.37,0,0,1,.37.38V11A.36.36,0,0,1,11.71,11.35Zm-8-.75h7.61V9.07H3.72Z"></path><path d="M8.36,5.11A.38.38,0,0,1,8,4.73V3.42H7.07V4.73a.38.38,0,1,1-.75,0V3a.37.37,0,0,1,.37-.37H8.36A.37.37,0,0,1,8.73,3V4.73A.38.38,0,0,1,8.36,5.11Z"></path><path d="M3.84,13.79a.38.38,0,0,1-.38-.37V12.25a.38.38,0,0,1,.75,0v1.17A.38.38,0,0,1,3.84,13.79Z"></path><path d="M5.31,13.79a.38.38,0,0,1-.37-.37V12.25a.38.38,0,0,1,.75,0v1.17A.38.38,0,0,1,5.31,13.79Z"></path><path d="M6.79,13.79a.37.37,0,0,1-.37-.37V12.25a.36.36,0,0,1,.37-.37.37.37,0,0,1,.38.37v1.17A.38.38,0,0,1,6.79,13.79Z"></path><path d="M8.27,13.79a.38.38,0,0,1-.38-.37V12.25a.37.37,0,0,1,.38-.37.36.36,0,0,1,.37.37v1.17A.37.37,0,0,1,8.27,13.79Z"></path><path d="M9.75,13.79a.38.38,0,0,1-.38-.37V12.25a.38.38,0,0,1,.75,0v1.17A.38.38,0,0,1,9.75,13.79Z"></path><path d="M11.22,13.79a.38.38,0,0,1-.37-.37V12.25a.38.38,0,0,1,.75,0v1.17A.38.38,0,0,1,11.22,13.79Z"></path><path d="M7.53,3.42A.37.37,0,0,1,7.16,3V.48A.37.37,0,0,1,7.53.11a.38.38,0,0,1,.38.37V3A.38.38,0,0,1,7.53,3.42Z"></path><path d="M11.72,9.06a.38.38,0,0,1-.38-.37A3.74,3.74,0,0,0,7.53,5,3.74,3.74,0,0,0,3.72,8.69a.38.38,0,0,1-.75,0A4.49,4.49,0,0,1,7.53,4.28a4.49,4.49,0,0,1,4.56,4.41A.37.37,0,0,1,11.72,9.06Z"></path></svg> </span> <a class="site-header__link svelte-5qrmpy" data-link="Politics" href="https://www.propublica.org/topics/politics">Politics</a> </li><li class="svelte-5qrmpy"><span class="icon svelte-5qrmpy"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 15 15" fill="currentColor"><title>Criminal Justice</title><path d="M13.48,4h-.11A20.22,20.22,0,0,0,1.76,4a.38.38,0,0,1-.47-.26.37.37,0,0,1,.25-.46,21,21,0,0,1,12.05,0,.37.37,0,0,1-.11.73Z"></path><path d="M10.53,15h-6a.38.38,0,1,1,0-.75h6a.38.38,0,0,1,0,.75Z"></path><path d="M7.5,15a.37.37,0,0,1-.37-.38V.42A.37.37,0,0,1,7.5,0a.38.38,0,0,1,.38.38V14.6A.38.38,0,0,1,7.5,15Z"></path><path d="M5.39,9.89H.46a.37.37,0,0,1-.31-.16.36.36,0,0,1,0-.35L2.57,3.16a.38.38,0,0,1,.35-.24h0a.38.38,0,0,1,.35.23L5.74,9.38a.36.36,0,0,1,0,.35A.37.37,0,0,1,5.39,9.89ZM1,9.14H4.84L2.92,4.31Z"></path><path d="M14.6,9.89H9.67a.37.37,0,0,1-.31-.16.36.36,0,0,1,0-.35l2.46-6.22a.38.38,0,0,1,.35-.24h0a.37.37,0,0,1,.35.23L15,9.38a.36.36,0,0,1,0,.35A.37.37,0,0,1,14.6,9.89Zm-4.38-.75h3.83L12.13,4.31Z"></path><path d="M2.92,11.75A3,3,0,0,1,.1,9.62a.36.36,0,0,1,.06-.33.38.38,0,0,1,.3-.15H5.39a.38.38,0,0,1,.3.15.39.39,0,0,1,.06.33A3,3,0,0,1,2.92,11.75ZM1,9.89A2.21,2.21,0,0,0,2.92,11,2.22,2.22,0,0,0,4.83,9.89Z"></path><path d="M12.13,11.75A3,3,0,0,1,9.3,9.62a.39.39,0,0,1,.06-.33.38.38,0,0,1,.3-.15h4.93a.38.38,0,0,1,.3.15.36.36,0,0,1,.06.33A3,3,0,0,1,12.13,11.75ZM10.22,9.89a2.19,2.19,0,0,0,3.81,0Z"></path></svg> </span> <a class="site-header__link svelte-5qrmpy" data-link="Criminal Justice" href="https://www.propublica.org/topics/criminal-justice">Criminal Justice</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="more…" href="https://www.propublica.org/topics/">more…</a> </li></ul> </div><div class="site-header__links site-header__links-region svelte-5qrmpy"><strong class="site-header__links-heading svelte-5qrmpy">Browse by Place </strong> <ul class="site-header__links-list svelte-5qrmpy"><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Midwest" href="https://www.propublica.org/midwest/">Midwest</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Northwest" href="https://www.propublica.org/northwest/">Northwest</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="South" href="https://www.propublica.org/south/">South</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Southwest" href="https://www.propublica.org/southwest/">Southwest</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Texas" href="https://www.propublica.org/texas/">Texas</a> </li></ul> </div><div class="site-header__links site-header__links-type svelte-5qrmpy"><strong class="site-header__links-heading svelte-5qrmpy">Type </strong> <ul class="site-header__links-list svelte-5qrmpy"><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Graphics &amp; Data" href="https://www.propublica.org/newsapps/">Graphics &amp; Data</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Newsletters" href="https://www.propublica.org/newsletters/">Newsletters</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Series" href="https://www.propublica.org/series/">Series</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Videos" href="https://www.propublica.org/video/">Videos</a> </li></ul> </div><div class="site-header__links site-header__links-special svelte-5qrmpy"> <ul class="site-header__links-list svelte-5qrmpy"><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Local Reporting Network" href="https://www.propublica.org/local-reporting-network/">Local Reporting Network</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Electionland" href="https://www.propublica.org/electionland/">Electionland</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Data Store" href="https://www.propublica.org/datastore/">Data Store</a> </li></ul> </div><div class="site-header__links site-header__links-info svelte-5qrmpy"><strong class="site-header__links-heading svelte-5qrmpy">Info </strong> <ul class="site-header__links-list svelte-5qrmpy"><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="About Us" href="https://www.propublica.org/about/">About Us</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Impact" href="https://www.propublica.org/impact/">Impact</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Jobs &amp; Fellowships" href="https://www.propublica.org/jobs/">Jobs &amp; Fellowships</a> </li><li class="svelte-5qrmpy"> <a class="site-header__link svelte-5qrmpy" data-link="Contact Us" href="https://www.propublica.org/contact/">Contact Us</a> </li></ul> </div>  <div class="site-header__links site-header__links-follow svelte-5qrmpy"><strong class="site-header__links-heading svelte-5qrmpy" data-svelte-h="svelte-19sje8q">Follow ProPublica</strong> <ul class="site-header__links-list site-header__links-list-follow svelte-5qrmpy"><li data-link="Bluesky" class="svelte-5qrmpy"> <a href="https://bsky.app/profile/propublica.org" class="button shape--circle  button-is-icon-only  svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--cool-70); --button-border: none; --button-color: white; --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="currentColor"><title>Bluesky</title><path d="M5.20079 2.42542C7.95442 4.48593 10.9155 8.67296 12 10.9221C13.0845 8.67768 16.0456 4.49064 18.7992 2.42542C20.7843 0.935439 24 -0.215052 24 3.45332C24 4.18416 23.5804 9.60656 23.3352 10.4883C22.477 13.5437 19.3556 14.3264 16.5784 13.8502C21.4303 14.6753 22.6656 17.4101 19.9969 20.1449C14.9328 25.3409 12.7214 18.8435 12.1556 17.179C12.0754 16.948 12.033 16.8113 12 16.8113C11.967 16.8113 11.9246 16.9527 11.8444 17.179C11.2786 18.8435 9.06248 25.3409 4.00314 20.1449C1.3391 17.4101 2.56974 14.6753 7.42161 13.8502C4.6444 14.3264 1.52299 13.5437 0.669548 10.4836C0.419646 9.60184 0 4.17945 0 3.4486C0 -0.219767 3.21572 0.930724 5.20079 2.4207V2.42542Z"></path></svg></span> <span class="text font--sans svelte-1r0prvj a11y">Bluesky</span>  </a></li> <li data-link="Instagram" class="svelte-5qrmpy"> <a href="https://www.instagram.com/propublica" class="button shape--circle  button-is-icon-only  svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--cool-70); --button-border: none; --button-color: white; --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="currentColor"><title>Instagram</title><path d="M12,2.32c3.15,0,3.53,0,4.77.07a6.51,6.51,0,0,1,2.19.4,3.58,3.58,0,0,1,1.36.89A3.58,3.58,0,0,1,21.21,5a6.51,6.51,0,0,1,.4,2.19c.06,1.24.07,1.62.07,4.77s0,3.53-.07,4.77a6.51,6.51,0,0,1-.4,2.19A4,4,0,0,1,19,21.21a6.51,6.51,0,0,1-2.19.4c-1.24.06-1.62.07-4.77.07s-3.53,0-4.77-.07A6.51,6.51,0,0,1,5,21.21a3.58,3.58,0,0,1-1.36-.89A3.58,3.58,0,0,1,2.79,19a6.51,6.51,0,0,1-.4-2.19c-.06-1.24-.07-1.62-.07-4.77s0-3.53.07-4.77A6.51,6.51,0,0,1,2.79,5a3.58,3.58,0,0,1,.89-1.36A3.58,3.58,0,0,1,5,2.79a6.51,6.51,0,0,1,2.19-.4c1.24-.06,1.62-.07,4.77-.07M12,.19C8.79.19,8.39.2,7.13.26A8.84,8.84,0,0,0,4.26.81,6,6,0,0,0,.81,4.26,8.84,8.84,0,0,0,.26,7.13C.2,8.39.19,8.79.19,12s0,3.61.07,4.87a8.84,8.84,0,0,0,.55,2.87,6,6,0,0,0,3.45,3.45,8.84,8.84,0,0,0,2.87.55c1.26.06,1.66.07,4.87.07s3.61,0,4.87-.07a8.84,8.84,0,0,0,2.87-.55,6,6,0,0,0,3.45-3.45,8.84,8.84,0,0,0,.55-2.87c.06-1.26.07-1.66.07-4.87s0-3.61-.07-4.87a8.84,8.84,0,0,0-.55-2.87A6,6,0,0,0,19.74.81,8.84,8.84,0,0,0,16.87.26C15.61.2,15.21.19,12,.19Z"></path><path d="M12,5.94A6.06,6.06,0,1,0,18.06,12,6.06,6.06,0,0,0,12,5.94Zm0,10A3.94,3.94,0,1,1,15.94,12,3.95,3.95,0,0,1,12,15.94Z"></path><circle cx="18.3" cy="5.7" r="1.42"></circle></svg></span> <span class="text font--sans svelte-1r0prvj a11y">Instagram</span>  </a></li> <li data-link="Facebook" class="svelte-5qrmpy"> <a href="https://www.facebook.com/propublica/" class="button shape--circle  button-is-icon-only  svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--cool-70); --button-border: none; --button-color: white; --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="currentColor"><title>Facebook</title><path d="M8.25 14.0297V24H13.6875V14.0297H17.7422L18.5859 9.44531H13.6875V7.82344C13.6875 5.4 14.6391 4.47188 17.0953 4.47188C17.8594 4.47188 18.4734 4.49062 18.8297 4.52812V0.370313C18.1594 0.1875 16.5187 0 15.5719 0C10.5609 0 8.25 2.36719 8.25 7.47187V9.44531H5.15625V14.0297H8.25Z"></path></svg></span> <span class="text font--sans svelte-1r0prvj a11y">Facebook</span>  </a></li> <li data-link="Twitter" class="svelte-5qrmpy"> <a href="https://x.com/propublica" class="button shape--circle  button-is-icon-only  svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--cool-70); --button-border: none; --button-color: white; --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="currentColor"><title>X</title><path d="M18.2439 2.25H21.5532L14.3251 10.5094L22.8282 21.75H16.172L10.9548 14.9344L4.99229 21.75H1.67822L9.40791 12.9141L1.25635 2.25H8.08135L12.7923 8.47969L18.2439 2.25ZM17.0813 19.7719H18.9142L7.08291 4.125H5.11416L17.0813 19.7719Z"></path></svg></span> <span class="text font--sans svelte-1r0prvj a11y">(Twitter)</span>  </a></li> <li data-link="YouTube" class="svelte-5qrmpy"> <a href="https://www.youtube.com/user/propublica" class="button shape--circle  button-is-icon-only  svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--cool-70); --button-border: none; --button-color: white; --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="currentColor"><title>YouTube</title><path d="M24 12C24 20 24 20 12 20C0 20 0 20 0 12C0 4 0 4 12 4C24 4 24 4 24 12ZM16.5 12L9 7.76471V16.2353L16.5 12Z"></path></svg></span> <span class="text font--sans svelte-1r0prvj a11y">YouTube</span>  </a></li> <li data-link="Threads" class="svelte-5qrmpy"> <a href="https://www.threads.net/@propublica" class="button shape--circle  button-is-icon-only  svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--cool-70); --button-border: none; --button-color: white; --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="currentColor"><title>Threads</title><path d="M17.0391 11.0484C17.1422 11.0906 17.2359 11.1375 17.3344 11.1797C18.7031 11.8406 19.7063 12.8297 20.2313 14.0578C20.9672 15.7687 21.0375 18.5484 18.8109 20.7703C17.1141 22.4672 15.0469 23.2313 12.1266 23.2547H12.1125C8.82187 23.2313 6.29531 22.125 4.59375 19.9641C3.07969 18.0422 2.30156 15.3656 2.27344 12.0141V12V11.9906C2.29688 8.63906 3.075 5.9625 4.58906 4.04062C6.29063 1.87969 8.82187 0.773438 12.1125 0.75H12.1266C15.4219 0.773438 17.9812 1.875 19.7344 4.02656C20.5969 5.09063 21.2344 6.37031 21.6375 7.85625L19.7438 8.3625C19.4109 7.15312 18.9094 6.12188 18.2344 5.29688C16.8656 3.61875 14.8125 2.75625 12.1172 2.7375C9.44531 2.76094 7.425 3.61875 6.10781 5.2875C4.87969 6.84844 4.24219 9.10781 4.21875 12C4.24219 14.8922 4.87969 17.1516 6.10781 18.7172C7.42031 20.3859 9.44531 21.2438 12.1172 21.2672C14.5266 21.2484 16.1203 20.6766 17.4469 19.35C18.9609 17.8406 18.9328 15.9844 18.45 14.8547C18.1641 14.1891 17.6484 13.6359 16.9547 13.2188C16.7813 14.4797 16.4016 15.4828 15.7969 16.2562C14.9953 17.2781 13.8563 17.8313 12.3891 17.9109C11.2828 17.9719 10.2187 17.7047 9.39375 17.1609C8.41875 16.5141 7.84688 15.5297 7.78594 14.3812C7.66875 12.1172 9.45938 10.4906 12.2484 10.3312C13.2375 10.275 14.1656 10.3172 15.0234 10.4625C14.9109 9.76875 14.6812 9.21563 14.3391 8.8125C13.8703 8.26406 13.1391 7.98281 12.1734 7.97812H12.1406C11.3625 7.97812 10.3125 8.19375 9.64219 9.21094L8.02969 8.10469C8.92969 6.74062 10.3875 5.99063 12.1453 5.99063H12.1828C15.1172 6.00938 16.8656 7.84219 17.0438 11.0391L17.0344 11.0484H17.0391ZM9.72656 14.2734C9.7875 15.45 11.0578 15.9984 12.2859 15.9281C13.4859 15.8625 14.8453 15.3938 15.075 12.4969C14.4563 12.3609 13.7719 12.2906 13.0406 12.2906C12.8156 12.2906 12.5906 12.2953 12.3656 12.3094C10.3547 12.4219 9.68438 13.3969 9.73125 14.2687L9.72656 14.2734Z"></path></svg></span> <span class="text font--sans svelte-1r0prvj a11y">Threads</span>  </a></li> <li data-link="LinkedIn" class="svelte-5qrmpy"> <a href="https://www.linkedin.com/company/propublica/posts/" class="button shape--circle  button-is-icon-only  svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--cool-70); --button-border: none; --button-color: white; --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg viewBox="0 0 24 24" fill="currentColor" xmlns="http://www.w3.org/2000/svg"><title>LinkedIn</title><path d="M6.65548 8.41229H2.64045C2.46226 8.41229 2.31787 8.55674 2.31787 8.73487V21.6335C2.31787 21.8116 2.46226 21.956 2.64045 21.956H6.65548C6.83368 21.956 6.97806 21.8116 6.97806 21.6335V8.73487C6.97806 8.55674 6.83368 8.41229 6.65548 8.41229Z"></path><path d="M4.64942 2C3.18852 2 2 3.18723 2 4.64652C2 6.10645 3.18852 7.29413 4.64942 7.29413C6.10916 7.29413 7.29671 6.10639 7.29671 4.64652C7.29677 3.18723 6.10916 2 4.64942 2Z"></path><path d="M16.868 8.09167C15.2554 8.09167 14.0634 8.7849 13.3403 9.57258V8.73484C13.3403 8.55671 13.1959 8.41226 13.0177 8.41226H9.17265C8.99445 8.41226 8.85007 8.55671 8.85007 8.73484V21.6334C8.85007 21.8116 8.99445 21.956 9.17265 21.956H13.1789C13.3571 21.956 13.5015 21.8116 13.5015 21.6334V15.2516C13.5015 13.1011 14.0856 12.2633 15.5847 12.2633C17.2174 12.2633 17.3471 13.6064 17.3471 15.3623V21.6335C17.3471 21.8117 17.4915 21.9561 17.6697 21.9561H21.6774C21.8556 21.9561 22 21.8117 22 21.6335V14.5584C22 11.3606 21.3903 8.09167 16.868 8.09167Z"></path></svg></span> <span class="text font--sans svelte-1r0prvj a11y">LinkedIn</span>  </a></li> <li data-link="RSS" class="svelte-5qrmpy"> <a href="https://www.propublica.org/feeds/propublica/main" class="button shape--circle  button-is-icon-only  svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--cool-70); --button-border: none; --button-color: white; --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg role="img" width="24" height="24" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><title>RSS</title><path d="M20 19.6598C20 19.75 19.9642 19.8365 19.9004 19.9002C19.8367 19.964 19.7502 19.9998 19.66 19.9998H17.3401C17.2499 19.9998 17.1635 19.964 17.0997 19.9002C17.0359 19.8365 17.0001 19.75 17.0001 19.6598C17.0022 18.5247 16.8508 17.3945 16.5501 16.3C16.2604 15.2486 15.8334 14.2399 15.2802 13.3001C14.7244 12.3657 14.0524 11.5055 13.2803 10.7402C12.5149 9.96799 11.6548 9.29599 10.7204 8.74024C9.77847 8.19108 8.77037 7.76432 7.72047 7.47029C6.62038 7.16109 5.48333 7.00298 4.3406 7.00031C4.29566 7.00271 4.25076 6.99497 4.20921 6.97766C4.16767 6.96035 4.13055 6.93392 4.10061 6.90032C4.06701 6.87038 4.04058 6.83326 4.02327 6.79172C4.00596 6.75017 3.99822 6.70527 4.00062 6.66033V4.34041C3.99822 4.29547 4.00596 4.25057 4.02327 4.20902C4.04058 4.16748 4.06701 4.13036 4.10061 4.10042C4.13055 4.06682 4.16767 4.04039 4.20921 4.02308C4.25076 4.00577 4.29566 3.99803 4.3406 4.00043C5.746 4.00053 7.14505 4.18886 8.50044 4.56041C9.81129 4.91981 11.0688 5.45106 12.2403 6.14035C13.3965 6.81934 14.4616 7.64258 15.4102 8.59025C16.3578 9.53878 17.1811 10.6039 17.8601 11.7601C18.5494 12.9316 19.0806 14.1891 19.44 15.5C19.8116 16.8554 19.9999 18.2544 20 19.6598ZM15.0002 19.6598C15.0002 19.75 14.9644 19.8365 14.9006 19.9002C14.8369 19.964 14.7504 19.9998 14.6602 19.9998H12.3403C12.2501 19.9998 12.1636 19.964 12.0999 19.9002C12.0361 19.8365 12.0003 19.75 12.0003 19.6598C12.0074 18.6284 11.7997 17.6067 11.3903 16.6599C10.6228 14.8248 9.15935 13.3686 7.32049 12.6101C6.37989 12.2034 5.36534 11.9958 4.3406 12.0001C4.29566 12.0025 4.25076 11.9948 4.20921 11.9775C4.16767 11.9602 4.13055 11.9337 4.10061 11.9001C4.06701 11.8702 4.04058 11.8331 4.02327 11.7915C4.00596 11.75 3.99822 11.7051 4.00062 11.6601V9.34022C3.99822 9.29528 4.00596 9.25037 4.02327 9.20883C4.04058 9.16729 4.06701 9.13017 4.10061 9.10023C4.13055 9.06663 4.16767 9.04019 4.20921 9.02288C4.25076 9.00557 4.29566 8.99783 4.3406 9.00023C5.29329 9.00091 6.24162 9.1287 7.1605 9.38022C8.05554 9.62739 8.91568 9.98691 9.7204 10.4502C10.5061 10.9162 11.2315 11.4771 11.8803 12.1201C12.5233 12.769 13.0842 13.4944 13.5502 14.28C14.0135 15.0847 14.373 15.9449 14.6202 16.8399C14.8717 17.7588 14.9995 18.7071 15.0002 19.6598ZM9.00042 17.4999C9.0038 17.8288 8.94091 18.155 8.81549 18.4591C8.69008 18.7632 8.50471 19.0389 8.27045 19.2698C8.04096 19.506 7.7655 19.6926 7.46109 19.8181C7.15667 19.9437 6.82976 20.0055 6.50052 19.9998C6.17104 20.0073 5.84359 19.9463 5.53891 19.8207C5.23424 19.695 4.95899 19.5074 4.73059 19.2698C4.493 19.0414 4.30543 18.7662 4.17977 18.4615C4.05412 18.1568 3.99311 17.8294 4.00062 17.4999C3.99492 17.1707 4.05675 16.8438 4.1823 16.5393C4.30785 16.2349 4.49445 15.9595 4.73059 15.73C4.9615 15.4957 5.23721 15.3103 5.5413 15.1849C5.84538 15.0595 6.17161 14.9966 6.50052 15C6.82881 14.997 7.15425 15.061 7.45689 15.1883C7.75953 15.3155 8.03297 15.5033 8.26045 15.74C8.49717 15.9675 8.68491 16.2409 8.81215 16.5435C8.9394 16.8462 9.00346 17.1716 9.00042 17.4999Z" fill="currentColor"></path></svg></span> <span class="text font--sans svelte-1r0prvj a11y">RSS</span>  </a></li></ul></div> </nav> </div>  </div>
                        <!--svelte-component-end-->
                            
    
<main class="content" id="main">

        <article class="article center">

        
            <!-- Class assignment -->


    
        

                    




<div class="opener  opener--grid opener--center opener--order-art-hed-dek opener--same-color-in-dark-mode" data-pp-location="article opener">

                            
        <figure class="opener__art-wrapper">
            <div class="opener__art opener__art-start--1 opener__art-width--6">
                <div class="opener__video-wrapper">

                            
                <video class="js-responsive-video-switch"
                    muted playsinline autoplay loop
                                        poster="https://assets-d.propublica.org/v5/images/20250507-revlimid-video-still.jpg"
                    data-mobile-poster="https://assets-d.propublica.org/v5/images/20250507-revlimid-video-still.jpg"
                                                            >
                    <source type="video/mp4" src="https://assets-d.propublica.org/v5/video/20250507-revlimid-bank-mobile.mp4" data-mobile-src="https://assets-d.propublica.org/v5/video/20250507-revlimid-bank-mobile.mp4" data-desktop-src="https://assets-d.propublica.org/v5/video/20250507-revlimid-bank-desktop.mp4">
                </video>
            
                </div><!-- close .video-wrapper -->
            </div><!-- close .opener__art -->
            
<figcaption class="attribution">
    
        <span class="attribution__credit">
        <span class="a11y">Credit: </span>
        Ceramics by Lisa Larson-Walker/ProPublica, video by Lisa Larson-Walker/ProPublica, Gerardo del Valle/ProPublica and Katie Campbell/ProPublica
    </span>
    
    
    </figcaption>

        </figure>


    
    <div class="opener__topic-title-dek-wrapper  opener__text-start--2 opener__text-width--4 opener__topic-title-dek-wrapper--valign-center opener__topic-title-dek-wrapper--mobile-fullbleed">

                    <span class="opener__topics  opener__topics--vertical-rule opener__topics--dark">
            <a class="opener__topics-link  opener__topics-link--dark" href="https://www.propublica.org/topics/health-care">Health Care</a>
        </span>
    
    <h1 class="opener__hed  opener__hed--vertical-rule opener__hed--dark" >        The Price of Remission
    </h1>

    
            <div class="article-meta-1  article-meta-1--dark">
            <span class="article-meta-1__byline">
                by <a class="name" href="https://www.propublica.org/people/david-armstrong">David Armstrong</a>            </span>
            <time class="article-meta-1__pubdate">
                <time class="timestamp" datetime="2025-05-08EDT05:00">May 8, 2025, 5 a.m. EDT</time>
            </time>
        </div>
    
    </div> <!-- Close .opener__topic-title-dek-wrapper -->

            <div class="content"> <!-- not sure if this is the best way to reestablish the text column -->
            <h2 class="opener__dek opener__dek--match-text-column" >                When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.
            </h2>
        </div>
    
</div>
        
<div class="article-meta-1
     article-meta-1--center      article-meta-1--hide-byline " data-pp-location="article meta">

    <span class="article-meta-1__byline" data-pp-location="article byine">
        by <a class="name" href="https://www.propublica.org/people/david-armstrong">David Armstrong</a>    </span>
    <time class="article-meta-1__pubdate">
        <time class="timestamp" datetime="2025-05-08EDT05:00">May 8, 2025, 5 a.m. EDT</time>
    </time>

    <div class="article-meta-1__section-actions
         article-meta-1__section-actions--center     " data-pp-location="article story-tools">
        <script type="application/json" class="svelte-config">
                            {"componentName":"ShareTools","props":{"pageTitle":"Why Is Cancer Drug Revlimid So Expensive?","pageUrl":"https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma"},"contextArray":[]}
                        </script>
                        <div class="share-tools" data-pp-click data-pp-location="share tools"> <button class="button shape--pill    svelte-1r0prvj" data-pp-skip="false" role="button" aria-haspopup="dialog" aria-expanded="false" data-state="closed" id="5A4lhy_QhI" data-melt-popover-trigger="" data-popover-trigger="" style="--button-bg-color: var(--color-neutral-10); --button-border: none; --button-color: var(--color-neutral-70); --button-font-size: var(--scale-2); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><g clip-path="url(#clip0_149_321)"><path fill-rule="evenodd" clip-rule="evenodd" d="M4 11C4.55228 11 5 11.4477 5 12V20C5 20.2652 5.10536 20.5196 5.29289 20.7071C5.48043 20.8946 5.73478 21 6 21H18C18.2652 21 18.5196 20.8946 18.7071 20.7071C18.8946 20.5196 19 20.2652 19 20V12C19 11.4477 19.4477 11 20 11C20.5523 11 21 11.4477 21 12V20C21 20.7957 20.6839 21.5587 20.1213 22.1213C19.5587 22.6839 18.7957 23 18 23H6C5.20435 23 4.44129 22.6839 3.87868 22.1213C3.31607 21.5587 3 20.7956 3 20V12C3 11.4477 3.44772 11 4 11Z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M11.2929 1.29289C11.6834 0.902369 12.3166 0.902369 12.7071 1.29289L16.7071 5.29289C17.0976 5.68342 17.0976 6.31658 16.7071 6.70711C16.3166 7.09763 15.6834 7.09763 15.2929 6.70711L12 3.41421L8.70711 6.70711C8.31658 7.09763 7.68342 7.09763 7.29289 6.70711C6.90237 6.31658 6.90237 5.68342 7.29289 5.29289L11.2929 1.29289Z" fill="currentColor"></path><path fill-rule="evenodd" clip-rule="evenodd" d="M12 1C12.5523 1 13 1.44772 13 2V15C13 15.5523 12.5523 16 12 16C11.4477 16 11 15.5523 11 15V2C11 1.44772 11.4477 1 12 1Z" fill="currentColor"></path></g><defs><clipPath id="clip0_149_321"><rect width="24" height="24" fill="white"></rect></clipPath></defs></svg></span> <span class="text font--sans svelte-1r0prvj">Share</span>  </button> </div>
                        <!--svelte-component-end-->
                                <script type="application/json" class="svelte-config">
                            {"componentName":"DarkModeToggle","props":{},"contextArray":[]}
                        </script>
                        <div class="dark-mode-toggle svelte-1x7qxk6"> <button aria-hidden class="button shape--circle  button-is-icon-only  svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: var(--color-bg); --button-border: 1px solid var(--color-neutral-10); --button-color: var(--color-text-supp); --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: 1.7rem; --icon-size: 1em;"><span class="icon-before svelte-1r0prvj"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><title>Contrast</title><circle cx="12" cy="12" r="10"></circle><path fill="currentColor" d="M12 18a6 6 0 000-12v12z"></path></svg> </span> <span class="text font--sans svelte-1r0prvj a11y">Change Appearance</span>  </button> <label class="a11y" for="dark-mode-toggle__select" data-svelte-h="svelte-ku6aby">Change Appearance</label> <select class="dark-mode-toggle__select svelte-1x7qxk6" id="dark-mode-toggle__select" data-pp-change data-pp-category="change-mode"><option value="auto">Auto</option><option value="light">Light</option><option value="dark">Dark</option></select> </div>
                        <!--svelte-component-end-->
                                        <a class="article-meta-1__republish btn btn--outline" style="--button-color: var(--color-neutral-10); color: var(--color-neutral-70)" href="#" data-pp-action="republish open">Republish</a>
            </div>

    </div>
     

    
    <div class="article-body" data-pp-location="article body" >

        
                    <div class="article-body__top-notes" data-pp-location="top-note">
                

                                                
            <div class="article-body__note article-body__note--newsletter" id="newsletter-txt-note">
                <p>ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive <a href="https://www.propublica.org/newsletters/the-big-story?source=www.propublica.org&amp;placement=top-note&amp;region=national">our biggest stories</a> as soon as they’re published.</p>

            </div>

                

            </div><!-- end .article-body__top-notes -->
        
        
        




                    

<figure
    data-pp-id="1"
    data-pp-blocktype="embed"
    class="bb-embed size04 right out02 wide-sm wrap
                hide-print
        ">

    


                        <iframe class="lazyload" id="noa-web-audio-player" style="border: none" src="https://embed-player.newsoveraudio.com/v4?key=pp03n4&id=https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma&bgColor=2B3136&color=04AEE0&playColor=04AEE0&progressBgColor=E0E0E2&progressBorderColor=2B3136&titleColor=E0E0E2&timeColor=E0E0E2&speedColor=E0E0E2&noaLinkColor=E0E0E2&noaLinkHighlightColor=04AEE0&feedbackButton=true" width="100%" height="110px"></iframe>
            
    
<figcaption class="attribution">
    
    
    
    </figcaption>


</figure>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="2.0"><span class="first-line">The pain jolted me awake.</span> It was barely dawn, a misty February morning in 2023. My side felt as if I’d been stabbed.</p>

<p data-pp-blocktype="copy" data-pp-id="2.1">I had been dealing with pain for weeks — a bothersome ache that felt like a bad runner’s cramp. But now it was so intense I had to brace myself against the wall to stand up.</p>

<p data-pp-blocktype="copy" data-pp-id="2.2">A few hours after arriving at the emergency room, I heard my name. A doctor asked me to follow him to a private area, where he told me a scan had uncovered something “concerning.” </p>

<p data-pp-blocktype="copy" data-pp-id="2.3">There were lesions, areas of bone destruction, on top of both of my hip bones and on my sternum. These were hallmarks of multiple myeloma. “Cancer,” he said.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="3.0">Multiple myeloma is a blood cancer that ravages bone, leaving distinctive holes in its wake. Subsequent scans showed “innumerable lesions” from my neck to my feet as well as two broken ribs and a compression fracture in my spine. There is no cure.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="4.0">I walked out of the ER in search of fresh air. I sat on a metal bench and did what many patients do. I turned to Google. The first link was a medical review stating that the average lifespan of a newly diagnosed patient was three to five years. My stomach churned.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="5.0">I soon learned that information was outdated. Most patients today live much longer, in large part due to a drug with a horrific past. It was a doctor at the hospital who first told me I would likely take a thalidomide drug as part of my treatment.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="6.0">That couldn’t be possible, I told him.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="8.0">I knew the story of thalidomide, or at least I thought I did. It represented one of the darkest chapters in the history of modern medicine, having caused thousands of severe birth defects after it was given to pregnant women in the 1950s and 1960s. The drug was banned in most of the world, and the scandal gave rise to the modern-day U.S. Food and Drug Administration.</p>
        
    
                    
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="10.0">It turns out the drug once relegated to a pharmaceutical graveyard had new life as a cancer fighter.</p>

<p data-pp-blocktype="copy" data-pp-id="10.1">That drug I take is called Revlimid. It is a derivative of thalidomide, a slightly tweaked version of the parent compound.</p>

<p data-pp-blocktype="copy" data-pp-id="10.2">Revlimid is now one of the bestselling pharmaceutical products of all time, with total sales of more than $100 billion. It has extended tens of thousands of lives — including my own.</p>

<p data-pp-blocktype="copy" data-pp-id="10.3">But Revlimid is also, I soon learned, extraordinarily expensive, costing nearly $1,000 for each daily pill. (Although, I later discovered, a capsule costs just 25 cents to make.)</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="11.0">That steep tab has put the drug’s lifesaving potential out of reach for some cancer patients, who have been forced into debt or simply stopped taking the drug. The price also helps fuel our ballooning insurance premiums.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="12.0">For decades, <a href="https://www.propublica.org/people/david-armstrong">I’ve reported on outrageous health care costs</a> in the U.S. and the burden they place on patients. I’ve revealed the tactics used by drug companies to <a href="https://www.statnews.com/2016/09/30/fentanyl-opioid-insys-subsys/">drive sales</a> and keep the price of their products high.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="13.0">Even with my experience, the cost of Revlimid stood out. When I started taking the drug, I’d look at the smooth, cylindrical capsule in my hand and consider the fact I was about to swallow something that costs about the same as a new iPhone. A month’s supply, which arrives in an ordinary, orange-tinged plastic bottle, is the same price as a new Nissan Versa.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="14.0">I wanted to know how this drug came to cost so much — and why the price keeps going up. The price of Revlimid has been hiked 26 times since it launched. Some of what happened was reported at the time. But no one has pieced together the full account of what the drugmaker Celgene did, how federal regulators failed to rein it in and what the story reveals about unrestrained drug pricing in America.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="15.0">What I discovered astonished even me.</p>

<p data-pp-blocktype="copy" data-pp-id="15.1">My journey started with an indefatigable New York City lawyer on a quest to give her dying husband a chance.</p>
        
    
                    

<figure
    data-pp-id="16"
    data-pp-blocktype="image"
    class="bb-image full center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="3000"
        height="1125"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=c3ef58ababb5be1b8fd1009378f50b05"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=150&amp;q=75&amp;w=400&amp;s=c02e1042f375f7a54c272e9d646395df 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=c3ef58ababb5be1b8fd1009378f50b05 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=450&amp;q=75&amp;w=1200&amp;s=f4d877f9594c846d2d6d604a2890da96 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=488&amp;q=75&amp;w=1300&amp;s=150e3a9039b09dd3e8714c22dca27929 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=544&amp;q=75&amp;w=1450&amp;s=bf89cf649648f86cee4667b03813605e 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=1600&amp;s=2afab0b863a199b658f0590521409b9e 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=750&amp;q=75&amp;w=2000&amp;s=3c9f7cd3d1e51ef4f47020764e2d82cc 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3500"
        height="987"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=924fea850599ef450014dd3b95520f07"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=113&amp;q=75&amp;w=400&amp;s=cd2b79ac566446a9778617a60eb41913 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=924fea850599ef450014dd3b95520f07 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=338&amp;q=75&amp;w=1200&amp;s=e72064d6b218917be2d60b1ba4e53529 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=367&amp;q=75&amp;w=1300&amp;s=0efc3f62eec584a90c59348d9d2daee8 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=409&amp;q=75&amp;w=1450&amp;s=a9e10d2269c4162db0faf2df056018ac 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=451&amp;q=75&amp;w=1600&amp;s=3a8ad0b2b8c9c9d7c7b0c057b7f16e4f 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-01desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=564&amp;q=75&amp;w=2000&amp;s=54eec283f853988b64727aad7d7f7e6f 2000w"
                    />

            
    
<figcaption class="attribution">
    
    
    
    </figcaption>

</figure>

        
    
                    <h3    data-pp-id="17"
    data-pp-blocktype="heading"
    class="bb-heading bb-heading--chapter-hed"
    id="tiny-and-terrifying"
    >
    Tiny and Terrifying
</h3>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="18.0">Beth Wolmer’s story begins on a moon-splashed beach in the Cayman Islands in the winter of 1995. She and her husband, Ira, were holding hands as they walked in the sand, enjoying a rare break from a hectic life as parents to a 1-year-old daughter and demanding jobs as 30-something professionals in New York City.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="19.0">They had met through friends and clicked from the start. On Sunday mornings, they sat together for hours, sharing sections of the newspaper and eating bagels. They planned trips to Europe and outings to the Metropolitan Museum of Art.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="20.0">Ira was an interventional cardiologist who followed his father into medicine. Beth was a lawyer at the high-powered firm Skadden Arps.</p>

<p data-pp-blocktype="copy" data-pp-id="20.1">“We had a great life,” Beth told me. “I specifically remember coming home on the bus and thinking: ‘My life is just perfect, perfect. I’m not going to change a thing.’”</p>

<p data-pp-blocktype="copy" data-pp-id="20.2">As they walked that night in the Caribbean, Ira felt a sharp pain in his cheekbone. The pain flared several more times during the trip, becoming so intense that it brought tears to his eyes.</p>

<p data-pp-blocktype="copy" data-pp-id="20.3">When he got home, Ira made an appointment to figure out what was wrong. Imaging tests revealed multiple myeloma. The prognosis was grim. The couple was told Ira had two years to live.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="21.0">Specialists recommended treatments that would only provide a brief reprieve. The couple searched for someone who could offer something more. That’s when they found Dr. Bart Barlogie in Little Rock, Arkansas.</p>
        
    
                    <figure
    data-pp-id="22"
    data-pp-blocktype="pull-quote"
    class="bb-pull-quote bb--border-top
        size04 left out02 wide-sm wrap">

    <blockquote class="bb-pull-quote__text">
        <p>I’ve never been more scared of a spouse of a patient than I was of her.</p>

    </blockquote>
        <figcaption class="bb-pull-quote__source">
        —Dr. David Siegel, who treated Ira Wolmer

    </figcaption>
    
</figure>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="23.0">Barlogie had been recruited to the University of Arkansas for Medical Sciences from the more prestigious MD Anderson Cancer Center in Houston. In Texas, Barlogie had been frustrated by a medical culture that he viewed as too timid in its approach to multiple myeloma.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="24.0">He remembers working on a Sunday when a newly diagnosed patient was admitted to the hospital. With few options, Barlogie decided to put the patient on a taxing, four-drug chemotherapy cocktail used for lymphoma patients. It didn’t work. The patient died from a sepsis infection, a known complication of the treatment.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="25.0">The attending physician later admonished him, Barlogie said, saying, “Bart, we have to learn to treat myeloma gently.” Barlogie said he thought to himself, “Fuck you.”</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="26.0">In Arkansas, Barlogie was in charge. He quickly developed a reputation as a practitioner willing to try anything to fight the fatal disease. Patients from around the world — including the actor Roy Scheider from the movie “Jaws” — flocked to his clinic.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="27.0">Beth and Ira heard Barlogie before they saw him. The cowboy boots he’d taken to donning since his time in Houston clacked down the linoleum hallway floors. A short, slight man, Barlogie had a booming voice with a German accent. He wore leather jackets and round, red-framed glasses on his bald head.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="28.0">When he strode into the exam room, he hugged Beth and Ira and told them they had come to the right place.</p>

<p data-pp-blocktype="copy" data-pp-id="28.1">Now retired, Barlogie recalls being struck by Beth’s intensity. He said she told him “you must do something” to help Ira.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="29.0">I met Barlogie at his home in Little Rock. We sat in his office, which is filled with photos of the red Ducati motorcycle he used to ride to work. An old license plate with the letters “MMCURED” sat on a shelf, reflecting his goal to find a cure for multiple myeloma.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="30.0">When Beth and Ira found him, Barlogie told me, he had been having some success with a novel approach that put patients through two stem cell transplants a few months apart, which he called a tandem stem cell transplant. With a transplant, a patient is bombarded with high-dose chemotherapy to kill the cancerous plasma cells. The patient is then infused with healthy stem cells that travel to the bone marrow.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="31.0">The intense chemotherapy can be grueling and poses a small risk of death.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="32.0">Ira underwent three transplants. Each time, he relapsed. By the fall of 1997, after two years of treatment, Ira’s thick black hair was gone. He was losing weight. Then he had a stroke. His kidneys failed and required dialysis. He developed pneumonia and had to be intubated.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="33.0">Beth was determined to keep him alive long enough for their toddler daughter to remember him. With a photograph of Ira smiling with their baby as motivation, she applied her lawyer’s tenacity to the case. She pored over medical journals and peppered oncologists with questions about why what they were trying wasn’t working or quizzing them about a promising study. When doctors told her there was nothing more they could do for her husband, she refused to accept it.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="34.0">“She is a tiny person, but she is terrifying,” said Dr. David Siegel, part of the team that treated Ira in Arkansas. “I’ve never been more scared of a spouse of a patient than I was of her.” He meant it as a compliment.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="35.0">By late fall in 1997, Ira was dying and Beth was desperate.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="36.0">A researcher told her about the work of Dr. Judah Folkman, a surgeon and researcher at Boston Children’s Hospital. Folkman believed the growth of cancerous tumors could be stunted by starving them of a supply of new blood vessels.</p>
        
    
                    

<figure
    data-pp-id="37"
    data-pp-blocktype="image"
    class="bb-image full center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="3000"
        height="1125"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=48f2d62415a92500e7ca7109206d3144"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=150&amp;q=75&amp;w=400&amp;s=eb75b743f2b77db0025a978dbefec415 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=48f2d62415a92500e7ca7109206d3144 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=450&amp;q=75&amp;w=1200&amp;s=c1c8718a11194fd77b7d6dcc3639448f 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=488&amp;q=75&amp;w=1300&amp;s=51103d6cd4fcc0cc83b50b6d6362b1f1 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=544&amp;q=75&amp;w=1450&amp;s=ecbfe11c4f7c6f9c691eafee8b2f8eef 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=1600&amp;s=f93bee1c253bed639ae1ae421bfb8057 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=750&amp;q=75&amp;w=2000&amp;s=95e7030cf9ad550730114a26daae4b85 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3500"
        height="987"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=b6060accf27232a0e52fc74b154dd1da"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=113&amp;q=75&amp;w=400&amp;s=10e507a87d7133acb4345fba55877f16 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=b6060accf27232a0e52fc74b154dd1da 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=338&amp;q=75&amp;w=1200&amp;s=234fedbd5edad7deee6b23463b43a981 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=367&amp;q=75&amp;w=1300&amp;s=048a4d499fd9cb5a147dc72e1b37a537 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=409&amp;q=75&amp;w=1450&amp;s=d09bc7d15c51e0d9853e7e290e1e5d41 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=451&amp;q=75&amp;w=1600&amp;s=c4464556e62a6074229bb9970091ad1a 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-02desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=564&amp;q=75&amp;w=2000&amp;s=be276d486cc4ccce394fa64b9abb1f67 2000w"
                    />

            
    
<figcaption class="attribution">
    
    
    
    </figcaption>

</figure>

        
    
                    <h3    data-pp-id="38"
    data-pp-blocktype="heading"
    class="bb-heading bb-heading--chapter-hed"
    id="thank-you-god"
    >
    “Thank You, God”
</h3>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="39.0">Folkman was a workaholic who, when he wasn’t in the operating room or the research lab, was traveling across the world to promote his novel theory of how to attack cancer. Peers had ridiculed his idea since he first proposed it in the 1970s. The prevailing belief at the time was that tumors didn’t need a new blood supply to grow.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="40.0">A young researcher in his lab, an ophthalmologist named Robert D’Amato, was at work on the top question Folkman had posed. Could they come up with a drug, in pill form, that blocks the growth of new blood vessels?</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="41.0">Folkman has since died, but it wasn’t difficult for me to track down D’Amato. He still works at Boston Children’s Hospital, where he has his own lab and holds the Judah Folkman Chair in Surgery. Now in his early 60s, D’Amato has a youthful energy and speaks in a rapid, matter-of-fact clip.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="42.0">D’Amato told me that he had set out to find existing drugs that block blood vessel growth. He started by thinking of his own body and side effects caused by certain drugs. A drug that causes hair loss might be the result of the blood supply to hair follicles being shut off, for example. But this exercise wasn’t producing any viable candidates.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="43.0">After giving it some thought, D’Amato realized he had myopically narrowed his search. What about a woman’s body? There were drugs that stopped menstrual cycles. Then there were drugs that caused birth defects in pregnant women. In both of those cases, it was possible the drug was inhibiting blood vessel growth. He came up with a list of 10 drugs. At the top of the list was one with a devastating history: thalidomide.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="44.0">Beginning in the 1950s, pregnant women in Europe, Australia and other countries were frequently prescribed thalidomide as a treatment for morning sickness and to help them sleep. The drug was thought to be harmless and in Germany was sold over the counter. An advertisement for thalidomide in the United Kingdom claimed it could “be given with complete safety to pregnant women and nursing mothers without adverse effect on mother or child.”</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="45.0">They were wrong.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="46.0">The drug was eventually linked to birth defects in more than 10,000 babies. Those babies were born without limbs or with shortened limbs, malformed hands, disfigured faces and damage to internal organs. Nearly half died within months of being born.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="47.0">By the early 1960s, the drug was widely banned, considered a shameful chapter in the history of pharmaceuticals. It was never sold in the U.S. thanks to the unwavering objections of a resolute reviewer at the FDA named Frances Oldham Kelsey. The close call, however, prompted Congress to require more rigorous safety and efficacy data from drug manufacturers and empower the FDA to monitor the industry more closely.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="48.0">D’Amato theorized that the thalidomide birth defects were the result of the drug stopping the growth of new blood vessels that the fetus needs to develop. He walked me through his experiments: He cracked a fertilized chicken egg on a glass petri dish and placed thalidomide on the surface. After two days, if no blood vessels grow on the embryo, a halo should appear around the thalidomide sample, showing the drug worked. It didn’t.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="49.0">Folkman told D’Amato to move on. But D’Amato couldn’t shake the disappointing results. He did more research and realized thalidomide needs to first be broken down in the body to have an effect on humans. He purchased metabolites of thalidomide, repeated the test and this time found a halo around the sample.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="50.0">He kept experimenting and in 1994 published a paper finding that thalidomide had “clear implications” for treating tumors.</p>

<p data-pp-blocktype="copy" data-pp-id="50.1">So when Beth called three years later, Folkman told her they should try it.</p>

<p data-pp-blocktype="copy" data-pp-id="50.2">Barlogie told me he didn’t think it would work. Beth said she had to convince him to try it.</p>

<p data-pp-blocktype="copy" data-pp-id="50.3">Barlogie agreed to test it on Ira and two other patients who were out of treatment options in early December.</p>
        
    
                    <figure
    data-pp-id="51"
    data-pp-blocktype="pull-quote"
    class="bb-pull-quote bb--border-top
        size04 right out02 wide-sm wrap">

    <blockquote class="bb-pull-quote__text">
        <p>I wanted him alive forever.</p>

    </blockquote>
        <figcaption class="bb-pull-quote__source">
        —Beth Wolmer

    </figcaption>
    
</figure>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="52.0">The drug did not work for Ira. Beth said just before he died, Ira sat up in bed, kissed her and smiled. It was March 10, 1998. He was 38.</p>

<p data-pp-blocktype="copy" data-pp-id="52.1">After years of frantically searching for anything that would help, the finality of his death was difficult to accept, she said. “I wanted him alive forever.”</p>

<p data-pp-blocktype="copy" data-pp-id="52.2">It is unclear what happened with the second patient. The third patient, however, started to get better.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="53.0">His name was Jimmy. Little more is known about him except that he was a patient of another oncologist at the hospital, Dr. Seema Singhal, and near death before he started the drug. “I told him it might work, but at the very least it would help him sleep,” Singhal said. Shortly after Jimmy took his first dose of thalidomide, Singhal left for a vacation.</p>
        
    
                    

<figure
    data-pp-id="54"
    data-pp-blocktype="image"
    class="bb-image size10 center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="1500"
        height="2250"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=704f18c84271db33d36b97a213d1886c"
        srcset="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=400&amp;s=4cd90ab12c102e292691013fb208f5dc 400w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=704f18c84271db33d36b97a213d1886c 800w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1800&amp;q=75&amp;w=1200&amp;s=5dc6f0dcec27581807ced8e5e3a8d248 1200w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1950&amp;q=75&amp;w=1300&amp;s=53d0074b4300b3ba00864cd872264f19 1300w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2175&amp;q=75&amp;w=1450&amp;s=88af3b2e9655e960ffe0302c39a9752d 1450w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2400&amp;q=75&amp;w=1600&amp;s=6b5c9393f1d951481061d6889be1f767 1600w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=3000&amp;q=75&amp;w=2000&amp;s=51307e5ca9055b0ab9db12df3b65ac5a 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3000"
        height="4500"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=2668846b03e57dce6e2b734536effa2f"
        srcset="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=400&amp;s=f370aaabc7f33d2066ac4b2fa93d9d93 400w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=2668846b03e57dce6e2b734536effa2f 800w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1800&amp;q=75&amp;w=1200&amp;s=9ef59240fab6c3c1b04069ed15d64f67 1200w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1950&amp;q=75&amp;w=1300&amp;s=8dd37fbd6b9dc80107bd50a42863ac0a 1300w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2175&amp;q=75&amp;w=1450&amp;s=304ee2e0ce62fc4679ea1c8af51b5b57 1450w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2400&amp;q=75&amp;w=1600&amp;s=e25890aa91f653ebff35d6f3362134ea 1600w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-thank-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=3000&amp;q=75&amp;w=2000&amp;s=0c0601fe50293fa21f4a566a21d51893 2000w"
                    />

            
    
<figcaption class="attribution">
        <span class="attribution__caption">Dr. Bart Barlogie and Dr. Seema Singhal</span>
    
        <span class="attribution__credit">
        <span class="a11y">Credit: </span>
        Painting by James Lee Chiahan for ProPublica
    </span>
    
    
    </figcaption>

</figure>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="55.0">When she returned two weeks later, her mailbox was full of lab results for Jimmy. He was still alive. She sat down to double-check the results, which showed declining amounts of a cancer marker. “For 30 minutes, I was the only person in the world who knew this worked,” she said.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="56.0">Singhal walked down to Barlogie’s office to give him the news. “He took me by the hand, opened a window and shouted, ‘Thank you, God,’” she said.</p>
        
    
                    

<figure
    data-pp-id="57"
    data-pp-blocktype="image"
    class="bb-image full center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="3000"
        height="1125"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=76bf55fa7151c8d2ee5e53ba17b3cad1"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=150&amp;q=75&amp;w=400&amp;s=1c51a5b6131a68815abcef434fa57cb2 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=76bf55fa7151c8d2ee5e53ba17b3cad1 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=450&amp;q=75&amp;w=1200&amp;s=f19f18a2c3b5c3650a0475a21cd8a23f 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=488&amp;q=75&amp;w=1300&amp;s=d39214535bbded8596f9e72538a09a63 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=544&amp;q=75&amp;w=1450&amp;s=862d6fd4d8e215f7f73a560c00a5a9e4 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=1600&amp;s=ae32163792d0e685360844dbc88a089c 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=750&amp;q=75&amp;w=2000&amp;s=daa418e886e473809327ec05f19d0fcd 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3500"
        height="987"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=982f9b3807f3a20bfaed3401bec67511"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=113&amp;q=75&amp;w=400&amp;s=2aaf62c6f725c25b56b4697c004d7f76 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=982f9b3807f3a20bfaed3401bec67511 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=338&amp;q=75&amp;w=1200&amp;s=ef19cce2fd48fa8a42ea3e0812ba2adb 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=367&amp;q=75&amp;w=1300&amp;s=57f3cbd0c581d2476b5dc15d1da437d9 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=409&amp;q=75&amp;w=1450&amp;s=8726c1badd2914a5ce304027f757708a 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=451&amp;q=75&amp;w=1600&amp;s=59491035a89ed24e278d059d72fbb3a1 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-03desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=564&amp;q=75&amp;w=2000&amp;s=6be435a60d02f6aa9eb9d0b0794edaac 2000w"
                    />

            
    
<figcaption class="attribution">
    
    
    
    </figcaption>

</figure>

        
    
                    <h3    data-pp-id="58"
    data-pp-blocktype="heading"
    class="bb-heading bb-heading--chapter-hed"
    id="violent-arguments"
    >
    “Violent Arguments”
</h3>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="59.0">Word of Jimmy’s stunning recovery in Arkansas quickly made its way to the offices of Celgene Corp., located in a small corporate park in a rural patch of northern New Jersey.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="60.0">The company had just wrapped up a brutal year-end accounting, which showed losses of $27 million on revenue of just $1.1 million. Money was so tight that executives engaged in what one of them called “violent arguments” over whether to charge employees for coffee.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="61.0">Celgene had acquired the rights to thalidomide patents held by researchers at Rockefeller University in 1992. The company, which was new to pharmaceuticals, planned to use the experience of obtaining FDA approval for thalidomide to develop other drugs.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="62.0">“It wasn’t meant to be a blockbuster,” said Sol Barer, who started at the company in 1987 and later became CEO.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="63.0">When Celgene announced plans to develop the disgraced drug for new uses, the only analyst following the company on Wall Street dropped coverage and told Celgene officials they didn’t know what they were doing.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="64.0">The company thought the largest market would be as a treatment for AIDS patients experiencing dangerous weight loss. To win approval of the drug, however, Celgene selected a use that was already in practice in parts of the world for a small group of patients.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="65.0">In July 1998, the FDA approved thalidomide for the treatment of a painful complication of leprosy. It was a momentous decision, coming just a few decades after the drug caused so much harm.</p>

<p data-pp-blocktype="copy" data-pp-id="65.1">The market for leprosy was tiny, but what happened with Jimmy in Arkansas changed everything for the company.</p>
        
    
                    

<figure
    data-pp-id="66"
    data-pp-blocktype="image"
    class="bb-image full center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="3000"
        height="1125"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=cbc538fcc6160e80b5852f3e9b378ba9"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=150&amp;q=75&amp;w=400&amp;s=a1942482a9fadf6676e2b6f9db9655ba 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=cbc538fcc6160e80b5852f3e9b378ba9 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=450&amp;q=75&amp;w=1200&amp;s=a944e22588c3221c336029a55f98532b 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=488&amp;q=75&amp;w=1300&amp;s=03e3fb21d58ce0c481a8353174b8d309 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=544&amp;q=75&amp;w=1450&amp;s=b19d3abf05a4300c633c34038313c147 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=1600&amp;s=6603b332d25db856f8bfb0d272fd531f 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=750&amp;q=75&amp;w=2000&amp;s=7f5a6407524bd18dea1079b45d138ef8 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3500"
        height="987"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=895af9600755c5b061801e7a5b542764"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=113&amp;q=75&amp;w=400&amp;s=e73026e30ac1067a482b569219521042 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=895af9600755c5b061801e7a5b542764 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=338&amp;q=75&amp;w=1200&amp;s=c3bf30067ffb0c6c1b2b58cbabf04099 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=367&amp;q=75&amp;w=1300&amp;s=b0f461f6a7f7cbb3c51feedc2c0f0f90 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=409&amp;q=75&amp;w=1450&amp;s=dd8b1d5adaacf35ad526d683445ed758 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=451&amp;q=75&amp;w=1600&amp;s=f39a4b43a708f24b22cdfdfaf0ca95c9 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-04desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=564&amp;q=75&amp;w=2000&amp;s=3fa0ab2d18cad208ac5fb40cfbd82873 2000w"
                    />

            
    
<figcaption class="attribution">
    
    
    
    </figcaption>

</figure>

        
    
                    <h3    data-pp-id="67"
    data-pp-blocktype="heading"
    class="bb-heading bb-heading--chapter-hed"
    id="blocked-exits"
    >
    Blocked Exits
</h3>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="68.0">The Arkansas doctors had been busy since first testing thalidomide on Ira Wolmer, Jimmy and the other patient. They quickly got approval to conduct a larger experiment funded by a grant from the U.S. National Institutes of Health. Now, in December 1998, they were ready to share their initial findings at the annual meeting of the American Society of Hematology.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="69.0">It had been three decades since a new therapy for multiple myeloma had been approved, and there was a buzz among the oncologists gathered in Miami Beach for the conference. So many doctors crowded into the room for the presentation that the fire marshal had to intervene several times to clear exit ways. Word had already spread among multiple myeloma specialists about Jimmy. Now, the assembled doctors wanted to know whether it had been a fluke or a discovery that would fundamentally change how they practiced.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="70.0">Singhal was tasked with presenting the data. It was a big stage for the 32-year-old doctor, who had only been practicing in the U.S. for two years.</p>
        
    
                    <figure
    data-pp-id="71"
    data-pp-blocktype="pull-quote"
    class="bb-pull-quote bb--border-top
        size04 left out02 wide-sm wrap">

    <blockquote class="bb-pull-quote__text">
        <p>It completely changed the treatment landscape.</p>

    </blockquote>
        <figcaption class="bb-pull-quote__source">
        —Dr. Seema Singhal

    </figcaption>
    
</figure>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="72.0">The 89 patients in the study were high-risk cases who had undergone prior treatment. They were patients who, like Ira, had run out of options. Now, after thalidomide treatment, one-third had declines in myeloma activity.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="73.0">Those were stunning numbers, unlike anything seen before in the treatment of multiple myeloma. When Singhal finished, the room erupted in applause.</p>

<p data-pp-blocktype="copy" data-pp-id="73.1">“It completely changed the treatment landscape,” she said.</p>

<p data-pp-blocktype="copy" data-pp-id="73.2">I wasn’t able to track down Jimmy, but I have a sense of how he might have felt when he realized the treatment was working.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="74.0">After my initial emergency room visit, it took time to confirm my diagnosis and do some additional testing. While I waited, the pain worsened. Painkillers barely made a dent. All I could picture was this cancer eating away at my bones, doing more damage every day.</p>
        
    
                    

<figure
    data-pp-id="75"
    data-pp-blocktype="image"
    class="bb-image size10 center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="1500"
        height="2250"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=142dc3bfd3bf62470232021becc5aff1"
        srcset="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=400&amp;s=04092f316e8f0d634aa37f051c925962 400w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=142dc3bfd3bf62470232021becc5aff1 800w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1800&amp;q=75&amp;w=1200&amp;s=a2f2683ee22753a861701215a9e580f2 1200w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1950&amp;q=75&amp;w=1300&amp;s=013236d708a294286d77ce02c775c727 1300w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2175&amp;q=75&amp;w=1450&amp;s=66d6f2b81261922313823cf338288718 1450w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2400&amp;q=75&amp;w=1600&amp;s=ed47cab352bf4209c27c7f31444fd298 1600w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=3000&amp;q=75&amp;w=2000&amp;s=5493a1b0a70a883f1fb7fd4dd6380936 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3000"
        height="4500"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=640967513f48fa38b1265e3ef262949b"
        srcset="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=400&amp;s=671d710b6687652989d3e9ad942dd09f 400w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=640967513f48fa38b1265e3ef262949b 800w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1800&amp;q=75&amp;w=1200&amp;s=0ee969ebeca701fd02e0b3f87469f568 1200w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1950&amp;q=75&amp;w=1300&amp;s=4ba7c8552ee015021efa3af2cd094b90 1300w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2175&amp;q=75&amp;w=1450&amp;s=b34a5e1bde29ef734b7e52d68f2c5bd0 1450w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2400&amp;q=75&amp;w=1600&amp;s=1ba5281913c24bace21f707addc0897c 1600w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-hallway-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=3000&amp;q=75&amp;w=2000&amp;s=749919711d101d0c1f843bd901ee9035 2000w"
                    />

            
    
<figcaption class="attribution">
        <span class="attribution__caption">David Armstrong</span>
    
        <span class="attribution__credit">
        <span class="a11y">Credit: </span>
        Painting by James Lee Chiahan for ProPublica
    </span>
    
    
    </figcaption>

</figure>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="76.0">Some patients wait months for care. I was lucky enough to meet my oncologist within weeks. He had a script for Revlimid ready to go, part of a regimen of four drugs I would take as standard induction therapy, and I was able to start it within days.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="77.0">The initial dose of Revlimid cost $18,255 for a month’s supply, and my insurance covered the cost.</p>

<p data-pp-blocktype="copy" data-pp-id="77.1">Within a month, my blood tests showed a massive drop in a key cancer indicator.</p>

<p data-pp-blocktype="copy" data-pp-id="77.2">My pain gradually subsided too. By the end of April, I wrote in my journal that the pain was a 3 or 4 instead of the usual 9 or 10. “It doesn’t hurt to get out of bed anymore,” I wrote.</p>
        
    
                    

<figure
    data-pp-id="78"
    data-pp-blocktype="image"
    class="bb-image full center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="3000"
        height="1125"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=62f3bdb00b30cab48ce4fdea5a06c627"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=150&amp;q=75&amp;w=400&amp;s=56f369538bef37b1df2713d8bb87a97d 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=62f3bdb00b30cab48ce4fdea5a06c627 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=450&amp;q=75&amp;w=1200&amp;s=ed0b3604cdaee648fb5015e0de251d28 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=488&amp;q=75&amp;w=1300&amp;s=26f5361266adda4351f733e34fd21fe3 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=544&amp;q=75&amp;w=1450&amp;s=eb14920f02e97280f222e749dae0e598 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=1600&amp;s=c14566c2ce84d06719f4415fde6ecc9b 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=750&amp;q=75&amp;w=2000&amp;s=dd16efcf9768c54e95233ee52500c75e 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3500"
        height="987"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=b595ce49f6393020d0d01ae1caa89cfb"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=113&amp;q=75&amp;w=400&amp;s=6686b67b231f0340f4ea2bba402fb0be 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=b595ce49f6393020d0d01ae1caa89cfb 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=338&amp;q=75&amp;w=1200&amp;s=c2d5b44d0eb5bdfcece661398f7ff207 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=367&amp;q=75&amp;w=1300&amp;s=33f5a30de7d9ce0dfc1eec4e7eb813e1 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=409&amp;q=75&amp;w=1450&amp;s=db71e15b15ffee4ae078e613f4c98157 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=451&amp;q=75&amp;w=1600&amp;s=0367970deba4bd109773f8e262515c1a 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-05desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=564&amp;q=75&amp;w=2000&amp;s=15bbd7ee90bf12ad2a42a2c006e868fd 2000w"
                    />

            
    
<figcaption class="attribution">
    
    
    
    </figcaption>

</figure>

        
    
                    <h3    data-pp-id="79"
    data-pp-blocktype="heading"
    class="bb-heading bb-heading--chapter-hed"
    id="a-piggy-bank"
    >
    A Piggy Bank
</h3>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="80.0">The discovery in Arkansas made thalidomide, which Celgene sold as Thalomid, an instant hit.</p>

<p data-pp-blocktype="copy" data-pp-id="80.1">As a result, Celgene’s revenue increased nearly sevenfold to $26.2 million in the year after the Miami presentation. It sold its thalidomide pills for $7.50 each.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="81.0">From those modest beginnings, Celgene took a slightly altered version of that pill and turned it into one of the bestselling and most expensive prescription drugs in history. Celgene’s success with Thalomid was the result of remarkable good fortune, a case where the heavy lifting of discovery and initial testing had already been done, by Beth Wolmer, D’Amato, Barlogie, Singhal and others.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="82.0">The development of the drug that would become Revlimid took me deep into the confounding, sharp-elbowed world of drug patents, which ostensibly protect drugmakers, allowing them to recoup the massive investments they made in developing a new product. Celgene drew on patent law, a drug safety system and even patient assistance programs to guard the exclusivity of its prized drug and the massive revenue it generated.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="83.0">Those tactics, detailed in reams of court filings, allowed Celgene to treat Revlimid like a piggy bank, tapping it whenever it wanted.</p>
        
    
                    <figure
    data-pp-id="84"
    data-pp-blocktype="pull-quote"
    class="bb-pull-quote bb--border-top
        size04 right out02 wide-sm wrap">

    <blockquote class="bb-pull-quote__text">
        <p>There was a common internal theme at Celgene that cancer patients were willing to pay almost any amount Celgene charged.</p>

    </blockquote>
        <figcaption class="bb-pull-quote__source">
        —David Schmidt, a former Celgene executive

    </figcaption>
    
</figure>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="85.0">Amid the early success of Thalomid, Celgene identified two potential threats: One was obvious. Thaldiomide caused birth defects, a looming risk that could result in it being pulled from the market.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="86.0">The other was that Celgene held limited patents on the drug. Patents are exclusive legal rights to inventions, and researchers file them on nearly every aspect of drug development as soon as they can, locking up everything from specific sets of ingredients to the way the drug is used and administered. The more robust patents a company has, the longer it can potentially ward off competitors.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="87.0">Thalidomide was an old drug and Celgene’s patents did not cover the active ingredient, leaving it open to competition. The patents it did have, covering items such as the optimal dosages and its use in treating particular diseases, were considered weaker and open to a court challenge. If Celgene could create a new version of thalidomide — ideally one that didn’t cause birth defects — the company could seek more and stronger patents that would extend beyond those of the original drug.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="88.0">So researchers at Celgene tested analogs of thalidomide, which are drugs that have a similar effect but are different from the parent compound in minor ways, such as having one less oxygen atom. The analogs are also more potent than the original, meaning they can achieve a similar effect at lower doses.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="89.0">Celgene was not alone in its efforts. D’Amato was also studying thalidomide analogs and filing patents on their use, which he and Boston Children’s Hospital licensed to a Celgene competitor, EntreMed Inc.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="90.0">With dueling patents, the companies sued each other in 2002.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="91.0">Celgene was newly flush with cash from rising sales of thalidomide. EntreMed, on the other hand, was burning through money as it focused most of its resources on developing other drugs discovered in Folkman’s lab.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="92.0">In December of 2002, the companies settled.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="93.0">Celgene agreed to pay Boston Children’s Hospital royalties from future sales of Revlimid. In exchange, the hospital and D’Amato licensed their patents of thalidomide analogs to Celgene. Celgene also agreed to pay EntreMed $27 million.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="94.0">For Celgene, the fight with EntreMed was a valuable experience. It learned that competition can be neutralized.</p>
        
    
                    

<figure
    data-pp-id="95"
    data-pp-blocktype="image"
    class="bb-image full center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="3000"
        height="1125"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=6f6beee98fdaf1527836601d66d33c70"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=150&amp;q=75&amp;w=400&amp;s=a9352220738a63732f9b3aed946d88a9 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=6f6beee98fdaf1527836601d66d33c70 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=450&amp;q=75&amp;w=1200&amp;s=8af3768b22b5fe2b7c95c52671f440e8 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=488&amp;q=75&amp;w=1300&amp;s=19a90e8aa32d4b423164cfa4efc6bda4 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=544&amp;q=75&amp;w=1450&amp;s=2d195755f4e606713e1e11ab5d7f2ff7 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=1600&amp;s=21a93d12cfb431449186d05b6ebbc31d 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=750&amp;q=75&amp;w=2000&amp;s=fb4b645e81123880ccfcad7c86a64622 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3500"
        height="987"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=d4a20ffbd9bea7b437231bdf1d3b1fcc"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=113&amp;q=75&amp;w=400&amp;s=4c01f47b6342367f7adcadc4dce4e118 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=d4a20ffbd9bea7b437231bdf1d3b1fcc 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=338&amp;q=75&amp;w=1200&amp;s=ca799ad7a72cf7679143ae240bd59235 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=367&amp;q=75&amp;w=1300&amp;s=72edb497c78b501efa61dd5157fec594 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=409&amp;q=75&amp;w=1450&amp;s=678ef056af411b54ef1eb7da0e3fd163 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=451&amp;q=75&amp;w=1600&amp;s=f23c57ebcea528984e34cea446a55c30 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-06desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=564&amp;q=75&amp;w=2000&amp;s=07a05a865787a69f153804aff10c902e 2000w"
                    />

            
    
<figcaption class="attribution">
    
    
    
    </figcaption>

</figure>

        
    
                    <h3    data-pp-id="96"
    data-pp-blocktype="heading"
    class="bb-heading bb-heading--chapter-hed"
    id="the-rise-of-revlimid"
    >
    The Rise of Revlimid
</h3>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="97.0">Celgene had kept the price of Thalomid low when it was initially intended for AIDS patients, CEO John Jackson told investors in 2004, as the company “didn’t want huge numbers of people demonstrating in front” of its office.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="98.0">That wasn’t a problem with cancer patients. There was “plenty of room for very substantial increases” in the price of the drug now, Jackson told investors.</p>
        
    
                    <figure
    data-pp-id="99"
    data-pp-blocktype="pull-quote"
    class="bb-pull-quote bb--border-top
        size04 left out02 wide-sm wrap">

    <blockquote class="bb-pull-quote__text">
        <p>It is time for us to take Jimbo to the wood shed.</p>

    </blockquote>
        <figcaption class="bb-pull-quote__source">
        —A senior Celgene official discussing a doctor critical of Revlimid

    </figcaption>
    
</figure>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="100.0">Just two days earlier, Celgene had hiked the price of Thalomid to $47 a pill.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="101.0">“There was a common internal theme at Celgene that cancer patients were willing to pay almost any amount Celgene charged,” wrote David Schmidt, a former national account manager at the company, in a whistleblower lawsuit he filed after his employment was terminated in 2008. The lawsuit was voluntarily dismissed by Schmidt. (Jackson didn’t respond to requests for comment; Schmidt declined to talk to me.)</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="102.0">When Celgene launched Revlimid in December of 2005, it set the initial price at $55,000 a year, or $218 a pill, which was about double what analysts expected.</p>

<p data-pp-blocktype="copy" data-pp-id="102.1">Seven months later, when the FDA approved the drug for multiple myeloma, the price jumped to $70,560 a year, or $280 a pill.</p>
        
    
                    

<figure
    data-pp-id="104"
    data-pp-blocktype="embed"
    class="bb-embed size06 center  wide-sm wrap
                     bb--border-top                 hide-print
        ">

    
<div class="lead-in">
            <p class="lead-in__title" id="the-price-of-revlimid-has-increased-26-times-since-fda-approval">The Price of Revlimid Has Increased 26 Times Since FDA Approval</p>
                <div class="lead-in__intro">
            <p>Each dot indicates a new manufacturer list price per pill.</p>

        </div>
    </div>


                        <iframe class="lazyload" title="Revlimid Price per Pill" aria-label="Interactive line chart" id="datawrapper-chart-281Qw" src="https://datawrapper.dwcdn.net/281Qw/1/" scrolling="no" frameborder="0" style="width: 0; min-width: 100% !important; border: none;" height="343" data-external="1"></iframe><script type="text/javascript">!function(){"use strict";window.addEventListener("message",(function(a){if(void 0!==a.data["datawrapper-height"]){var e=document.querySelectorAll("iframe");for(var t in a.data["datawrapper-height"])for(var r,i=0;r=e[i];i++)if(r.contentWindow===a.source){var d=a.data["datawrapper-height"][t]+"px";r.style.height=d}}}))}();
</script>
            
    
<figcaption class="attribution">
    
        <span class="attribution__credit">
        <span class="a11y">Credit: </span>
        Source: AnalySource
    </span>
    
    
    </figcaption>


</figure>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="105.0">The cost to manufacture each Revlimid pill, meanwhile, was 25 cents. I found a deposition marked “highly confidential” in which a top Celgene executive testified that the cost started at a quarter and never changed.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="106.0">Even on Wall Street, which cheered higher pricing, the initial cost of Revlimid prompted concern among analysts who tracked the company that such aggressive maneuvering would cause insurers to push back. In the U.S., that is one of the only real checks on the price of prescription drugs.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="107.0">That fear turned out to be unfounded, and Celgene would repeatedly test the bounds of how high it could go.</p>

<p data-pp-blocktype="copy" data-pp-id="107.1">At the same time, Celgene worked to mute any criticism of Revlimid.</p>

<p data-pp-blocktype="copy" data-pp-id="107.2">In 2005, Celgene received reports that Los Angeles oncologist Dr. James Berenson was “bashing” Revlimid in presentations sponsored by patient groups.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="108.0">In one email, a senior company official said, “it is time for us to take Jimbo to the wood shed.” The company discussed a range of options for dealing with the doctor, from taking legal action to arranging a sit-down with Celgene’s chief executive.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="109.0">Ultimately, the company appears to have decided on a friendlier course of action. Berenson became a frequent paid speaker and consultant for the company, with payments totaling at least $333,000, according to Celgene disclosures. Berenson declined to comment.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="110.0">He wasn’t the only doctor the company befriended. Payment records show that between 2013 and 2018, Celgene paid doctors $11 million for speaking engagements and consulting work related to Revlimid. At one point, Celgene rented a suite at the Houston Astros baseball stadium to throw a party for the entire multiple myeloma department at the MD Anderson Cancer Center, according to court testimony. The center said it was unable to verify any of those details.</p>
        
    
                    <figure
    data-pp-id="111"
    data-pp-blocktype="pull-quote"
    class="bb-pull-quote bb--border-top
        size04 left out02 wide-sm wrap">

    <blockquote class="bb-pull-quote__text">
        <p>They remind me of an octopus with many, many tentacles, and at the end of each tentacle is a wad of cash.</p>

    </blockquote>
        <figcaption class="bb-pull-quote__source">
        —David Mitchell, president of Patients For Affordable Drugs

    </figcaption>
    
</figure>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="112.0">Celgene went on to spread its largess across the multiple myeloma world. It funded patient groups, sponsored medical meetings and contracted with prestigious academic medical centers.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="113.0">“They remind me of an octopus with many, many tentacles, and at the end of each tentacle is a wad of cash,” said David Mitchell, a former Washington, D.C., communications executive who launched a nonprofit organization to fight for lower prices after he was diagnosed with multiple myeloma. “Everybody relies on the money.” Mitchell said his group, Patients For Affordable Drugs, does not accept donations from any entity that profits from the development or distribution of pharmaceuticals.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="114.0">At the same time it showered doctors and patient groups with money, Celgene was shutting Beth Wolmer out. She told me that John Jackson, the CEO at the time, had promised her a paid board seat at the company as a way of compensating her for her role in the discovery before the company cut off communication.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="115.0">Wolmer sued Celgene in federal court in 2009, seeking $300 million or more for alleged misappropriation of her idea and what she termed the “unjust enrichment” of Celgene.</p>

<p data-pp-blocktype="copy" data-pp-id="115.1">Celgene said it never promised to compensate Wolmer. The company also suggested she greatly inflated her role in the discovery and, in any event, waited too long to take legal action.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="116.0">In 2010, a judge granted Celgene’s motion for summary judgment in the case, agreeing that the statute of limitations had expired while at the same time expressing “admiration” for Wolmer’s “contribution to the struggle against this terrible disease.”</p>
        
    
                    

<figure
    data-pp-id="117"
    data-pp-blocktype="image"
    class="bb-image size10 center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="1500"
        height="2250"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=fd7927b93755273e8a635a0c610826ef"
        srcset="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=400&amp;s=a1252f87bd17332f12f1e01b7638c3ca 400w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=fd7927b93755273e8a635a0c610826ef 800w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1800&amp;q=75&amp;w=1200&amp;s=8f9a5bf36cb3c40ebe92e1a462d9cc01 1200w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1950&amp;q=75&amp;w=1300&amp;s=6fe2892f05abb64353e0a071934fd376 1300w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2175&amp;q=75&amp;w=1450&amp;s=67156969504352f6896f6d9d6bb05395 1450w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2400&amp;q=75&amp;w=1600&amp;s=3878df7919ca1fe1514e7402709e01ff 1600w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-mobile.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=3000&amp;q=75&amp;w=2000&amp;s=090881dc9e45ea77593f3af7bd0f8d02 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3000"
        height="4500"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=108102a8ed46bc8d2717bc9d541c8870"
        srcset="https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=400&amp;s=bd191ec1ec96d51a6c5e66fa98acd88c 400w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=800&amp;s=108102a8ed46bc8d2717bc9d541c8870 800w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1800&amp;q=75&amp;w=1200&amp;s=79d1d21247b28ff7d482d6ae437551b4 1200w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1950&amp;q=75&amp;w=1300&amp;s=387c8519ca5fe46fe3ed004a33bd62d9 1300w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2175&amp;q=75&amp;w=1450&amp;s=5af2ead27ceaba7aac3c24926ab2c939 1450w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2400&amp;q=75&amp;w=1600&amp;s=cb250de408dcdc78ae50caae01b1ba48 1600w, https://img.assets-d.propublica.org/v5/images/20250506-revlimid-moonlight-desktop.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=3000&amp;q=75&amp;w=2000&amp;s=af4f1f98b10d863c0cac443d448d2485 2000w"
                    />

            
    
<figcaption class="attribution">
        <span class="attribution__caption">Ira and Beth Wolmer in the Cayman Islands</span>
    
        <span class="attribution__credit">
        <span class="a11y">Credit: </span>
        Painting by James Lee Chiahan for ProPublica
    </span>
    
    
    </figcaption>

</figure>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="118.0">Wolmer has remarried and changed her name to Jacobson. She remains disappointed about the way she was treated by Celgene. “There was no ambiguity about who found the purpose of this drug, and I’m thrilled that it’s helping so many people,” she said. “Why they treated me that way? I don’t know.”</p>
        
    
                    

<figure
    data-pp-id="119"
    data-pp-blocktype="image"
    class="bb-image full center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="3000"
        height="1125"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=7b4d30b0554c9bf7e140017ae56e2452"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=150&amp;q=75&amp;w=400&amp;s=4300fc5bb67ef7dd67251014ef35e128 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=7b4d30b0554c9bf7e140017ae56e2452 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=450&amp;q=75&amp;w=1200&amp;s=87088267375a58ebe8cb6f35bf1b7ceb 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=488&amp;q=75&amp;w=1300&amp;s=70c4de0abfd7e84eacea44663ff86be4 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=544&amp;q=75&amp;w=1450&amp;s=247769a9b0bfec95b057bb591dc6f5d4 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=1600&amp;s=313e6844b3b7d13c27a939c901498ca4 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=750&amp;q=75&amp;w=2000&amp;s=da513fd12758b7ca39b7d7f7db84198c 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3500"
        height="987"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=3a0ec4eee836423f6fe6e554a6d66426"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=113&amp;q=75&amp;w=400&amp;s=57a07b3299ff4df6ae266a5be603b97c 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=3a0ec4eee836423f6fe6e554a6d66426 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=338&amp;q=75&amp;w=1200&amp;s=b22184fa75fa9ff58949aee270a33059 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=367&amp;q=75&amp;w=1300&amp;s=060641ca02ddf8f5f531e02b83cfdb21 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=409&amp;q=75&amp;w=1450&amp;s=6fab5d97f8856cf28aace162df7067c1 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=451&amp;q=75&amp;w=1600&amp;s=7a5c0f7bcf475c118446606f80c3f737 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-07desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=564&amp;q=75&amp;w=2000&amp;s=3ebbae1613711d6290a8492cd6f62106 2000w"
                    />

            
    
<figcaption class="attribution">
    
    
    
    </figcaption>

</figure>

        
    
                    <h3    data-pp-id="120"
    data-pp-blocktype="heading"
    class="bb-heading bb-heading--chapter-hed"
    id="the-generic-threat"
    >
    The Generic Threat
</h3>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="121.0">After the FDA approved Revlimid in late 2005, it also granted Celgene something else: seven years of market exclusivity because the drug treats a rare disease. In those seven years, Celgene raised the price of the drug nine times, increasing the price per pill by 82% to $397 in 2012.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="122.0">The company also fended off challengers by claiming its patents protected the drug from competition until 2027.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="123.0">But by 2010 generic makers were already working on copies of the drug, preparing to challenge those patents and enter the market earlier. A government analysis has found that generics generally lower the price of brand name drugs by an average of 85% after just one year.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="124.0">Celgene was well aware of the danger generics posed and warned in a 2012 financial filing that their entry into the market could have a “material adverse effect” on its finances. At that point, Revlimid sales made up 70% of the company’s revenue.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="125.0">Celgene needed another move.</p>

<p data-pp-blocktype="copy" data-pp-id="125.1">The drug still posed a risk of birth defects like the parent compound. In approving the drug, the FDA had mandated a strict safety program to control its prescription and distribution.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="126.0">Celgene realized early on that this could also be a tool to thwart competition. An internal company presentation at the time noted that the safety program could make it “more difficult for generic companies to access” thalidomide for testing.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="127.0">Generic drug makers are required by the FDA to test their version against the brand name drug, so they need to buy small amounts of Revlimid from the company.</p>

<p data-pp-blocktype="copy" data-pp-id="127.1">By 2012, at least six generic makers had requested to purchase Revlimid for testing. In every case, Celgene refused.</p>

<p data-pp-blocktype="copy" data-pp-id="127.2">Federal regulators took notice. The FDA had warned Celgene that it could not use the safety program “to block or delay approval” of generic competitors. Now, it appeared to be doing just that.</p>

<p data-pp-blocktype="copy" data-pp-id="127.3">The Federal Trade Commission, which enforces antitrust laws, had been investigating Celgene for years and in June of 2012 notified the company it was poised to take action.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="128.0">In a previously unreported letter, the FTC said that its staff had recommended filing a legal complaint against the company for refusing to sell to competitors, thereby keeping them out of the marketplace.</p>
        
    
                    <figure
    data-pp-id="129"
    data-pp-blocktype="pull-quote"
    class="bb-pull-quote bb--border-top
        size04 left out02 wide-sm wrap">

    <blockquote class="bb-pull-quote__text">
        <p>The commission’s patience is wearing thin.</p>

    </blockquote>
        <figcaption class="bb-pull-quote__source">
        —FTC official Richard Feinstein to a Celgene attorney

    </figcaption>
    
</figure>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="130.0">In its letter, the FTC noted that while Celgene refused to sell its drugs to potential competitors, it routinely provided Revlimid to other third parties around the world, including researchers and universities studying the drug.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="131.0">Then, in August of 2012, the FDA directed Celgene to sell a small amount of Revlimid to a generic competitor.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="132.0">With both federal agencies bearing down on Celgene, a closed-door meeting was held at FDA headquarters at the end of August. The FTC sent five lawyers, and 11 FDA staffers attended. Celgene showed up with a large contingent that included in-house lawyers and outside counsel.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="133.0">Celgene started by denying it was using the safety program to block generics, according to minutes of the meeting. (The minutes were filed in a court case against Celgene, and it is unclear if they were prepared by the agencies or the company.) Citing the threat of birth defects, the company said that it had legitimate safety concerns about selling Revlimid to generic companies and that it needed to protect its investment in the drug.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="134.0">Jane Axelrad, an associate director for the FDA, told Celgene that it was raising safety concerns because “the company does not want generics on the market,” according to the minutes. She declined to comment.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="135.0">The meeting ended without a resolution. The FDA had no way of enforcing its directive to Celgene. The FTC staff, however, was still determined to act. The agency had spent more than two years investigating Celgene. It hired experts, deposed Celgene officials and obtained internal company documents.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="136.0">The staff drafted a complaint alleging the company engaged in unfair actions to maintain a monopoly, hoping either that it would push the company to agree to sell to competitors to avoid legal action or that Celgene would be forced to do so by the courts, according to a person familiar with the agency’s stance.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="137.0">“The commission’s patience is wearing thin,” FTC official Richard Feinstein wrote to the company’s lawyer in February 2013. “We have reached a point where the staff may be instructed in the very near future to commence litigation.” (Feinstein did not respond to emails seeking a comment.)</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="138.0">Celgene appeared to relent, telling the FTC that it would sell to generic makers, as long as the FDA approved their safety plan. In July, the FDA approved the safety protocols of generic maker Mylan.</p>

<p data-pp-blocktype="copy" data-pp-id="138.1">Still, Celgene refused to sell.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="139.0">Jon Leibowitz, who was the chairman of the FTC at the time, told me that Celgene’s promise to cooperate, even if it didn’t result in any sales to generic makers, lessened interest in the case among his fellow commissioners. Three of five commissioners need to vote in favor of commencing litigation. Now, in retrospect, he said that “if we knew then what we know now” about the delays, “we certainly would have brought a case.”</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="140.0">The agency would close its case in 2017 without taking any action.</p>

<p data-pp-blocktype="copy" data-pp-id="140.1">With would-be generic competitors sidelined by Celgene’s refusal to sell drugs for testing, the company continued to raise the price of Revlimid.</p>
        
    
                    <figure
    data-pp-id="141"
    data-pp-blocktype="pull-quote"
    class="bb-pull-quote bb--border-top
        size04 left out02 wide-sm wrap">

    <blockquote class="bb-pull-quote__text">
        <p>They could raise their price any time they wanted to.</p>

    </blockquote>
        <figcaption class="bb-pull-quote__source">
        —Francis Brown, former Celgene sales executive

    </figcaption>
    
</figure>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="142.0">On a Saturday morning in early March of 2014, Celgene President Mark Alles sent an internal email complaining of disappointing first quarter Revlimid sales. Revenue from the star drug, which had surpassed $1 billion the previous quarter, was down by about 1% — or $11.4 million.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="143.0">“I have to consider every legitimate opportunity available to us to improve our Q1 performance,” he wrote. But the only idea he proposed was a familiar one: raise the price of the drug.</p>

<p data-pp-blocktype="copy" data-pp-id="143.1">Alles said he wanted a meeting the following Monday to discuss an immediate 4% price increase, followed by another increase of 3% at the beginning of September.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="144.0">The company implemented those hikes, along with a third in December. It brought the price of Revlimid to $9,854 a month, or $469 a pill, and helped boost Revlimid sales for the year to $5 billion. Alles didn’t respond to my requests for comment.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="145.0">“They could raise their price any time they wanted to,” said Francis Brown, a former sales executive at the company, in a 2015 deposition. I wasn’t able to reach Brown for comment.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="146.0">Celgene found a solution to the generic threat when it struck a deal to settle a lawsuit brought by generic maker NATCO Pharma in 2015. NATCO could bring a generic to market, Celgene agreed, but not for seven more years — in March 2022. Even then, the generic would be limited to less than 10% of the total market for Revlimid in the first year, with gradual increases after that.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="147.0">The deal set the bar for deals with other rivals for limited generic sales, and it ensured that unlimited generic competition — and lower prices — would not arrive until 2026.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="148.0">The delayed entry of generics may have been bad news for patients and health care payors, but there was one constituency that was thrilled with the 2015 deal. Celgene’s stock jumped nearly 10% the day after it was announced.</p>
        
    
                    

<figure
    data-pp-id="149"
    data-pp-blocktype="image"
    class="bb-image full center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="3000"
        height="1125"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=e0ede6eea9284285617f0d2879cc7ec5"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=150&amp;q=75&amp;w=400&amp;s=d6ba57413192804aeb54a254ccbb0026 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=e0ede6eea9284285617f0d2879cc7ec5 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=450&amp;q=75&amp;w=1200&amp;s=8e1d201d90c0ebd2e5e5416299414d4f 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=488&amp;q=75&amp;w=1300&amp;s=cb9f48c570e8a9c31462dc4e8cd5a332 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=544&amp;q=75&amp;w=1450&amp;s=559a832e8f0fa6659cfdcf48a6d60ff1 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=1600&amp;s=f110631a473d9e846d6f73f22156dc88 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=750&amp;q=75&amp;w=2000&amp;s=c652d6a55c1be53a5a01936251ba9c83 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3500"
        height="987"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=0d8b1c6b0f047c8e36d4186fda85c314"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=113&amp;q=75&amp;w=400&amp;s=438ef9d315b56c5b87cc1c688553d651 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=0d8b1c6b0f047c8e36d4186fda85c314 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=338&amp;q=75&amp;w=1200&amp;s=f9249514c9cee1ff90fa0c2d6bff8723 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=367&amp;q=75&amp;w=1300&amp;s=ec87ab8c58ec35a4d7bf2762e0219555 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=409&amp;q=75&amp;w=1450&amp;s=da717c625cb82a6f5a1bfa784e513ada 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=451&amp;q=75&amp;w=1600&amp;s=6be32d5938c12c975872200128c91659 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-08desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=564&amp;q=75&amp;w=2000&amp;s=19c26028505cada1c1e9204aab500a20 2000w"
                    />

            
    
<figcaption class="attribution">
    
    
    
    </figcaption>

</figure>

        
    
                    <h3    data-pp-id="150"
    data-pp-blocktype="heading"
    class="bb-heading bb-heading--chapter-hed"
    id="ridiculous-ugly-and-killer"
    >
    “Ridiculous,” “Ugly” and “Killer”
</h3>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="151.0">Revlimid turned out to be a unicorn for Celgene, a drug whose financial success proved impossible to replicate.</p>

<p data-pp-blocktype="copy" data-pp-id="151.1">In October of 2017, Celgene announced it was abandoning a once-promising effort to develop a drug for Crohn’s disease. Shares of Celgene declined by 11%.</p>

<p data-pp-blocktype="copy" data-pp-id="151.2">As it had done so many times in the past, Celgene tapped Revlimid to try to mitigate the damage. The day it announced the failure of the Crohn’s drug, it quietly raised the price of Revlimid by 9%.</p>

<p data-pp-blocktype="copy" data-pp-id="151.3">By the end of the year, Celgene had cumulatively raised the cost 20% to $662 a pill, the largest one-year increase in the drug’s history.</p>

<p data-pp-blocktype="copy" data-pp-id="151.4">That made Revlimid the most expensive Medicare drug that year, with the government insurance program spending $3.3 billion to provide it to 37,459 patients.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="152.0">At Celgene, the brash increases triggered rare internal dissent. Betty Swartz, the company’s vice president of U.S. market access, objected to the measures in a pricing meeting with the CEO, who at the time was Alles, and other top executives. She said her concerns were swiftly dismissed, according to a whistleblower lawsuit she filed and later dismissed.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="153.0">“Why would you be afraid to take an increase on our products?” she said the CEO told her. “What could be the worst thing that happens ... a tweet here or there and bad press for a bit.” Swartz declined to comment.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="154.0">The price increases added to the burden faced by many patients. In online groups, patients use words like “ridiculous,” “ugly” and “killer” when talking about the financial pain they have experienced related to the high costs associated with Revlimid. Some have taken out mortgages, raided retirement funds or cut back on everyday expenses like groceries to pay for Revlimid. Others have found overseas suppliers who ship the drug for pennies on the dollar, although doctors caution there’s no way to guarantee quality. Some just decide not to take the drug.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="155.0">By increasing the price of Revlimid, Celgene executives in several instances boosted their pay. That’s because bonuses were tied to meeting revenue and earnings targets. In some years, executives would not have hit those targets without the Revlimid price increases, a congressional investigation later found.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="156.0">In total, Celgene paid a handful of top executives about a half-billion dollars in the 12 years after Revlimid was approved.</p>

<p data-pp-blocktype="copy" data-pp-id="156.1">Robert Hugin, who worked as Celgene’s CEO and then executive chairman, received $51 million in total compensation from 2015 to 2017. Hugin retired in 2018 to launch an unsuccessful Senate bid. </p>

<p data-pp-blocktype="copy" data-pp-id="156.2">Even sales reps earned more than $1 million a year and were rewarded with trips to resorts such as the Four Seasons in Maui. That pay is more than two times what the average oncologist earns.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="157.0">I connected with Hugin just before Christmas while he was driving. He was ardent in his defense of the pricing of Revlimid. He told me the drug passes any cost-benefit analysis because of its impact on multiple myeloma patients like myself. “People recognize when you have a breakthrough therapy and you have an opportunity to deliver that, you want to deliver that across the world,” he said. “And I think Revlimid is an example of a product that ends up to be a global lifesaver because of what it did.”</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="158.0">Hugin told me that when Revlimid has unlimited generic competition, the price will be “cheaper than aspirin” and patients will benefit from that low price for many decades.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="159.0">Celgene also cited the cost of developing drugs and its expansive research efforts as reasons for the high cost of Revlimid. Celgene said it spent $800 million to develop Revlimid and spent several hundred million more on additional trials to study the use of the drug in other cancers. Those combined figures represent about 2% to 3% of Revlimid sales through 2018.</p>
        
    
                    <figure
    data-pp-id="160"
    data-pp-blocktype="pull-quote"
    class="bb-pull-quote bb--border-top
        size04 left out02 wide-sm wrap">

    <blockquote class="bb-pull-quote__text">
        <p>The drug didn’t get any better. The cancer patients didn’t get any better. You just got better at making money. You just refined your skills at price gouging.</p>

    </blockquote>
        <figcaption class="bb-pull-quote__source">
        —Former Rep. Katie Porter, D-Calif.

    </figcaption>
    
</figure>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="161.0">By the end of 2018, Celgene’s stock was down 56% over the past 15 months amid development failures. Despite the raft of bad news, Alles’ total pay that year increased by $3 million to $16.2 million.</p>

<p data-pp-blocktype="copy" data-pp-id="161.1">Celgene tried desperately to boost its flagging stock price by buying back $6 billion of its own shares that year.</p>

<p data-pp-blocktype="copy" data-pp-id="161.2">Ultimately, the buyback was not enough. Just days into the new year in 2019, Celgene announced it had agreed to be acquired by Bristol Myers Squibb in a deal valued at $74 billion.</p>

<p data-pp-blocktype="copy" data-pp-id="161.3">As part of a severance agreement, top Celgene executives stood to make millions once the deal closed. For Alles, that meant a potential estimated payday of $27.9 million.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="162.0">In the fall of 2020, Alles appeared before the House Oversight Committee, which was investigating the high cost of prescription drugs. He said pricing decisions “reflected our commitment to patient access, the value of a medicine to patients and the health care system, the continuous effort to discover new medicines and new uses for existing medicines, and the need for financial flexibility.”</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="163.0">When it came time for questions, then-Rep. Katie Porter, D-Calif., quizzed Alles in rapid-fire style about Revlimid. Did the drug change as the price increased? Did it work faster? Were there fewer side effects? The drug was the same, Alles responded.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="164.0">“So, to recap here,” Porter said. “The drug didn’t get any better. The cancer patients didn’t get any better. You just got better at making money. You just refined your skills at price gouging.”</p>
        
    
                    

<figure
    data-pp-id="165"
    data-pp-blocktype="image"
    class="bb-image full center  wide-sm wrap 
                ">

    


            
    


    <img
        class="hide-above-sm"
        alt=""
        width="3000"
        height="1125"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=a4dfc266f75e13d10a0a8697bbbbb008"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=150&amp;q=75&amp;w=400&amp;s=261b530f890b4fd0fe2a3936ccb3569b 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=300&amp;q=75&amp;w=800&amp;s=a4dfc266f75e13d10a0a8697bbbbb008 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=450&amp;q=75&amp;w=1200&amp;s=704f3e4c236d25aadaa46599839d8bc8 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=488&amp;q=75&amp;w=1300&amp;s=3c2bf1457770988278eb7da3781512d2 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=544&amp;q=75&amp;w=1450&amp;s=e9056843ee60d61a64bc212170170457 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=600&amp;q=75&amp;w=1600&amp;s=d08666bc0421407393f6264baab67784 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09mobilehi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=750&amp;q=75&amp;w=2000&amp;s=e77bf659606a95bf18c3c80b2543e49d 2000w"
                    />

                
    


    <img
        class="hide-below-sm"
        alt=""
        width="3500"
        height="987"
        loading="lazy" js-autosizes        src="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=a6ee2df43f5d3d34809475adf282c449"
        srcset="https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=113&amp;q=75&amp;w=400&amp;s=c11c08f63c2e84e7ad340126903da174 400w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=226&amp;q=75&amp;w=800&amp;s=a6ee2df43f5d3d34809475adf282c449 800w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=338&amp;q=75&amp;w=1200&amp;s=1e6d23d5298c1ca30eded700719774b4 1200w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=367&amp;q=75&amp;w=1300&amp;s=3d8ba85092cc6d0d910302ca3f47513b 1300w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=409&amp;q=75&amp;w=1450&amp;s=da96b212a8acf0739bfcd230636ed6c0 1450w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=451&amp;q=75&amp;w=1600&amp;s=130ae6cc4608017b25950ac780c38412 1600w, https://img.assets-d.propublica.org/v5/images/20250505-revlimid-secondary-09desktophi.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=564&amp;q=75&amp;w=2000&amp;s=fa4c2d8a535a3c2514e4001ec3e6d71e 2000w"
                    />

            
    
<figcaption class="attribution">
    
    
    
    </figcaption>

</figure>

        
    
                    <h3    data-pp-id="166"
    data-pp-blocktype="heading"
    class="bb-heading bb-heading--chapter-hed"
    id="the-drumbeat-continues"
    >
    The Drumbeat Continues
</h3>

        
    
                    
<p data-pp-blocktype="copy" data-pp-id="167.0">High prices have consequences beyond individual patients. While there have been tremendous advancements in the treatment of my disease, there is still no cure. The specter of relapse hovers over every blood test, every new ache or pain.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="168.0">The day I learned I was in remission, in November 2023, was bittersweet. I wrote at the time that I didn’t get to ring a bell — the traditional sign that a cancer patient has finished treatment. Instead, my doctor explained the next step: “maintenance” treatment.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="169.0">This includes not only continuing Revlimid, but making monthly visits to my cancer center to get a shot of a bone-strengthening drug, have another drug injected into my stomach and blood drawn for lab tests.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="170.0">“The visit,” I wrote that day, “only reinforced the fact that I’m a patient, and I always will be.”</p>

<p data-pp-blocktype="copy" data-pp-id="170.1">For most of us, cancer will return at some point after treatment. And for most patients, the drugs eventually stop working.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="171.0">Revlimid can also be difficult to live with. Some patients quit the drug after developing severe gastrointestinal issues, infections or liver problems. The drug also poses an increased risk of stroke, heart attack and secondary cancers.</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="172.0">Those are the trade-offs for keeping multiple myeloma in check.</p>
        
    
                                  <aside
    data-pp-id="173"
    data-pp-blocktype="promo"
    data-pp-location="story promo"
    dir="ltr"
    class="bb-promo-story story-promo-group size04 right out02 wide-sm wrap | hide-print" >

    <div class="story-promo-group__logo user-level--0__show user-level--1__show">
        
<svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 574.24 75" fill="currentColor">
    <title>ProPublica</title>
    <path d="M66.4,13.48,66,14.91l6.23,11.45,1.15.47L75,26.29V75H50.95A41.2,41.2,0,0,0,62.13,46.88a40.61,40.61,0,0,0-3.39-16.26,45.17,45.17,0,0,1,7.79-4.95l1.69-.2.14-.41L65,18.83H64.5l-.88,1.29c-2.91,1.9-4.67,2.3-8.54,3.79A41.35,41.35,0,0,0,20.46,5.42,39.87,39.87,0,0,0,0,10.91V0H75V8.81ZM57.32,47A37.54,37.54,0,0,1,44.65,75H0V16A37,37,0,0,1,57.32,47ZM43.7,37.06c0-8.13-6-12-17.75-12H7.18v3.66l4.2.95V62.2l-4.2.95v3.73H27.85V63.14l-7.18-.95V50.14h5.15C37.26,50.14,43.7,45.53,43.7,37.06Zm-9.76.27c0,5.15-2.78,8.33-7.25,8.33h-6V29.47H27C31.37,29.47,33.94,32.32,33.94,37.33Z"/><path d="M116.53,60.07l9.15,1.08v4.2H99.39v-4.2l5.28-1.36v-44l-5.28-1.36V10.41H123c15.31,0,22.9,5.28,22.9,16.13,0,11.18-8.33,17.41-23.1,17.41h-6.3Zm0-21.14h6.84c6.44,0,10.5-4.61,10.5-12.06,0-7.18-3.73-11.45-10.09-11.45h-7.25Z"/><path d="M200.74,61.15v4.2H185.9l-16-20.6h-2.51v15l5.28,1.36v4.2H150.27v-4.2l5.28-1.36V23.35l-5-1.36V17.93H175.2c10.5,0,17.55,5.08,17.55,12.67,0,8.4-5.76,12.2-11,13.55l13.48,15.79ZM167.41,39.74h4.47c5.76,0,8.81-3.18,8.81-8.88,0-5.35-2.85-7.93-8.81-7.93h-4.47Z"/><path d="M199.59,41.64c0-14.77,9.82-24.73,25.68-24.73s25.68,10,25.68,24.73-9.82,24.73-25.68,24.73S199.59,56.48,199.59,41.64Zm38.89,0c0-9.69-3.25-19.17-13.21-19.17S212.05,32,212.05,41.64s3.25,19.17,13.21,19.17S238.48,51.33,238.48,41.64Z"/><path d="M270.79,60.07l9.15,1.08v4.2H253.31v-4.2l5.62-1.36v-44l-5.62-1.36V10.41h24c15.31,0,22.9,5.28,22.9,16.13,0,11.18-8.33,17.41-23.1,17.41h-6.3Zm0-21.14h6.84c6.44,0,10.5-4.61,10.5-12.06,0-7.18-3.73-11.45-10.1-11.45h-7.25Z"/><path d="M354.26,22l-4.95,1.36V47c0,12.87-7.79,19.38-20.05,19.38-13.62,0-20.73-7.86-20.73-20v-23L303.58,22V17.93h22V22l-5.08,1.36V47.74c0,7.25,4.34,12.06,11.45,12.06,6.84,0,11.25-4.47,11.25-11.31V23.35L338.14,22V17.93h16.12Z"/><path d="M403.85,52.21c0,8.88-7.11,13.14-22,13.14H357.58v-4.2l5.56-1.36V23.35L358.26,22V17.93h23.92c12.6,0,19.51,3.79,19.51,11.72,0,6.17-4.06,9.08-10.91,9.89v.27C399.31,40.76,403.85,45.1,403.85,52.21ZM375,38.32h5.76c6.1,0,9-2.78,9-7.79,0-5.22-3.12-7.59-9-7.59H375Zm16.8,13.41c0-5.62-3.79-8.67-11.25-8.67H375V60.34h6.64C388.07,60.34,391.79,57.29,391.79,51.74Z"/><path d="M451.07,48.62l-4.4,16.73H408v-4.2l5.28-1.36V23.35L407.65,22V17.93h22.76V22l-5.28,1.36v37l14.16-.81L447,47.26Z"/><path d="M475.4,61.15v4.2H453v-4.2l5.28-1.36V23.35L453,22V17.93H475.4V22l-5.28,1.36V59.8Z"/><path d="M478,41.78c0-15.85,12.13-24.86,27-24.86a35.6,35.6,0,0,1,18.29,5.15l-2,13.21h-4.2l-1.69-9.08a13.23,13.23,0,0,0-10.09-4.13c-9.15,0-14.7,6.57-14.7,18.22,0,13.21,6.84,19.31,15.24,19.31,6.17,0,10.23-3.39,13.41-9.55l4.27,2c-4.27,10-11.65,14.36-21.07,14.36C488.4,66.37,478,56.48,478,41.78Z"/><path d="M574.24,61.15v4.2H551.48v-4.2L557,60l-2.85-8.13h-16.6l-3.12,8.2,5.42,1.15-.07,4.2-16.53-.07v-4.2l4.27-1.08,14.9-37.33-4-1.29V17.93h13.69L569.3,60Zm-27.57-31-.47-1.56-.47,1.56-6.23,16.73h12.94Z"/>
</svg>
    </div>

    
    <div class="user-level--2__show user-level--3__show">
        
<div class="lead-in">
            <p class="lead-in__title" id="read-more">Read More</p>
        </div>

    </div>

    
                    
    
        
        <a href="https://www.propublica.org/article/trump-nih-cuts-transgender-research-grants" class="story-promo section-articles" >

            
                                                                                                                                
                                    
                    <div class="story-promo__art">
                        <img
                            class="lazyload"
                            alt=""
                            src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271%27%20height%3D%271%27%20style%3D%27background%3Atransparent%27%2F%3E"
                            width="75"
                            height="75"
                            data-sizes="auto"
                            data-srcset="https://img.assets-d.propublica.org/v5/images/GettyImages-2208336966-bw_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=75&amp;q=70&amp;w=75&amp;s=18ea345ee5c2fb529aff7d369457e3ac 75w, https://img.assets-d.propublica.org/v5/images/GettyImages-2208336966-bw_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=150&amp;q=70&amp;w=150&amp;s=af56fe78ce23a3b4896e295ddd4d13d5 150w, https://img.assets-d.propublica.org/v5/images/GettyImages-2208336966-bw_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=400&amp;q=70&amp;w=400&amp;s=680840c5ebbcf5dfec3a97c232fb0d4c 400w"
                            />
                    </div>
                
            
            <div class="story-promo__info" dir="auto">
                <strong class="story-promo__hed">Trump’s NIH Axed Research Grants Even After a Judge Blocked the Cuts, Internal Records Show</strong>
                            </div>
        </a>

    
</aside>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="174.0">Meanwhile, the drumbeat of price increases continues under Bristol Myers Squibb, helping the company bring in $48 billion in revenue from Revlimid since it purchased Celgene. Bristol said its pricing “reflects the continued clinical benefit Revlimid brings to patients, along with other economic factors.” The company said it is “committed to achieving unfettered patient access to our medicines” and provides some financial support for eligible patients. “While BMS develops prices for its medicines, we do not determine what patients will pay out of pocket.”</p>
        
    
                    
<p data-pp-blocktype="copy" data-pp-id="175.0">Last July, the cost of my monthly Revlimid prescription increased by 7% to $19,660.</p>

<p data-pp-blocktype="copy" data-pp-id="175.1">At the beginning of this year, my insurer switched me to generic Revlimid. I didn’t fight it, thinking it would result in a dramatic decrease in what ProPublica’s health plan pays for the drug.</p>

<p data-pp-blocktype="copy" data-pp-id="175.2">It turns out it is not much of a savings: The generic costs $17,349 a month.</p>
        
    
                    <div class="article-body__bottom-notes" data-pp-location="bottom-note">
                                    

                                    
        <div class="article-body__note article-body__note--contributor-line" data-pp-location="bottom-note" >
                        <p><a href="https://www.propublica.org/people/alec-glassford">Alec Glassford</a> contributed research.</p>

        </div>

    
            </div><!-- end .article-body__bottom-notes -->
        
    </div>

    <footer class="article-footer" data-pp-location="article footer">
        
    
    <div class="topics-list  size02 out02 wrap left wide-md | hide-print">
        <p class="topics-list__label"><strong>Filed under —</strong></p>
        <ul class="topics-list__group">
                            <li class="topics-list__topic">
                    <a class="topics-list__topic-link" href="https://www.propublica.org/topics/health-care">Health Care</a>
                </li>
                    </ul>
    </div>
        
        <div class="rich-byline-group">






    <div class="rich-byline">

                            
            <div class="rich-byline__info">
                <div class="stack stack--row">
                    <a class="rich-byline__name" href="https://www.propublica.org/people/david-armstrong">David Armstrong</a>

                                        <ul class="rich-byline__social-list | stack stack--row stack--spacing-2">
                                                                        <li>
                            <a
                                class="btn btn--icon-only btn--circular"
                                style="--button-color: var(--color-neutral-10); --button-text-color: var(--color-neutral-full); --button-size: 1.2rem;"
                                title="X (Twitter)" href="https://twitter.com/DavidArmstrongX"
                            >
                                <span class="icon" style="--icon-size: 1em">
                                    
<svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="currentColor">
    <title>X</title>
    <path d="M18.2439 2.25H21.5532L14.3251 10.5094L22.8282 21.75H16.172L10.9548 14.9344L4.99229 21.75H1.67822L9.40791 12.9141L1.25635 2.25H8.08135L12.7923 8.47969L18.2439 2.25ZM17.0813 19.7719H18.9142L7.08291 4.125H5.11416L17.0813 19.7719Z"/>
</svg>
                                </span>
                            </a>
                        </li>
                                                                                                <li>
                            <a class="btn btn--icon-only btn--black btn--circular"
                                style="--button-color: var(--color-neutral-10); --button-text-color: var(--color-neutral-full); --button-size: 1.2rem;"
                                title="Bluesky"
                                href="https://bsky.app/profile/davidarmstrongx.bsky.social"
                            >
                                <span class="icon" style="--icon-size: 1em">
                                    
<svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="currentColor">
    <title>Bluesky</title>
    <path d="M5.20079 2.42542C7.95442 4.48593 10.9155 8.67296 12 10.9221C13.0845 8.67768 16.0456 4.49064 18.7992 2.42542C20.7843 0.935439 24 -0.215052 24 3.45332C24 4.18416 23.5804 9.60656 23.3352 10.4883C22.477 13.5437 19.3556 14.3264 16.5784 13.8502C21.4303 14.6753 22.6656 17.4101 19.9969 20.1449C14.9328 25.3409 12.7214 18.8435 12.1556 17.179C12.0754 16.948 12.033 16.8113 12 16.8113C11.967 16.8113 11.9246 16.9527 11.8444 17.179C11.2786 18.8435 9.06248 25.3409 4.00314 20.1449C1.3391 17.4101 2.56974 14.6753 7.42161 13.8502C4.6444 14.3264 1.52299 13.5437 0.669548 10.4836C0.419646 9.60184 0 4.17945 0 3.4486C0 -0.219767 3.21572 0.930724 5.20079 2.4207V2.42542Z"/>
</svg>
                                </span>
                            </a>
                        </li>
                                                                                                <li>
                            <a
                                class="btn btn--icon-only btn--black btn--circular"
                                style="--button-color: var(--color-neutral-10); --button-text-color: var(--color-neutral-full); --button-size: 1.2rem;"
                                title="LinkedIn" href="https://www.linkedin.com/in/david-armstrong-80109a108"
                            >
                                <span class="icon" style="--icon-size: 1em">
                                    
<svg viewBox="0 0 24 24" fill="currentColor" xmlns="http://www.w3.org/2000/svg">
    <title>LinkedIn</title>
    <path d="M6.65548 8.41229H2.64045C2.46226 8.41229 2.31787 8.55674 2.31787 8.73487V21.6335C2.31787 21.8116 2.46226 21.956 2.64045 21.956H6.65548C6.83368 21.956 6.97806 21.8116 6.97806 21.6335V8.73487C6.97806 8.55674 6.83368 8.41229 6.65548 8.41229Z"/>
    <path d="M4.64942 2C3.18852 2 2 3.18723 2 4.64652C2 6.10645 3.18852 7.29413 4.64942 7.29413C6.10916 7.29413 7.29671 6.10639 7.29671 4.64652C7.29677 3.18723 6.10916 2 4.64942 2Z"/>
    <path d="M16.868 8.09167C15.2554 8.09167 14.0634 8.7849 13.3403 9.57258V8.73484C13.3403 8.55671 13.1959 8.41226 13.0177 8.41226H9.17265C8.99445 8.41226 8.85007 8.55671 8.85007 8.73484V21.6334C8.85007 21.8116 8.99445 21.956 9.17265 21.956H13.1789C13.3571 21.956 13.5015 21.8116 13.5015 21.6334V15.2516C13.5015 13.1011 14.0856 12.2633 15.5847 12.2633C17.2174 12.2633 17.3471 13.6064 17.3471 15.3623V21.6335C17.3471 21.8117 17.4915 21.9561 17.6697 21.9561H21.6774C21.8556 21.9561 22 21.8117 22 21.6335V14.5584C22 11.3606 21.3903 8.09167 16.868 8.09167Z"/>
</svg>
                                </span>
                            </a>
                        </li>
                                            </ul> <!-- end .rich-byline__social-list -->
                                    </div>

                                    <p class="rich-byline__bio-short">I investigate health care.</p>

                
                <ul class="rich-byline__more">
                    <li class="rich-byline__more-item">
                        <a href="https://www.propublica.org/people/david-armstrong">More Stories</a>
                    </li>
                                        <li class="rich-byline__more-item" style="anchor-name: --contactAnchor146246;">
                                                

                
    
    
    
<script type="application/json" class="svelte-config">
                            {
            "componentName": "ContactTools",
            "props": {
                "emailAddress": "david.armstrong@propublica.org",
                "signalNumber": "718-710-9494",
                "signalUsername": "",
                "phoneNumber": "718-710-9494",
                "buttonText": "Have a Tip for a Story?",
                "buttonProps": {"bgColor":"var(--color-text-hed)","shape":"round-rect","textColor":"var(--color-bg)","textSize":"var(--scale-2)"}
            },
            "contextArray": []
        }
                        </script>
                        <div class="contact-tools" data-pp-click data-pp-location="contact tools"> <button class="button shape--pill    svelte-1r0prvj" data-pp-skip="false" role="button" aria-haspopup="dialog" aria-expanded="false" data-state="closed" id="DwHI60oMip" data-melt-popover-trigger="" data-popover-trigger="" style="--button-bg-color: var(--color-neutral-10); --button-border: none; --button-color: var(--color-neutral-70); --button-font-size: var(--scale-2); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"> <span class="text font--sans svelte-1r0prvj">Contact Me</span>  </button>  </div>
                        <!--svelte-component-end-->
                                            </li>
                                    </ul> <!-- end .rich-byline__contact-list -->

                                <div class="rich-byline__contact-prompt-tail" style="--anchor: --contactAnchor146246;"></div>
                <p class="rich-byline__contact-prompt">Please send me tips and information on subjects in need of investigating.</p>
                
            </div> <!-- end .rich-byline__info -->

        
    </div> <!-- end .rich-byline -->


</div> <!-- end .rich-byline-group -->
    </footer>

    </article>
    
    <div class="post-article" data-pp-location="post-article">

    </div><!-- end .post-article -->

</main><!-- end .content -->

<div class="page-recirc">
    <div class="page-recirc__content">
                    <div class="page-recirc__promo-set">
                <figure
    class="promo-set
            promo-set--on-article-page
            ">
    <h4>
        What We’re Watching
    </h4>
    <div class="promo-set__dek">
        <p>During Donald Trump’s second presidency, ProPublica will focus on the areas most in need of scrutiny. Here are some of the issues our reporters will be watching — and how to get in touch with them securely.</p>

    </div>
    <div class="promo-set__container">
                                    
    <div class="promo-set__card promo-set__card--story promo-set__card--current">
        <div class="promo-set__art">
            
    

                    
                    
    
        <div class="lead-art thumbnail">
            <a class="aspect-1-1" href="https://www.propublica.org/article/second-trump-presidency-issues-contact">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271%27%20height%3D%271%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/GettyImages-2194375058_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5139&amp;fp-y=0.4078&amp;h=105&amp;q=75&amp;w=105&amp;s=f753553f6268204aa269d48613e7801e 105w, https://img.assets-d.propublica.org/v5/images/GettyImages-2194375058_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5139&amp;fp-y=0.4078&amp;h=210&amp;q=75&amp;w=210&amp;s=14c865beea974876465c59cc843d6bff 210w, https://img.assets-d.propublica.org/v5/images/GettyImages-2194375058_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5139&amp;fp-y=0.4078&amp;h=550&amp;q=75&amp;w=550&amp;s=a09e46e6fd05433724a28c3aa84529b0 550w"
                    width="105"
                    height="105"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
        </div>
                    <div class="promo-set__card-description">
                <p><a href="https://www.propublica.org/article/second-trump-presidency-issues-contact">Learn more about our reporting team.</a> We will continue to share our areas of interest as the news develops.</p>

            </div>
            </div>
                                                
    
    <div class="promo-set__card promo-set__card--reporter ">
                    
    


    <img
        class="promo-set__art promo-set__art--headshot"
        alt="Photo of Sharon Lerner"
        width="400"
        height="400"
                src="https://img.assets-c3.propublica.org/images/bio/Sharon-Lerner-1x1_2024-01-03-204306_ifac.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=800&amp;s=171c103ac32af50a4f1899305a676267"
        srcset="https://img.assets-c3.propublica.org/images/bio/Sharon-Lerner-1x1_2024-01-03-204306_ifac.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=400&amp;q=75&amp;w=400&amp;s=b04b03870c6a5554bab77ed95673eb3e 400w, https://img.assets-c3.propublica.org/images/bio/Sharon-Lerner-1x1_2024-01-03-204306_ifac.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=800&amp;s=171c103ac32af50a4f1899305a676267 800w, https://img.assets-c3.propublica.org/images/bio/Sharon-Lerner-1x1_2024-01-03-204306_ifac.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=1200&amp;s=7c63776281f3f159938a297720445834 1200w, https://img.assets-c3.propublica.org/images/bio/Sharon-Lerner-1x1_2024-01-03-204306_ifac.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1300&amp;q=75&amp;w=1300&amp;s=811edc362716ac4514b2e73b957f8f29 1300w, https://img.assets-c3.propublica.org/images/bio/Sharon-Lerner-1x1_2024-01-03-204306_ifac.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1450&amp;q=75&amp;w=1450&amp;s=a5819812fc97da678e474ea56548dd11 1450w, https://img.assets-c3.propublica.org/images/bio/Sharon-Lerner-1x1_2024-01-03-204306_ifac.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1600&amp;q=75&amp;w=1600&amp;s=4d8dc3df841532b80c44e924b095dad7 1600w, https://img.assets-c3.propublica.org/images/bio/Sharon-Lerner-1x1_2024-01-03-204306_ifac.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2000&amp;q=75&amp;w=2000&amp;s=560e341954ba471a6229afca2ed9ea9d 2000w"
                    />

                            <div class="promo-set__card-description">
                <h5>Sharon Lerner</h5>
<p>I cover health and the environment and the agencies that govern them, including the Environmental Protection Agency.</p>

            </div>
                


    
    
    
<script type="application/json" class="svelte-config">
                            {
            "componentName": "ContactTools",
            "props": {
                "emailAddress": "sharon.lerner@propublica.org",
                "signalNumber": "718-877-5236",
                "signalUsername": "",
                "phoneNumber": "718-877-5236",
                "buttonText": "Contact Me",
                "buttonProps": {"bgColor":"var(--color-text-hed)","shape":"round-rect","textColor":"var(--color-bg)","textSize":"var(--scale-2)"}
            },
            "contextArray": []
        }
                        </script>
                        <div class="contact-tools" data-pp-click data-pp-location="contact tools"> <button class="button shape--pill    svelte-1r0prvj" data-pp-skip="false" role="button" aria-haspopup="dialog" aria-expanded="false" data-state="closed" id="DwHI60oMip" data-melt-popover-trigger="" data-popover-trigger="" style="--button-bg-color: var(--color-neutral-10); --button-border: none; --button-color: var(--color-neutral-70); --button-font-size: var(--scale-2); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"> <span class="text font--sans svelte-1r0prvj">Contact Me</span>  </button>  </div>
                        <!--svelte-component-end-->
                            </div>
                                                
    
    <div class="promo-set__card promo-set__card--reporter ">
                    
    


    <img
        class="promo-set__art promo-set__art--headshot"
        alt="Photo of Andy Kroll"
        width="400"
        height="400"
                src="https://img.assets-c3.propublica.org/images/bio/Andy-Kroll-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=800&amp;s=810e78ae16e75ae7a62b51b0e7863f5e"
        srcset="https://img.assets-c3.propublica.org/images/bio/Andy-Kroll-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=400&amp;q=75&amp;w=400&amp;s=3cb1943aedb5553c9477e2cd1ddc4ec8 400w, https://img.assets-c3.propublica.org/images/bio/Andy-Kroll-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=800&amp;s=810e78ae16e75ae7a62b51b0e7863f5e 800w, https://img.assets-c3.propublica.org/images/bio/Andy-Kroll-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=1200&amp;s=796c2139b7e43ffad6d28496950c1527 1200w, https://img.assets-c3.propublica.org/images/bio/Andy-Kroll-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1300&amp;q=75&amp;w=1300&amp;s=97d2f36696753d4b5fb3dd34741e4faa 1300w, https://img.assets-c3.propublica.org/images/bio/Andy-Kroll-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1450&amp;q=75&amp;w=1450&amp;s=f6dd542f719741b42d52adac4a7e7df6 1450w, https://img.assets-c3.propublica.org/images/bio/Andy-Kroll-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1600&amp;q=75&amp;w=1600&amp;s=095e66f15b5a29377fd3a4d2439d63f9 1600w, https://img.assets-c3.propublica.org/images/bio/Andy-Kroll-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2000&amp;q=75&amp;w=2000&amp;s=59daa347cf8498e417b9088037f3c248 2000w"
                    />

                            <div class="promo-set__card-description">
                <h5>Andy Kroll</h5>
<p>I cover justice and the rule of law, including the Justice Department, U.S. attorneys and the courts.</p>

            </div>
                


    
    
    
<script type="application/json" class="svelte-config">
                            {
            "componentName": "ContactTools",
            "props": {
                "emailAddress": "andy.kroll@propublica.org",
                "signalNumber": "202-215-6203",
                "signalUsername": "",
                "phoneNumber": "202-215-6203",
                "buttonText": "Contact Me",
                "buttonProps": {"bgColor":"var(--color-text-hed)","shape":"round-rect","textColor":"var(--color-bg)","textSize":"var(--scale-2)"}
            },
            "contextArray": []
        }
                        </script>
                        <div class="contact-tools" data-pp-click data-pp-location="contact tools"> <button class="button shape--pill    svelte-1r0prvj" data-pp-skip="false" role="button" aria-haspopup="dialog" aria-expanded="false" data-state="closed" id="DwHI60oMip" data-melt-popover-trigger="" data-popover-trigger="" style="--button-bg-color: var(--color-neutral-10); --button-border: none; --button-color: var(--color-neutral-70); --button-font-size: var(--scale-2); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"> <span class="text font--sans svelte-1r0prvj">Contact Me</span>  </button>  </div>
                        <!--svelte-component-end-->
                            </div>
                                                
    
    <div class="promo-set__card promo-set__card--reporter ">
                    
    


    <img
        class="promo-set__art promo-set__art--headshot"
        alt="Photo of Melissa Sanchez"
        width="400"
        height="400"
                src="https://img.assets-c3.propublica.org/images/bio/20200121-melissa-sanchez-portrait-sized-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=800&amp;s=3332b529bee4867c79d0e8515833c201"
        srcset="https://img.assets-c3.propublica.org/images/bio/20200121-melissa-sanchez-portrait-sized-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=400&amp;q=75&amp;w=400&amp;s=3bc0ae0940542c8dfd2580e43f6e1aaf 400w, https://img.assets-c3.propublica.org/images/bio/20200121-melissa-sanchez-portrait-sized-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=800&amp;s=3332b529bee4867c79d0e8515833c201 800w, https://img.assets-c3.propublica.org/images/bio/20200121-melissa-sanchez-portrait-sized-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=1200&amp;s=3a9cfd5d8ae0ab265db7ce411daeb045 1200w, https://img.assets-c3.propublica.org/images/bio/20200121-melissa-sanchez-portrait-sized-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1300&amp;q=75&amp;w=1300&amp;s=7f884c08915bf8f51b0aa8fc6de27a74 1300w, https://img.assets-c3.propublica.org/images/bio/20200121-melissa-sanchez-portrait-sized-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1450&amp;q=75&amp;w=1450&amp;s=aa83026328e4f7bb309c9f513aa07845 1450w, https://img.assets-c3.propublica.org/images/bio/20200121-melissa-sanchez-portrait-sized-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1600&amp;q=75&amp;w=1600&amp;s=7a97f36e4608a84251eefaee1521849c 1600w, https://img.assets-c3.propublica.org/images/bio/20200121-melissa-sanchez-portrait-sized-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2000&amp;q=75&amp;w=2000&amp;s=7840dce39b9b670f8bcbf0f51a65562d 2000w"
                    />

                            <div class="promo-set__card-description">
                <h5>Melissa Sanchez</h5>
<p>I report on immigration and labor, and I am based in Chicago.</p>

            </div>
                


    
    
    
<script type="application/json" class="svelte-config">
                            {
            "componentName": "ContactTools",
            "props": {
                "emailAddress": "melissa.sanchez@propublica.org",
                "signalNumber": "",
                "signalUsername": "msanchez.84",
                "phoneNumber": "872-444-0011",
                "buttonText": "Contact Me",
                "buttonProps": {"bgColor":"var(--color-text-hed)","shape":"round-rect","textColor":"var(--color-bg)","textSize":"var(--scale-2)"}
            },
            "contextArray": []
        }
                        </script>
                        <div class="contact-tools" data-pp-click data-pp-location="contact tools"> <button class="button shape--pill    svelte-1r0prvj" data-pp-skip="false" role="button" aria-haspopup="dialog" aria-expanded="false" data-state="closed" id="DwHI60oMip" data-melt-popover-trigger="" data-popover-trigger="" style="--button-bg-color: var(--color-neutral-10); --button-border: none; --button-color: var(--color-neutral-70); --button-font-size: var(--scale-2); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"> <span class="text font--sans svelte-1r0prvj">Contact Me</span>  </button>  </div>
                        <!--svelte-component-end-->
                            </div>
                                                
    
    <div class="promo-set__card promo-set__card--reporter ">
                    
    


    <img
        class="promo-set__art promo-set__art--headshot"
        alt="Photo of Jesse Coburn"
        width="400"
        height="400"
                src="https://img.assets-c3.propublica.org/images/bio/Jesse-Coburn-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=800&amp;s=10f6ed75833d0c1965211df2b79660e7"
        srcset="https://img.assets-c3.propublica.org/images/bio/Jesse-Coburn-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=400&amp;q=75&amp;w=400&amp;s=60beeb4d6f81e4c09ac4c15512adbd97 400w, https://img.assets-c3.propublica.org/images/bio/Jesse-Coburn-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=800&amp;s=10f6ed75833d0c1965211df2b79660e7 800w, https://img.assets-c3.propublica.org/images/bio/Jesse-Coburn-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1200&amp;q=75&amp;w=1200&amp;s=099f2b4e7684e137bb19100524a961c0 1200w, https://img.assets-c3.propublica.org/images/bio/Jesse-Coburn-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1300&amp;q=75&amp;w=1300&amp;s=f9c56c686d6881eb42dc122f55459f33 1300w, https://img.assets-c3.propublica.org/images/bio/Jesse-Coburn-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1450&amp;q=75&amp;w=1450&amp;s=63b2a160afcbbe699afb2bbf30d2fbd6 1450w, https://img.assets-c3.propublica.org/images/bio/Jesse-Coburn-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1600&amp;q=75&amp;w=1600&amp;s=e9d7e6cc061cda74eaf398ee03a64c07 1600w, https://img.assets-c3.propublica.org/images/bio/Jesse-Coburn-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=2000&amp;q=75&amp;w=2000&amp;s=7a3afc11e47aafbee2095d35a7a6beaf 2000w"
                    />

                            <div class="promo-set__card-description">
                <h5>Jesse Coburn</h5>
<p>I cover housing and transportation, including the companies working in those fields and the regulators overseeing them.</p>

            </div>
                


    
    
    
<script type="application/json" class="svelte-config">
                            {
            "componentName": "ContactTools",
            "props": {
                "emailAddress": "jesse.coburn@propublica.org",
                "signalNumber": "917-239-6642",
                "signalUsername": "",
                "phoneNumber": "917-239-6642",
                "buttonText": "Contact Me",
                "buttonProps": {"bgColor":"var(--color-text-hed)","shape":"round-rect","textColor":"var(--color-bg)","textSize":"var(--scale-2)"}
            },
            "contextArray": []
        }
                        </script>
                        <div class="contact-tools" data-pp-click data-pp-location="contact tools"> <button class="button shape--pill    svelte-1r0prvj" data-pp-skip="false" role="button" aria-haspopup="dialog" aria-expanded="false" data-state="closed" id="DwHI60oMip" data-melt-popover-trigger="" data-popover-trigger="" style="--button-bg-color: var(--color-neutral-10); --button-border: none; --button-color: var(--color-neutral-70); --button-font-size: var(--scale-2); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: 1em;"> <span class="text font--sans svelte-1r0prvj">Contact Me</span>  </button>  </div>
                        <!--svelte-component-end-->
                            </div>
                                                
    <div class="promo-set__card promo-set__card--story ">
        <div class="promo-set__art">
            
    
                        <div class="lead-art thumbnail">
            <a class="aspect-1-1" href="https://www.propublica.org/tips/federal-workers/">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%271%27%20height%3D%271%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-c3.propublica.org/images/externals/20191029-federal-govt-callout-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=105&amp;q=75&amp;w=105&amp;s=0a60d7bd67f2e3095a377faa198bb2f5 105w, https://img.assets-c3.propublica.org/images/externals/20191029-federal-govt-callout-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=210&amp;q=75&amp;w=210&amp;s=0d517224dd079c35961d25f2115fe1a8 210w, https://img.assets-c3.propublica.org/images/externals/20191029-federal-govt-callout-1x1.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=550&amp;q=75&amp;w=550&amp;s=4e550db924d22b24792b51f281cf898d 550w"
                    width="105"
                    height="105"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
        </div>
                    <div class="promo-set__card-description">
                <p>If you don’t have a specific tip or story in mind, we could still use your help. Sign up to be a member of our <a href="https://www.propublica.org/tips/federal-workers/">federal worker source network</a> to stay in touch.</p>

            </div>
            </div>
                        </div>
    <nav class="promo-set__nav">
                    <a href="#" class="promo-set__nav--current"><span></span>&nbsp;</a>
                    <a href="#"><span></span>&nbsp;</a>
                    <a href="#"><span></span>&nbsp;</a>
                    <a href="#"><span></span>&nbsp;</a>
                    <a href="#"><span></span>&nbsp;</a>
                    <a href="#"><span></span>&nbsp;</a>
            </nav>
    <p class="promo-set__survey">We’re trying something new. <a href="https://iteratehq.com/propublica/670eabefffb484af7dc7db86">Was it helpful?</a></p>
</figure>
            </div>
        
                <div class="page-recirc__topics-band">
                        


<script type="application/json" class="svelte-config">
                            {"componentName":"ArticlePageSectionMoreInTopic","props":{"title":"More in Health Care","url":"https://www.propublica.org/topics/health-care"},"contextArray":[]}
                        </script>
                        <div class="article-page-section-more-in-topic | hide-print svelte-6dgbqi" data-pp-location="recirc more in topic"> <div class="page-section svelte-8uolrw"><strong class="page-section__heading svelte-8uolrw"><a href="https://www.propublica.org/topics/health-care" class="link-style--no-decoration link-style--hover-underline svelte-8uolrw">More in Health Care</a> <div class="icon svelte-8uolrw"><svg role="img" xmlns="http://www.w3.org/2000/svg" fill="none" height="16" viewBox="0 0 16 16" width="16"><title>Caret</title><path clip-rule="evenodd" d="m9.5858 8.00008-5.29289-5.2929 1.41421-1.41421 6.70708 6.70711-6.70708 6.70712-1.41421-1.4142z" fill="currentColor" fill-rule="evenodd"></path></svg></div></strong>  <div class="page-section__container page-section__container--full-below-lg svelte-8uolrw  page-section__container--scroll-snap    stack stack--row stack--spacing-gutter"><!-- HTML_TAG_START -->    

        
                    
<div class="story-card story-card--standard">
    
    


                    
    
        <div class="lead-art">
            <a class="aspect-3-2" href="https://www.propublica.org/article/texas-abortion-ban-sepsis-rates-dallas-houston">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%273%27%20height%3D%272%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/05072025_regional_difference_promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=267&amp;q=75&amp;w=400&amp;s=c4d6376c2a47daad6f573c291b0ece7d 400w, https://img.assets-d.propublica.org/v5/images/05072025_regional_difference_promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=533&amp;q=75&amp;w=800&amp;s=423475f245a0110519568c5dafa21163 800w, https://img.assets-d.propublica.org/v5/images/05072025_regional_difference_promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=1200&amp;s=e797bcc50b0e7bf6be469dce99878b2b 1200w, https://img.assets-d.propublica.org/v5/images/05072025_regional_difference_promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1067&amp;q=75&amp;w=1600&amp;s=a51befbfc77b9ca5956bc1dc2f2d2478 1600w"
                    width="400"
                    height="267"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
    <div class="story-card__description">
                        <a class="story-card__series" href="https://www.propublica.org/series/life-of-the-mother">Life of the Mother</a>
        
        <h3 class="story-card__hed" >
            <a href="https://www.propublica.org/article/texas-abortion-ban-sepsis-rates-dallas-houston">
                                    Under Texas’ Abortion Ban, Where a Pregnant Woman Lives Can Determine Her Risk of Developing Sepsis
                            </a>
        </h3>

        <p class="story-card__dek" >
                            While the rates of dangerous infections spiked across the state after it banned abortion in 2021, women in Houston fared far worse than those in Dallas, according to ProPublica’s first-of-its-kind analysis.
                    </p>

        <p class="story-card__byline">
                        <span class="story-card__byline-author">
                by <a class="name" href="https://www.propublica.org/people/kavitha-surana">Kavitha Surana</a>, <a class="name" href="https://www.propublica.org/people/lizzie-presser">Lizzie Presser</a> and <a class="name" href="https://www.propublica.org/people/andrea-suozzo">Andrea Suozzo</a>,
            </span>
                        <span class="story-card__byline-dateline">
                <time class="timestamp" datetime="2025-05-07EDT16:20">May 7, 2025, 4:20 p.m. EDT</time>
            </span>
        </p>

            </div>
</div>
    

        
                    
<div class="story-card story-card--standard">
    
    

                    
                    
    
        <div class="lead-art">
            <a class="aspect-3-2" href="https://www.propublica.org/article/arizona-medicaid-fraud-investigation-taxpayer-funds">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%273%27%20height%3D%272%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/CL_AZMayesAnnoucement_5-1-25_20_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=267&amp;q=75&amp;w=400&amp;s=549ac9d9bc351793bb80093a9aebabe4 400w, https://img.assets-d.propublica.org/v5/images/CL_AZMayesAnnoucement_5-1-25_20_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=533&amp;q=75&amp;w=800&amp;s=d7f4c402d4456482b1bce640b63caa85 800w, https://img.assets-d.propublica.org/v5/images/CL_AZMayesAnnoucement_5-1-25_20_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=1200&amp;s=8032c3d0823fe613d7efc876e39700db 1200w, https://img.assets-d.propublica.org/v5/images/CL_AZMayesAnnoucement_5-1-25_20_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1067&amp;q=75&amp;w=1600&amp;s=4eee9d2eb39428adc363e66465778a60 1600w"
                    width="400"
                    height="267"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
    <div class="story-card__description">
                
        <h3 class="story-card__hed" >
            <a href="https://www.propublica.org/article/arizona-medicaid-fraud-investigation-taxpayer-funds">
                                    Arizona Has Recovered Just 5% of Taxpayer Dollars Lost in a $2.5 Billion Medicaid Fraud Scheme
                            </a>
        </h3>

        <p class="story-card__dek" >
                            The state has so far indicted more than 100 individuals and recouped $125 million. But despite state and federal efforts, it’s likely that most of the stolen taxpayer money won’t be recovered, officials say.
                    </p>

        <p class="story-card__byline">
                        <span class="story-card__byline-author">
                by <span class="name">Jasmine Demers</span>, <a href="http://azcir.org">Arizona Center for Investigative Reporting</a>,
            </span>
                        <span class="story-card__byline-dateline">
                <time class="timestamp" datetime="2025-05-06EDT07:00">May 6, 2025, 7 a.m. EDT</time>
            </span>
        </p>

            </div>
</div>
    

        
                    
<div class="story-card story-card--standard">
    
    


                    
    
        <div class="lead-art">
            <a class="aspect-3-2" href="https://www.propublica.org/article/trump-veterans-affairs-budget-staff-cuts-jeopardize-cancer-research">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%273%27%20height%3D%272%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/Veterans-Alerts-Promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=267&amp;q=75&amp;w=400&amp;s=889ba6bc72fb0319f8b97424b3b231f2 400w, https://img.assets-d.propublica.org/v5/images/Veterans-Alerts-Promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=533&amp;q=75&amp;w=800&amp;s=e83d6d76de2a1e4a5f2964f6a40464bd 800w, https://img.assets-d.propublica.org/v5/images/Veterans-Alerts-Promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=1200&amp;s=a97fe8b7909c24ed8d6e630230bf693c 1200w, https://img.assets-d.propublica.org/v5/images/Veterans-Alerts-Promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1067&amp;q=75&amp;w=1600&amp;s=bcd2d7085ac30f167b2dee2e69a950ba 1600w"
                    width="400"
                    height="267"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
    <div class="story-card__description">
                
        <h3 class="story-card__hed" >
            <a href="https://www.propublica.org/article/trump-veterans-affairs-budget-staff-cuts-jeopardize-cancer-research">
                                    Internal VA Emails Reveal How Trump Cuts Jeopardize Veterans’ Care, Including To “Life-Saving Cancer Trials”
                            </a>
        </h3>

        <p class="story-card__dek" >
                            Despite a congressional mandate to expand care for veterans, internal Veterans Affairs messages obtained by ProPublica paint a stark portrait of how chaotic cost cutting has already imperiled tests of treatments for cancer, opioid addiction and more.
                    </p>

        <p class="story-card__byline">
                        <span class="story-card__byline-author">
                by <a class="name" href="https://www.propublica.org/people/eric-umansky">Eric Umansky</a> and <a class="name" href="https://www.propublica.org/people/vernal-coleman">Vernal Coleman</a>,
            </span>
                        <span class="story-card__byline-dateline">
                <time class="timestamp" datetime="2025-05-06EDT05:00">May 6, 2025, 5 a.m. EDT</time>
            </span>
        </p>

            </div>
</div>
    

        
                    
<div class="story-card story-card--standard">
    
    

                    
                    
    
        <div class="lead-art">
            <a class="aspect-3-2" href="https://www.propublica.org/article/arizona-medicaid-fraud-carmen-heredia-resigns">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%273%27%20height%3D%272%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/USATSI_20682395_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=267&amp;q=75&amp;w=400&amp;s=15052c8fbe2d132259d3a63509120e74 400w, https://img.assets-d.propublica.org/v5/images/USATSI_20682395_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=533&amp;q=75&amp;w=800&amp;s=d0cc0ef273dea682768489ec9bf41db8 800w, https://img.assets-d.propublica.org/v5/images/USATSI_20682395_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=1200&amp;s=bd3aad540add60652099a1ff84ab9d50 1200w, https://img.assets-d.propublica.org/v5/images/USATSI_20682395_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1067&amp;q=75&amp;w=1600&amp;s=4c7b44a664335a34d4931bb7e10abb4f 1600w"
                    width="400"
                    height="267"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
    <div class="story-card__description">
                
        <h3 class="story-card__hed" >
            <a href="https://www.propublica.org/article/arizona-medicaid-fraud-carmen-heredia-resigns">
                                    Director of Arizona Medicaid Agency Resigns Following Fraud Scheme Response
                            </a>
        </h3>

        <p class="story-card__dek" >
                            Under Carmen Heredia’s leadership, the agency withheld payment to more than 300 businesses as it investigated fraud allegations. The state’s swift response left patients homeless, ProPublica and the Arizona Center for Investigative Reporting found.
                    </p>

        <p class="story-card__byline">
                        <span class="story-card__byline-author">
                by <a class="name" href="https://www.propublica.org/people/mary-hudetz">Mary Hudetz</a>,
            </span>
                        <span class="story-card__byline-dateline">
                <time class="timestamp" datetime="2025-05-02EDT15:40">May 2, 2025, 3:40 p.m. EDT</time>
            </span>
        </p>

            </div>
</div>
    

        
                    
<div class="story-card story-card--standard">
    
    


                    
    
        <div class="lead-art">
            <a class="aspect-3-2" href="https://www.propublica.org/article/utah-farmers-therapy-mental-health-suicide-rates">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%273%27%20height%3D%272%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/PROPUBLICA.AGMENTALHEALTH.XXXX25-3-tn-0600_preview_maxWidth_3000_maxHeight_3000_ppi_72_embedColorProfile_true_quality_95.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=267&amp;q=75&amp;w=400&amp;s=52fd3bf642e53a4dea0a7c23f7447448 400w, https://img.assets-d.propublica.org/v5/images/PROPUBLICA.AGMENTALHEALTH.XXXX25-3-tn-0600_preview_maxWidth_3000_maxHeight_3000_ppi_72_embedColorProfile_true_quality_95.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=533&amp;q=75&amp;w=800&amp;s=a19f2d2f6230af536e5c4296f605966d 800w, https://img.assets-d.propublica.org/v5/images/PROPUBLICA.AGMENTALHEALTH.XXXX25-3-tn-0600_preview_maxWidth_3000_maxHeight_3000_ppi_72_embedColorProfile_true_quality_95.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=1200&amp;s=14cbfb2f15c4682c0b304dc9995afdda 1200w, https://img.assets-d.propublica.org/v5/images/PROPUBLICA.AGMENTALHEALTH.XXXX25-3-tn-0600_preview_maxWidth_3000_maxHeight_3000_ppi_72_embedColorProfile_true_quality_95.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1067&amp;q=75&amp;w=1600&amp;s=a1e316cae96217b5f562990dad4ed913 1600w"
                    width="400"
                    height="267"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
    <div class="story-card__description">
                
        <h3 class="story-card__hed" >
            <a href="https://www.propublica.org/article/utah-farmers-therapy-mental-health-suicide-rates">
                                    Utah Farmers Signed Up for Federally Funded Therapy. Then the Money Stopped.
                            </a>
        </h3>

        <p class="story-card__dek" >
                            Farmers are dying by suicide at the third-highest rate by vocation in Utah. But after a federal program offering mental health support ran out of money, the state did not continue it.
                    </p>

        <p class="story-card__byline">
                        <span class="story-card__byline-author">
                by <span class="name">Jessica Schreifels</span>, <a href="https://www.sltrib.com/">The Salt Lake Tribune</a>,
            </span>
                        <span class="story-card__byline-dateline">
                <time class="timestamp" datetime="2025-04-30EDT08:00">April 30, 2025, 8 a.m. EDT</time>
            </span>
        </p>

                <p class="story-card__unit">Local Reporting Network</p>
            </div>
</div>
    

        
                    
<div class="story-card story-card--standard">
    
    


                    
    
        <div class="lead-art">
            <a class="aspect-3-2" href="https://www.propublica.org/article/blue-cross-blue-shield-louisiana-insurance-lawsuit-breast-cancer-doctors">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%273%27%20height%3D%272%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/20250331_ProPublica_insurers-and-doctors-01_1800-1200-1_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=267&amp;q=75&amp;w=400&amp;s=7e17d0d2fe24ca50f6064322082bf9bc 400w, https://img.assets-d.propublica.org/v5/images/20250331_ProPublica_insurers-and-doctors-01_1800-1200-1_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=533&amp;q=75&amp;w=800&amp;s=5f6b4805974c1fbc96ed0f700b0ff3e9 800w, https://img.assets-d.propublica.org/v5/images/20250331_ProPublica_insurers-and-doctors-01_1800-1200-1_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=1200&amp;s=b4c47ba9948ed1d9cd4de92336f2531d 1200w, https://img.assets-d.propublica.org/v5/images/20250331_ProPublica_insurers-and-doctors-01_1800-1200-1_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1067&amp;q=75&amp;w=1600&amp;s=32db8f0b8554e5db0565653f71cebd64 1600w"
                    width="400"
                    height="267"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
    <div class="story-card__description">
                        <a class="story-card__series" href="https://www.propublica.org/series/uncovered">Uncovered</a>
        
        <h3 class="story-card__hed" >
            <a href="https://www.propublica.org/article/blue-cross-blue-shield-louisiana-insurance-lawsuit-breast-cancer-doctors">
                                    “Slow Pay, Low Pay or No Pay”
                            </a>
        </h3>

        <p class="story-card__dek" >
                            Blue Cross authorized mastectomies and breast reconstructions for women with cancer but refused to pay the full doctors’ bills. A jury called it fraud and awarded the practice $421 million.
                    </p>

        <p class="story-card__byline">
                        <span class="story-card__byline-author">
                by <a class="name" href="https://www.propublica.org/people/t-christian-miller">T. Christian Miller</a>,
            </span>
                        <span class="story-card__byline-dateline">
                <time class="timestamp" datetime="2025-04-12EDT05:00">April 12, 2025, 5 a.m. EDT</time>
            </span>
        </p>

            </div>
</div>
<!-- HTML_TAG_END --></div> </div> </div>
                        <!--svelte-component-end-->
                                </div>
        
        <div class="page-recirc__most-read">
        

    
<div class="most-read | hide-print" data-pp-location="most read">

    <strong class="most-read__heading">Most Read</strong>

    <ol class="most-read-group">
                    <div class="most-read-story">
                

        
                    
<div class="story-card story-card--standard">
    
    

                    
                    
    
        <div class="lead-art">
            <a class="aspect-3-2" href="https://www.propublica.org/article/cfpb-gavin-kliger-doge-conflict-of-interest-consumer-financial-protection-bureau">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%273%27%20height%3D%272%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/20250505doge-cfpb-folo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=267&amp;q=75&amp;w=400&amp;s=4ff76e7ef127fbe0767c1f5eb9b81516 400w, https://img.assets-d.propublica.org/v5/images/20250505doge-cfpb-folo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=533&amp;q=75&amp;w=800&amp;s=117162c87fa26bed176d1c7465174bdb 800w, https://img.assets-d.propublica.org/v5/images/20250505doge-cfpb-folo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=1200&amp;s=ae65a838db32caa471a2cea3c571d707 1200w, https://img.assets-d.propublica.org/v5/images/20250505doge-cfpb-folo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1067&amp;q=75&amp;w=1600&amp;s=8a44633493d501044fa6548fcfe72b23 1600w"
                    width="400"
                    height="267"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
    <div class="story-card__description">
                
        <h3 class="story-card__hed" >
            <a href="https://www.propublica.org/article/cfpb-gavin-kliger-doge-conflict-of-interest-consumer-financial-protection-bureau">
                                    DOGE Aide Who Helped Gut CFPB Was Warned About Potential Conflicts of Interest
                            </a>
        </h3>

        <p class="story-card__dek" >
                            Before he helped fire most Consumer Financial Protection Bureau staffers, DOGE’s Gavin Kliger was warned about his investments and advised to not take any actions that could benefit him personally, according to a person familiar with the situation.
                    </p>

        <p class="story-card__byline">
                        <span class="story-card__byline-author">
                by <a class="name" href="https://www.propublica.org/people/jake-pearson">Jake Pearson</a>,
            </span>
                        <span class="story-card__byline-dateline">
                <time class="timestamp" datetime="2025-05-07EDT06:00">May 7, 2025, 6 a.m. EDT</time>
            </span>
        </p>

            </div>
</div>
            </div>
                    <div class="most-read-story">
                

        
                    
<div class="story-card story-card--standard">
    
    


                    
    
        <div class="lead-art">
            <a class="aspect-3-2" href="https://www.propublica.org/article/trump-veterans-affairs-budget-staff-cuts-jeopardize-cancer-research">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%273%27%20height%3D%272%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/Veterans-Alerts-Promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=267&amp;q=75&amp;w=400&amp;s=889ba6bc72fb0319f8b97424b3b231f2 400w, https://img.assets-d.propublica.org/v5/images/Veterans-Alerts-Promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=533&amp;q=75&amp;w=800&amp;s=e83d6d76de2a1e4a5f2964f6a40464bd 800w, https://img.assets-d.propublica.org/v5/images/Veterans-Alerts-Promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=1200&amp;s=a97fe8b7909c24ed8d6e630230bf693c 1200w, https://img.assets-d.propublica.org/v5/images/Veterans-Alerts-Promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1067&amp;q=75&amp;w=1600&amp;s=bcd2d7085ac30f167b2dee2e69a950ba 1600w"
                    width="400"
                    height="267"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
    <div class="story-card__description">
                
        <h3 class="story-card__hed" >
            <a href="https://www.propublica.org/article/trump-veterans-affairs-budget-staff-cuts-jeopardize-cancer-research">
                                    Internal VA Emails Reveal How Trump Cuts Jeopardize Veterans’ Care, Including To “Life-Saving Cancer Trials”
                            </a>
        </h3>

        <p class="story-card__dek" >
                            Despite a congressional mandate to expand care for veterans, internal Veterans Affairs messages obtained by ProPublica paint a stark portrait of how chaotic cost cutting has already imperiled tests of treatments for cancer, opioid addiction and more.
                    </p>

        <p class="story-card__byline">
                        <span class="story-card__byline-author">
                by <a class="name" href="https://www.propublica.org/people/eric-umansky">Eric Umansky</a> and <a class="name" href="https://www.propublica.org/people/vernal-coleman">Vernal Coleman</a>,
            </span>
                        <span class="story-card__byline-dateline">
                <time class="timestamp" datetime="2025-05-06EDT05:00">May 6, 2025, 5 a.m. EDT</time>
            </span>
        </p>

            </div>
</div>
            </div>
                    <div class="most-read-story">
                

        
                    
<div class="story-card story-card--standard">
    
    

                    
                    
    
        <div class="lead-art">
            <a class="aspect-3-2" href="https://www.propublica.org/article/noaa-michigan-lab-toxic-algae-blooms-great-lakes-drinking-water">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%273%27%20height%3D%272%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/20250501-Hagen-NOAAAlgaeBloom-2286_preview_maxWidth_3000_maxHeight_3000_ppi_72_embedColorProfile_true_quality_95.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=267&amp;q=75&amp;w=400&amp;s=44a93404ad87a4fccd1078e64dcd08fd 400w, https://img.assets-d.propublica.org/v5/images/20250501-Hagen-NOAAAlgaeBloom-2286_preview_maxWidth_3000_maxHeight_3000_ppi_72_embedColorProfile_true_quality_95.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=533&amp;q=75&amp;w=800&amp;s=0d8634778a9baf764643265c43775020 800w, https://img.assets-d.propublica.org/v5/images/20250501-Hagen-NOAAAlgaeBloom-2286_preview_maxWidth_3000_maxHeight_3000_ppi_72_embedColorProfile_true_quality_95.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=1200&amp;s=915b665b99d16265be7525ace4bcc04f 1200w, https://img.assets-d.propublica.org/v5/images/20250501-Hagen-NOAAAlgaeBloom-2286_preview_maxWidth_3000_maxHeight_3000_ppi_72_embedColorProfile_true_quality_95.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1067&amp;q=75&amp;w=1600&amp;s=a9144ea5544d76e20cae13c8eb34d116 1600w"
                    width="400"
                    height="267"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
    <div class="story-card__description">
                
        <h3 class="story-card__hed" >
            <a href="https://www.propublica.org/article/noaa-michigan-lab-toxic-algae-blooms-great-lakes-drinking-water">
                                    Millions of People Depend on the Great Lakes’ Water Supply. Trump Decimated the Lab Protecting It.
                            </a>
        </h3>

        <p class="story-card__dek" >
                            The Trump administration’s slashing of budgets and staff have Great Lakes scientists concerned that they have lost the ability to protect the public from toxic algal blooms, which can kill animals and sicken people.
                    </p>

        <p class="story-card__byline">
                        <span class="story-card__byline-author">
                by <a class="name" href="https://www.propublica.org/people/anna-clark">Anna Clark</a>,
            </span>
                        <span class="story-card__byline-dateline">
                <time class="timestamp" datetime="2025-05-06EDT06:00">May 6, 2025, 6 a.m. EDT</time>
            </span>
        </p>

            </div>
</div>
            </div>
                    <div class="most-read-story">
                

        
                    
<div class="story-card story-card--standard">
    
    


                    
    
        <div class="lead-art">
            <a class="aspect-3-2" href="https://www.propublica.org/article/texas-abortion-ban-sepsis-rates-dallas-houston">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%273%27%20height%3D%272%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/05072025_regional_difference_promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=267&amp;q=75&amp;w=400&amp;s=c4d6376c2a47daad6f573c291b0ece7d 400w, https://img.assets-d.propublica.org/v5/images/05072025_regional_difference_promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=533&amp;q=75&amp;w=800&amp;s=423475f245a0110519568c5dafa21163 800w, https://img.assets-d.propublica.org/v5/images/05072025_regional_difference_promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=800&amp;q=75&amp;w=1200&amp;s=e797bcc50b0e7bf6be469dce99878b2b 1200w, https://img.assets-d.propublica.org/v5/images/05072025_regional_difference_promo.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.5&amp;fp-y=0.5&amp;h=1067&amp;q=75&amp;w=1600&amp;s=a51befbfc77b9ca5956bc1dc2f2d2478 1600w"
                    width="400"
                    height="267"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
    <div class="story-card__description">
                        <a class="story-card__series" href="https://www.propublica.org/series/life-of-the-mother">Life of the Mother</a>
        
        <h3 class="story-card__hed" >
            <a href="https://www.propublica.org/article/texas-abortion-ban-sepsis-rates-dallas-houston">
                                    Under Texas’ Abortion Ban, Where a Pregnant Woman Lives Can Determine Her Risk of Developing Sepsis
                            </a>
        </h3>

        <p class="story-card__dek" >
                            While the rates of dangerous infections spiked across the state after it banned abortion in 2021, women in Houston fared far worse than those in Dallas, according to ProPublica’s first-of-its-kind analysis.
                    </p>

        <p class="story-card__byline">
                        <span class="story-card__byline-author">
                by <a class="name" href="https://www.propublica.org/people/kavitha-surana">Kavitha Surana</a>, <a class="name" href="https://www.propublica.org/people/lizzie-presser">Lizzie Presser</a> and <a class="name" href="https://www.propublica.org/people/andrea-suozzo">Andrea Suozzo</a>,
            </span>
                        <span class="story-card__byline-dateline">
                <time class="timestamp" datetime="2025-05-07EDT16:20">May 7, 2025, 4:20 p.m. EDT</time>
            </span>
        </p>

            </div>
</div>
            </div>
                    <div class="most-read-story">
                

        
                    
<div class="story-card story-card--standard">
    
    

                    
                    
    
        <div class="lead-art">
            <a class="aspect-3-2" href="https://www.propublica.org/article/drug-enforcement-administration-ends-body-camera-program-trump">
                <img
                    alt=""
                    src="data:image/svg+xml;charset=utf-8,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%273%27%20height%3D%272%27%20style%3D%27background%3Atransparent%27%2F%3E"
                    srcset="https://img.assets-d.propublica.org/v5/images/AP25060194665074_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true-1mb.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.4891&amp;fp-y=0.2374&amp;h=267&amp;q=75&amp;w=400&amp;s=1d59079cc8d34b3691341b9635d477b1 400w, https://img.assets-d.propublica.org/v5/images/AP25060194665074_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true-1mb.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.4891&amp;fp-y=0.2374&amp;h=533&amp;q=75&amp;w=800&amp;s=e87782148bed29fd298d4b3c98106205 800w, https://img.assets-d.propublica.org/v5/images/AP25060194665074_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true-1mb.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.4891&amp;fp-y=0.2374&amp;h=800&amp;q=75&amp;w=1200&amp;s=8c4b30a1cc08ca6b611bd2b0e85a2c61 1200w, https://img.assets-d.propublica.org/v5/images/AP25060194665074_maxWidth_3000_maxHeight_3000_ppi_72_quality_95_embedColorProfile_true-1mb.jpg?crop=focalpoint&amp;fit=crop&amp;fm=webp&amp;fp-x=0.4891&amp;fp-y=0.2374&amp;h=1067&amp;q=75&amp;w=1600&amp;s=64581ca888f155789793ba48a8209689 1600w"
                    width="400"
                    height="267"
                    loading="lazy"
                    js-autosizes
                />
            </a>
        </div>
    
    <div class="story-card__description">
                
        <h3 class="story-card__hed" >
            <a href="https://www.propublica.org/article/drug-enforcement-administration-ends-body-camera-program-trump">
                                    The DEA Once Touted Body Cameras for Their “Enhanced Transparency.” Now the Agency Is Abandoning Them.
                            </a>
        </h3>

        <p class="story-card__dek" >
                            An internal email obtained by ProPublica said the agency made the change to be “consistent” with a Trump executive order. But at least two other federal law enforcement agencies are still requiring body cameras.
                    </p>

        <p class="story-card__byline">
                        <span class="story-card__byline-author">
                by <a class="name" href="https://www.propublica.org/people/mario-ariza">Mario Ariza</a>,
            </span>
                        <span class="story-card__byline-dateline">
                <time class="timestamp" datetime="2025-05-06EDT15:30">May 6, 2025, 3:30 p.m. EDT</time>
            </span>
        </p>

            </div>
</div>
            </div>
            </ol> <!-- end .most-read-group -->

</div> <!-- end .most-read -->

        </div>
    </div>
</div>

    
<style>

    /* re-assert som CSS Custom Properties from v5 */
    .admin-shortcuts {
        --fonts-sans: "Graphik", sans-serif;
        --scale0: 1rem;
        --scale-1: 13px;
        --scale-2: 11px;
        --scale-3: 9px;
        --spacing-2: 4px;
        --spacing-1: 8px;
        --spacing0: 16px;
        --spacing1: 24px;
        --spacing2: 32px;
        --spacing3: 64px;
    }

    .admin-shortcuts {
        position: fixed;
        z-index: 10000;
        bottom: 0;
        right: var(--spacing0);
        width: auto;
        display: flex;
        flex-direction: row;
        justify-content: center;
        align-content: center;
        gap: var(--spacing0);
        padding: var(--spacing-1) var(--spacing0);
        background-color: black;
        color: white;
        font-size: var(--scale-1);
        font-family: var(--fonts-sans);
        border-radius: 0.25rem 0.25rem 0 0;
    }

    .admin-shortcuts__link {
        display: inline-block;
        text-decoration: none;
        color: inherit;
        display: flex;
        gap: 0.33em;
    }

    .admin-shortcuts__user:before {
        content: "";
        width: 0.66em;
        height: 0.66em;
        border-radius: 100%;
        background-color: #14b84f; /* green 50 */
    }

    .admin-shortcuts__user {
        padding-right: calc(var(--spacing-2) * 4);
        border-right: 1px solid hsla(0, 0%, 100%, 0.2);
    }

    .admin-shortcuts__user:before,
    .admin-shortcuts__icon {
        align-self: center;
    }

    .admin-shortcuts__icon {
        width: 1.1em;
        height: 1.1em;
    }
</style>


    <script type="application/json" class="svelte-config">
                            {"componentName":"SiteFooter","props":{"newsletterSignupProps":{"source":"https://www.propublica.org/","region":"national"}},"contextArray":[]}
                        </script>
                        <footer class="site-footer hide-print svelte-1ueinol" id="site-footer" data-pp-location="footer"><div class="site-footer__section-newsletter svelte-1ueinol"><div class="site-footer__newsletter-wrap svelte-1ueinol"><strong class="site-footer__newsletter-heading svelte-1ueinol" data-svelte-h="svelte-1f8pah3">Stay informed with the Daily Digest.</strong> <div class="newsletter-signup__input-wrap svelte-1ueinol"><form class="newsletter-signup" action="https://signup.propublica.org/newsletter/turing" method="post" name="newsletterSignup"><div role="region" aria-live="polite" class="newsletter-signup__feedback" data-svelte-h="svelte-2nawdb"><p class="newsletter-signup__error-message"></p></div> <div class="newsletter-signup__input-wrap newsletter-signup__input-wrap--null svelte-10wydf7"><span class="icon"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><title>Mail</title><path d="M4 4h16c1.1 0 2 .9 2 2v12c0 1.1-.9 2-2 2H4c-1.1 0-2-.9-2-2V6c0-1.1.9-2 2-2z"></path><polyline points="22,6 12,13 2,6"></polyline></svg></span> <label for="site-footer-signup" class="a11y">Email Address:</label> <input class="newsletter-signup__input-text svelte-10wydf7" type="email" placeholder="Enter your email" id="site-footer-signup" name="email" required> <div class="newsletter-signup__submit-btn-wrapper svelte-10wydf7"> <button class="button shape--circle  button-is-icon-only  svelte-1r0prvj" data-pp-skip="false" style="--button-bg-color: transparent; --button-border: none; --button-color: var(--color-light-none); --button-font-size: var(--scale-1); --button-horizontal-spacing: var(--scale-1); --button-size: var(--scale3); --icon-size: fill;"><span class="icon-before svelte-1r0prvj"><svg role="img" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><title>Arrow Right</title><path fill-rule="evenodd" clip-rule="evenodd" d="M22 12C22 17.5228 17.5228 22 12 22C6.47715 22 2 17.5228 2 12C2 6.47715 6.47715 2 12 2C17.5228 2 22 6.47715 22 12ZM16.7064 11.2922L12.7071 7.29289C12.3166 6.90237 11.6834 6.90237 11.2929 7.29289C10.9024 7.68342 10.9024 8.31658 11.2929 8.70711L13.5858 11H8C7.44772 11 7 11.4477 7 12C7 12.5523 7.44772 13 8 13H13.5858L11.2929 15.2929C10.9024 15.6834 10.9024 16.3166 11.2929 16.7071C11.6834 17.0976 12.3166 17.0976 12.7071 16.7071L16.7064 12.7078L16.7136 12.7005C16.8901 12.5208 16.9992 12.2746 17 12.003L17 12L17 11.997C16.9996 11.8625 16.9727 11.7343 16.9241 11.6172C16.8764 11.502 16.8063 11.3938 16.7136 11.2995L16.7064 11.2922Z" fill="currentColor"></path></svg></span> <span class="text font--sans svelte-1r0prvj a11y">Sign Up</span>  </button></div> <input type="hidden" name="stlist" value="The Daily Digest">  <input type="hidden" name="success_location" value="https://www.propublica.org/forms/thankyou"> <input type="hidden" name="error_location" value="https://www.propublica.org/forms/error"> <input type="hidden" name="placement" value="site-footer"> <input type="hidden" name="region" value="national"> <input type="hidden" name="source" value="https://www.propublica.org/"></div> <div class="newsletter-signup__post-signup-prompt" role="region" aria-live="polite" data-svelte-h="svelte-1uvtbcq"></div></form>  </div></div> </div>  <div class="site-footer__wrap-outer svelte-1ueinol"><div class="site-footer__wrap-inner svelte-1ueinol"> <div class="site-footer__section-logo svelte-1ueinol"><a class="site-footer__wordmark svelte-1ueinol" href="https://www.propublica.org/"><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 574.24 75" fill="currentColor"><title>ProPublica</title><path d="M66.4,13.48,66,14.91l6.23,11.45,1.15.47L75,26.29V75H50.95A41.2,41.2,0,0,0,62.13,46.88a40.61,40.61,0,0,0-3.39-16.26,45.17,45.17,0,0,1,7.79-4.95l1.69-.2.14-.41L65,18.83H64.5l-.88,1.29c-2.91,1.9-4.67,2.3-8.54,3.79A41.35,41.35,0,0,0,20.46,5.42,39.87,39.87,0,0,0,0,10.91V0H75V8.81ZM57.32,47A37.54,37.54,0,0,1,44.65,75H0V16A37,37,0,0,1,57.32,47ZM43.7,37.06c0-8.13-6-12-17.75-12H7.18v3.66l4.2.95V62.2l-4.2.95v3.73H27.85V63.14l-7.18-.95V50.14h5.15C37.26,50.14,43.7,45.53,43.7,37.06Zm-9.76.27c0,5.15-2.78,8.33-7.25,8.33h-6V29.47H27C31.37,29.47,33.94,32.32,33.94,37.33Z"></path><path d="M116.53,60.07l9.15,1.08v4.2H99.39v-4.2l5.28-1.36v-44l-5.28-1.36V10.41H123c15.31,0,22.9,5.28,22.9,16.13,0,11.18-8.33,17.41-23.1,17.41h-6.3Zm0-21.14h6.84c6.44,0,10.5-4.61,10.5-12.06,0-7.18-3.73-11.45-10.09-11.45h-7.25Z"></path><path d="M200.74,61.15v4.2H185.9l-16-20.6h-2.51v15l5.28,1.36v4.2H150.27v-4.2l5.28-1.36V23.35l-5-1.36V17.93H175.2c10.5,0,17.55,5.08,17.55,12.67,0,8.4-5.76,12.2-11,13.55l13.48,15.79ZM167.41,39.74h4.47c5.76,0,8.81-3.18,8.81-8.88,0-5.35-2.85-7.93-8.81-7.93h-4.47Z"></path><path d="M199.59,41.64c0-14.77,9.82-24.73,25.68-24.73s25.68,10,25.68,24.73-9.82,24.73-25.68,24.73S199.59,56.48,199.59,41.64Zm38.89,0c0-9.69-3.25-19.17-13.21-19.17S212.05,32,212.05,41.64s3.25,19.17,13.21,19.17S238.48,51.33,238.48,41.64Z"></path><path d="M270.79,60.07l9.15,1.08v4.2H253.31v-4.2l5.62-1.36v-44l-5.62-1.36V10.41h24c15.31,0,22.9,5.28,22.9,16.13,0,11.18-8.33,17.41-23.1,17.41h-6.3Zm0-21.14h6.84c6.44,0,10.5-4.61,10.5-12.06,0-7.18-3.73-11.45-10.1-11.45h-7.25Z"></path><path d="M354.26,22l-4.95,1.36V47c0,12.87-7.79,19.38-20.05,19.38-13.62,0-20.73-7.86-20.73-20v-23L303.58,22V17.93h22V22l-5.08,1.36V47.74c0,7.25,4.34,12.06,11.45,12.06,6.84,0,11.25-4.47,11.25-11.31V23.35L338.14,22V17.93h16.12Z"></path><path d="M403.85,52.21c0,8.88-7.11,13.14-22,13.14H357.58v-4.2l5.56-1.36V23.35L358.26,22V17.93h23.92c12.6,0,19.51,3.79,19.51,11.72,0,6.17-4.06,9.08-10.91,9.89v.27C399.31,40.76,403.85,45.1,403.85,52.21ZM375,38.32h5.76c6.1,0,9-2.78,9-7.79,0-5.22-3.12-7.59-9-7.59H375Zm16.8,13.41c0-5.62-3.79-8.67-11.25-8.67H375V60.34h6.64C388.07,60.34,391.79,57.29,391.79,51.74Z"></path><path d="M451.07,48.62l-4.4,16.73H408v-4.2l5.28-1.36V23.35L407.65,22V17.93h22.76V22l-5.28,1.36v37l14.16-.81L447,47.26Z"></path><path d="M475.4,61.15v4.2H453v-4.2l5.28-1.36V23.35L453,22V17.93H475.4V22l-5.28,1.36V59.8Z"></path><path d="M478,41.78c0-15.85,12.13-24.86,27-24.86a35.6,35.6,0,0,1,18.29,5.15l-2,13.21h-4.2l-1.69-9.08a13.23,13.23,0,0,0-10.09-4.13c-9.15,0-14.7,6.57-14.7,18.22,0,13.21,6.84,19.31,15.24,19.31,6.17,0,10.23-3.39,13.41-9.55l4.27,2c-4.27,10-11.65,14.36-21.07,14.36C488.4,66.37,478,56.48,478,41.78Z"></path><path d="M574.24,61.15v4.2H551.48v-4.2L557,60l-2.85-8.13h-16.6l-3.12,8.2,5.42,1.15-.07,4.2-16.53-.07v-4.2l4.27-1.08,14.9-37.33-4-1.29V17.93h13.69L569.3,60Zm-27.57-31-.47-1.56-.47,1.56-6.23,16.73h12.94Z"></path></svg></a> <strong class="site-footer__tagline svelte-1ueinol" data-svelte-h="svelte-1xxi0b1">Investigative Journalism in the Public Interest</strong> <p class="site-footer__copyright svelte-1ueinol">© Copyright 2025 Pro Publica Inc.</p></div>   <nav class="site-footer__section-links svelte-1ueinol">   <div class="site-footer__links-sites svelte-1ueinol"> <strong class="site-footer__links-heading svelte-1ueinol">Sites</strong> <ul class="site-footer__links-list svelte-1ueinol hide-below-sm" id="site-footer__links-list-sites"><li class="site-footer__link"><a href="https://www.propublica.org/" class="svelte-1ueinol">ProPublica</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/local-reporting-network/" class="svelte-1ueinol">Local Reporting Network</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/texas/" class="svelte-1ueinol">Texas Tribune Partnership</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/datastore/" class="svelte-1ueinol">The Data Store</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/electionland/" class="svelte-1ueinol">Electionland</a>  </li></ul> </div>   <div class="site-footer__links-sections svelte-1ueinol"> <strong class="site-footer__links-heading svelte-1ueinol">Sections</strong> <ul class="site-footer__links-list svelte-1ueinol hide-below-sm" id="site-footer__links-list-sections"><li class="site-footer__link"><a href="https://www.propublica.org/topics/" class="svelte-1ueinol">Topics</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/series/" class="svelte-1ueinol">Series</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/video/" class="svelte-1ueinol">Videos</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/newsapps/" class="svelte-1ueinol">News Apps</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/getinvolved/" class="svelte-1ueinol">Get Involved</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/nerds/" class="svelte-1ueinol">The Nerd Blog</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/atpropublica/" class="svelte-1ueinol">@ProPublica</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/events/" class="svelte-1ueinol">Events</a>  </li></ul> </div>   <div class="site-footer__links-info svelte-1ueinol"> <strong class="site-footer__links-heading svelte-1ueinol">Info</strong> <ul class="site-footer__links-list svelte-1ueinol hide-below-sm" id="site-footer__links-list-info"><li class="site-footer__link"><a href="https://www.propublica.org/about/" class="svelte-1ueinol">About</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/leadership/" class="svelte-1ueinol">Board and Advisors</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/staff/" class="svelte-1ueinol">Officers and Staff</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/diversity/" class="svelte-1ueinol">Diversity</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/jobs/" class="svelte-1ueinol">Jobs</a> and <a href="https://www.propublica.org/fellowships/" class="svelte-1ueinol">Fellowships</a> </li><li class="site-footer__link"><a href="https://www.propublica.org/media-center/" class="svelte-1ueinol">Media Center</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/reports/" class="svelte-1ueinol">Reports</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/impact/" class="svelte-1ueinol">Impact</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/awards/" class="svelte-1ueinol">Awards</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/corrections/" class="svelte-1ueinol">Corrections</a>  </li></ul> </div>   <div class="site-footer__links-policies svelte-1ueinol"> <strong class="site-footer__links-heading svelte-1ueinol">Policies</strong> <ul class="site-footer__links-list svelte-1ueinol hide-below-sm" id="site-footer__links-list-policies"><li class="site-footer__link"><a href="https://www.propublica.org/code-of-ethics/" class="svelte-1ueinol">Code of Ethics</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/advertising/" class="svelte-1ueinol">Advertising Policy</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/legal/" class="svelte-1ueinol">Privacy Policy</a>  </li></ul> </div>   <div class="site-footer__links-follow svelte-1ueinol"> <strong class="site-footer__links-heading svelte-1ueinol">Follow</strong> <ul class="site-footer__links-list svelte-1ueinol hide-below-sm" id="site-footer__links-list-follow"><li class="site-footer__link"><a href="https://www.propublica.org/newsletters/" data-pp-view="" data-pp-action="visit" class="svelte-1ueinol">Newsletters</a>  </li><li class="site-footer__link"><a href="https://itunes.apple.com/us/app/propublica/id355298887?mt=8" class="svelte-1ueinol">iOS</a> and <a href="https://play.google.com/store/apps/details?id=com.propublica&amp;amp;hl=en" class="svelte-1ueinol">Android</a> </li><li class="site-footer__link"><a href="https://www.propublica.org/feeds/propublica/main" class="svelte-1ueinol">RSS Feed</a>  </li></ul> </div>   <div class="site-footer__links-more svelte-1ueinol"> <strong class="site-footer__links-heading svelte-1ueinol">More</strong> <ul class="site-footer__links-list svelte-1ueinol hide-below-sm" id="site-footer__links-list-more"><li class="site-footer__link"><a href="https://www.propublica.org/tips/" class="svelte-1ueinol">Send Us Tips</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/steal-our-stories/" class="svelte-1ueinol">Steal Our Stories</a>  </li><li class="site-footer__link"><a href="http://p53lf57qovyuvwsc6xnrppyply3vtqm7l6pcobkmyqsiofyeznfu5uqd.onion/" class="svelte-1ueinol">Browse via Tor</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/contact/" class="svelte-1ueinol">Contact Us</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/donate/" data-pp-view="" data-pp-action="visit classy" class="svelte-1ueinol">Donate</a>  </li><li class="site-footer__link"><a href="https://www.propublica.org/support/other-ways-to-give/" class="svelte-1ueinol">More Ways to Give</a>  </li></ul> </div></nav> </div> </div>  </footer>
                        <!--svelte-component-end-->
                        
    <div class="modal-republish | modal -js-hide" tabindex="-1" role="dialog" title="Republish Story" data-pp-location="republish modal">
    <div class="content">

    <div class="modal__header">
        <a class="modal__close-button btn btn--icon-only btn--transparent" style="--button-size: var(--scale3)" href="#" tabindex="0"
            role="button" aria-labelledby="modal-republish__hed" aria-describedby="modal-republish__intro" data-pp-action="republish close">
            <div class="btn__icon" aria-hidden="true">
                
<svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
    <title>Close</title>
    <line x1="18" y1="6" x2="6" y2="18"></line>
    <line x1="6" y1="6" x2="18" y2="18"></line>
</svg>
            </div>
            <span class="a11y">Close this dialogue</span>
        </a>
    </div>
    <!-- end .collapsible-header -->

    <div class="modal-republish__content-wrapper">

        <div class="modal__content modal-republish__content">

            <div class="modal-republish__instructions republish-instructions">

                <h3 id="modal-republish__hed">Republish This Story for Free</h3>

                <p class="modal-republish__license"><a rel="license" href="https://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons License (CC BY-NC-ND 3.0)</a></p>

                <hr/>

                <p id="modal-republish__intro" class="modal-republish__intro">Thank you for your interest in republishing this story. You are free to republish it so long as you do the following:</p>

                <ul>
                    <li>You have to credit <em>ProPublica and any co-reporting partners</em>. In the byline, we prefer “Author Name, Publication(s).” At the top of the text of your story, include a line that reads: “This story was originally published by ProPublica.” You must link the word “ProPublica” to the original URL of the story.</li>

                    <li>If you’re republishing online, you must link to the URL of this story on propublica.org, include all of the links from our story, including our newsletter sign up language and link, and use our <a href="/pixelping">PixelPing tag</a>.</li>

                    <li>If you use canonical metadata, please use the ProPublica URL. For more information about canonical metadata, <a href="https://support.google.com/webmasters/answer/139066?hl=en">refer to this Google SEO link</a>.</li>

                    <li>You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)</li>

                    <li>You cannot republish our photographs or illustrations without specific permission. Please contact <a href="/cdn-cgi/l/email-protection#f8959d9c91998a919f908c8bb8888a97888d9a94919b99d6978a9f"><span class="__cf_email__" data-cfemail="8ee3ebeae7effce7e9e6fafdcefefce1fefbece2e7edefa0e1fce9">[email&#160;protected]</span></a>.</li>

                    <li>It’s okay to put our stories on pages with ads, but not ads specifically sold against our stories. You can’t state or imply that donations to your organization support ProPublica’s work.</li>

                    <li>You can’t sell our material separately or syndicate it. This includes publishing or syndicating our work on platforms or apps such as Apple News, Google News, etc.</li>

                    <li>You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually. (To inquire about syndication or licensing opportunities, contact <a href="/cdn-cgi/l/email-protection#9ef2f7fdfbf0edf7f0f9deeeecf1eeebfcf2f7fdffb0f1ecf9"><span class="__cf_email__" data-cfemail="2945404a4c475a40474e69595b46595c4b45404a4807465b4e">[email&#160;protected]</span></a>.)</li>

                    <li>You can’t use our work to populate a website designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.</li>

                    <li>We do not generally permit translation of our stories into another language.</li>

                    <li>Any website our stories appear on must include a prominent and effective way to contact you.</li>

                </ul>
            </div>

            <div class="modal-republish__section-copy">
                <textarea readonly class="-js-copy-textarea" aria-hidden="true" tabindex="-1"></textarea>
                <a href="#" class="btn -js-copy-btn" style="--button-color: var(--color-accent-50)" data-pp-action="republish copy">Copy HTML</a>
            </div>

        </div>

    </div>

    </div>
</div>
<!-- end #modal-republish -->

          
  
<script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="application/json" class="svelte-config">
                            {"componentName":"BottomPanelCta","props":{"contentUrl":"https://www.propublica.org//api_components/modal-default.json"},"contextArray":[]}
                        </script>
                         <div data-pp-location="modal" data-pp-view data-pp-category="newsletter_signup" id="cta" class="cta cta-type-panel cta-fixed cta-closed svelte-rz6ji1" aria-hidden="true"><button id="cta-close" class="cta-close svelte-rz6ji1" data-svelte-h="svelte-12f7hfy"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svelte-rz6ji1"><line x1="18" y1="6" x2="6" y2="18"></line><line x1="6" y1="6" x2="18" y2="18"></line></svg></button> <div class="cta-container cta-undefined svelte-rz6ji1"><div class="cta-message svelte-rz6ji1"><h2 class="cta-heading svelte-rz6ji1">undefined</h2> <p class="cta-text svelte-rz6ji1">undefined</p></div> </div></div> <div id="cta-toast" class="cta-toast  svelte-rz6ji1" role="alert" style="background-color: var(--blue-70);"><div id="cta-toast-text" class="cta-toast-text svelte-rz6ji1"></div> <button id="cta-toast-button" class="cta-toast-button svelte-rz6ji1" data-svelte-h="svelte-8kx5h6"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svelte-rz6ji1"><line x1="18" y1="6" x2="6" y2="18"></line><line x1="6" y1="6" x2="18" y2="18"></line></svg></button> </div>
                        <!--svelte-component-end-->
                        
    <script type="application/json" class="svelte-config">
                            {"componentName":"GridOverlay","props":{"isVisible":false},"contextArray":[]}
                        </script>
                        <div class="grid-overlay svelte-173h0g9 grid-overlay--hide" data-svelte-h="svelte-110w1v9"><div class="grid-overlay__content svelte-173h0g9"></div> </div>
                        <!--svelte-component-end-->
                        
    <script src="https://assets.propublica.org/static/prod/v5/js/main.ac80f736.js"></script>

            <script>
        // Google Tag Manager
        (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
          new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
          j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
          'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
          })(window,document,'script','dataLayer','GTM-K8BNLGX');
        // End Google Tag Manager

        PP.utils.loadJS('https://ak.sail-horizon.com/spm/spm.v1.min.js',function() {
            while(!window.hasOwnProperty("Sailthru")) {
                setTimeout(Function.prototype(), 500);
            }
            Sailthru.init({ "customerId" : "c1d320b4976cc13366759531bf948c3a" });
        });

        // Parse.ly
                  PP.utils.loadJS('//cdn.parsely.com/keys/propublica.org/p.js');
            </script>
    <!-- GA4 (for no-JS pages) -->
    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-K8BNLGX"
      height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    
    <script>PP.utils.loadJS('https://www.google.com/recaptcha/api.js?onload=grecaptchaLoaded&render=6LcC1roqAAAAAK9equRCqsCagWPYzf79SKrxGFGY');</script>

        <script>
        const noAds = new URLSearchParams(window.location.search).get('__no-ads');
        let adTimeout = new URLSearchParams(window.location.search).get('__ad-timeout');
        if( noAds === null ) {
            if( adTimeout === null ) { adTimeout = 0; }
            setTimeout(function() {
                PP.utils.loadJS('https://htlbid.com/v3/propublica.org/htlbid.js',function() {
                    window.htlbid = window.htlbid || {};
                    htlbid.cmd = htlbid.cmd || [];
                    htlbid.cmd.push(function() {
                        htlbid.layout("universal"); // Leave as "universal" or add custom layout
                                                    htlbid.setTargeting("is_testing", "no");
                                                htlbid.setTargeting("is_home", "no"); // Set to "yes" on the homepage
                        htlbid.setTargeting("post_tags", "health-care");
                    });
                });
            }, adTimeout);
        }
    </script>

    <!-- Begin Convert Experiences code-->
<script>
    // This variable prevents Convert from creating an overlay that can cover the page. Because we use deferred loading, we never want this overlay.
    // https://support.convert.com/hc/en-us/articles/205160025-Disable-Body-Hiding-in-Convert-Experiences
    var _conv_prevent_bodyhide = true;
</script>
<script defer src="//cdn-4.convertexperiments.com/js/1004759-1004714.js"></script>
<!-- End Convert Experiences code -->

        
    <!-- Iterate Code -->

<!-- Iterate baseline styles: additional styles included in pp-v5-shared -->
<style>
.iterate__container {
    font-family: var(--fonts-sans, "graphik") !important;
}
</style>

<script>

// Iterate setup script
window.iterateSettings = {
    apiKey: 'eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJjb21wYW55X2lkIjoiNjJmM2M2ZGNjYmVhNDQwMDAxNDZmMjRjIiwiaWF0IjoxNjYwMTQzMzI1fQ.HJYYZWnRLo7nKQHPteT9eeNeXePWXpYAyhaNyFAES-Y',
};
(function(i,t,e,r,a){if(t.getElementById(r)){return}
i.IterateObjectName=a;var z=function(){z.c(arguments)};z.q=[];
z.c=function(args){z.q.push(args)};i[a]=z;
function l() {var js,fjs=t.getElementsByTagName(e)[0];js=t.createElement(e);js.id=r;js.async=1;js.src="https://platform.iteratehq.com/loader.js";fjs.parentNode.insertBefore(js,fjs)};
if(t.readyState==="complete") {l();} else if(i.attachEvent) {i.attachEvent('onload', l);} else{i.addEventListener('load', l, false);}
}(window, document,'script','iterate-js','Iterate'));

// Start Iterate: this will check the server to see if a survey should be displayed
Iterate('install')

// Pass custom properties to Iterate: the 2nd parameter is user-level data, the 3rd parameter is response-level data
var url = new URL(window.location.href);
Iterate('identify', null, {
    canonical: 'https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma',
    utm_campaign: url.searchParams.get("utm_campaign"),
    utm_medium: url.searchParams.get("utm_medium"),
    utm_source: url.searchParams.get("utm_source")
})

</script>

<!-- End Iterate Code -->

    <script type="text/javascript">
  const forceDark = () => document.documentElement.classList.add("force-dark-mode");
  forceDark();

</script>
<script type="application/ld+json">{"@context":"http://schema.org","@graph":[{"@type":"NewsArticle","author":{"@id":"https://www.propublica.org#identity"},"copyrightHolder":{"@id":"https://www.propublica.org#identity"},"copyrightYear":"2025","creator":["David Armstrong"],"dateCreated":"2025-04-24T15:44:53-04:00","dateModified":"2025-05-07T20:33:20-04:00","datePublished":"2025-05-08T05:00:00-04:00","description":"When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.","headline":"Why Is Cancer Drug Revlimid So Expensive?","image":{"@type":"ImageObject","url":"https://img.assets-c3.propublica.org/images/articles/20250506-revlimid-lead-og.jpg?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=630&imgixProfile=propublicaAssets&q=90&w=1200&s=9e7f0c54edd2b9007de2f93dbfa9efd9"},"inLanguage":"en-us","mainEntityOfPage":"https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma","name":"Why Is Cancer Drug Revlimid So Expensive?","publisher":{"@id":"#creator"},"thumbnailUrl":"https://img.assets-c3.propublica.org/images/articles/20250506-revlimid-lead-og.jpg?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=630&imgixProfile=propublicaAssets&q=90&w=1200&s=9e7f0c54edd2b9007de2f93dbfa9efd9","url":"https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma"},{"@id":"https://www.propublica.org#identity","@type":"NewsMediaOrganization","address":{"@type":"PostalAddress","addressCountry":"US","addressLocality":"New York","addressRegion":"NY","postalCode":"10013","streetAddress":"155 Avenue of the Americas, 13th Floor"},"description":"ProPublica is an independent, non-profit newsroom that produces investigative journalism in the public interest.","email":"info@propublica.org","name":"ProPublica","sameAs":["https://twitter.com/propublica","https://www.facebook.com/propublica/","https://en.wikipedia.org/wiki/ProPublica","https://www.youtube.com/user/propublica","https://github.com/propublica","https://www.linkedin.com/company/propublica/","https://www.instagram.com/propublica","https://www.pinterest.com/propublica","https://vimeo.com/propublica"],"telephone":"1-212-514-5250","url":"https://www.propublica.org"},{"@id":"#creator","@type":"Organization"},{"@type":"BreadcrumbList","description":"Breadcrumbs list","itemListElement":[{"@type":"ListItem","item":"https://www.propublica.org","name":"Homepage","position":1},{"@type":"ListItem","item":"https://www.propublica.org/article/revlimid-price-cancer-celgene-drugs-fda-multiple-myeloma","name":"The Price of Remission","position":2}],"name":"Breadcrumbs"}]}</script></body>
</html>
